dobutamine has been researched along with Cardiac Failure in 736 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 189 (25.68) | 18.7374 |
| 1990's | 192 (26.09) | 18.2507 |
| 2000's | 207 (28.13) | 29.6817 |
| 2010's | 121 (16.44) | 24.3611 |
| 2020's | 27 (3.67) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, PW | 1 |
| Bostwick, JS; Brigance, R; Finlay, HJ; Gargalovic, PS; Generaux, CN; Luk, CE; Meng, W; Onorato, JM; Pi, Z; Rossi, KA; Schumacher, WA; Wang, T; Wexler, RR | 1 |
| Ambinathan, JPN; Burns, KD; Cherney, DZI; Godoy, LC; Lytvyn, A; Lytvyn, Y; Osuntokun, O; Parker, JD; Testani, JM | 1 |
| Ochiai, ME; Pereira Barretto, AC; Silva, EVC; Vieira, KRN | 1 |
| Filipiak, KJ; Gasecka, A; Jaguszewski, MJ; Pruc, M; Rafique, Z; Szarpak, L; Szwed, P | 1 |
| Bandyopadhyay, D; Biswas, S; Briasoulis, A; Fonarow, GC; Goel, A; Gupta, R; Lanier, GM; Malik, AH; Naidu, SS | 1 |
| Bader, I; Bergin, P; Dagan, M; Easton, K; Hare, JL; Kaye, DM; Lankaputhra, M; Leet, A; Linton, A; McLean, C; Patel, HC; Taylor, A; Tee, SL; Yeung, T | 1 |
| Anand, V; Kane, GC; Lee, AT; McCully, RB; Pellikka, PA; Pislaru, C; Pislaru, SV; Scott, CG | 1 |
| Le Jemtel, T; Rajapreyar, I; Samson, R; Stencel, J | 1 |
| Acharya, P; Al-Masry, AA; Bajwa, S; Bakel, AV; Boda, I; Dalia, T; Goyal, A; Mastoris, I; Maurides, S; Noonan, G; Parimi, N; Sami, F; Sauer, A; Shah, Z; Tran, C | 1 |
| Eaton, RE; Haas, GJ; Kissling, KT; McLaughlin, EM; Pickworth, KK | 1 |
| Aydın, C; Kaplangoray, M | 1 |
| Alkadri, J; Hu, R; Jeffers, MS; McDonald, B; McIsaac, DI; Ross, J | 1 |
| Billia, F; Brahmbhatt, DH; Fung, NL; Luis Scolari, F; Luk, A; Mihajlovic, V; Otsuki, M; Overgaard, CB; Rodenas-Alesina, E; Wang, VN | 1 |
| Dong, N; Guo, Q; Lan, H; Li, C; Shi, J; Wang, G; Xiong, T; Zhang, J; Zheng, Q | 1 |
| Fujita, T; Fukushima, N; Fukushima, S; Hada, T; Kainuma, S; Kamiya, H; Kunioka, S; Mochizuki, H; Seguchi, O; Shimojima, M; Tadokoro, N; Tsukamoto, Y; Watanabe, T | 1 |
| AbouEzzeddine, OF; Behfar, A; Borlaug, BA; Chareonthaitawee, P; Fudim, M; Kemp, BJ; Mullan, BP; Pislaru, SV; Redfield, MM | 1 |
| How, OJ; Kildal, AB; Myrmel, T; Rødland, L; Rønning, L | 1 |
| Cheng, J; Kelly, J; Lupi, K; Malloy, R | 1 |
| Araújo, I; Campos, L; Cunha, GJL; Fernandes, L; Ferraz, M; Fonseca, C; Gomes, RV; Morais, R; Rocha, BML | 1 |
| Gyoda, Y; Kawauchi, J; Oikawa, Y; Sakuma, E; Watanabe, J | 1 |
| Agoston, G; Amor, M; Arbucci, R; Barbieri, A; Beleslin, B; Bombardini, T; Borguezan Daros, C; Boshchenko, A; Boskovic, N; Bossone, E; Camarozano, AC; Carpeggiani, C; Celutkiene, J; Ciampi, Q; Citro, R; Colonna, P; Cortigiani, L; Costantino, FM; D'Alfonso, MG; D'Andrea, A; de Castro E Silva Pretto, JL; DE Nes, M; Dekleva, M; DI Salvo, G; Djordjevic-Dikic, A; Dodi, C; Ferrara, F; Gaibazzi, N; Gligorova, S; Gregori, D; Haberka, M; Kasprzak, JD; Kovacevic Preradovic, T; Lattanzi, F; Lowenstein, J; Merlo, PM; Monte, IP; Mori, F; Morrone, D; Nikolic, A; Ostojic, M; Paterni, M; Petrovic, M; Picano, E; Rabia, G; Re, F; Reisenhofer, B; Rigo, F; Rodrìguez-Zanella, H; Ryabova, T; Salamé, M; Salustri, A; Scali, MC; Severino, S; Simova, I; Szymczyk, E; Tesic, M; Torres, MA; Varga, A; Vargas Mieles, PE; Vladova, M; Wdowiak-Okrojek, K; Wejner-Mik, P; Wierzbowska-Drabik, K; Zagatina, A; Zhuravskaya, N | 1 |
| Bottio, T; Gerosa, G; Piperata, A | 1 |
| Jakovljevic, DG; MacGowan, GA; Mungulmare, K; Okwose, NC; Sengupta, SP | 1 |
| Ahn, C; Aronow, WS; Cooper, HA; Gass, AL; Gupta, CA; Khan, MH; Lanier, GM; Levine, A; Lloji, A; Mody, BP; Zaid, S | 1 |
| Cun, Y; Jianlong, W | 1 |
| Alvarez, J; Bettex, D; Bouchez, S; Fruhwald, S; Girardis, M; Grossini, E; Guarracino, F; Heringlake, M; Herpain, A; Pollesello, P; Toller, W; Tritapepe, L | 1 |
| Filipiak, KJ; Gasecka, A; Jaguszewski, MJ; Szarpak, L; Targonski, R | 1 |
| Dadfar, B; Doye, AA; Gwathmey, JK; Jaleel, R; Naushad, J; Parambathazhath, J; Siri-Angkul, N; Xie, LH | 1 |
| Biskupiak, J; Bress, AP; King, JB; Munger, MA; Sainski-Nguyen, A; Shah, RU | 1 |
| Balik, M; Mokotedi, CM | 1 |
| Carpeggiani, C; Ciampi, Q; Michelassi, C; Picano, E; Villari, B | 1 |
| Almeida, I; Caetano, F; Costa, M; Fernandes, A; Gonçalves, L; Madeira, M; Reis, L | 1 |
| Hirai, T; Joho, S; Kinugawa, K; Nakagaito, M; Nakamura, M; Ushijima, R | 1 |
| Ceyssens, W; Dupont, M; Jacobs, L; Luwel, E; Martens, P; Mullens, W; Potargent, P; Renaers, M; Van Aerde, H; Vercammen, J | 1 |
| Gerds, TA; Jakobsen, CJ; Karaliunaite, Z; Nielsen, DV; Skals, RK; Torp-Pedersen, C | 1 |
| Al Madfai, F; Ming, LC; Patel, RP; Peterson, GM; Valah, B; Wanandy, T; Zaidi, STR | 1 |
| Bischoff, E; Boehme, P; Dinh, W; Hoffmann, J; Hüser, J; Kolkhof, P; Mondritzki, T; Park, JW; Sandner, P; Truebel, H; Vogel, J; Walsh, S; White, J | 1 |
| Apostolopoulou, SC; Kakava, F; Rammos, S; Tsoutsinos, A; Vagenakis, GA | 1 |
| Adesiyun, T; Beard, D; Davis, RE; Hashimoto, T; Hendrick, JP; Hoxie, HR; Hsu, S; Kass, DA; Kim, GE; Lee, DI; Nakagawa, R; O'Brien, JJ; Tunin, RS; Wennogle, LP; Yao, W; Zhu, G | 1 |
| Anker, SD; Balligand, JL; Bauersachs, J; Brutsaert, D; Carrier, L; Chlopicki, S; Cleland, JG; de Boer, RA; de Keulenaer, G; Dietl, A; Eschenhagen, T; Fischmeister, R; Hamdani, N; Harjola, VP; Heinzel, FR; Heymans, S; Hilfiker-Kleiner, D; Holzmeister, J; Limongelli, G; Linke, WA; Lund, LH; Lyon, AR; Maack, C; Manstein, DJ; Masip, J; Mebazaa, A; Metra, M; Metzger, J; Mueller, C; Papp, Z; Pieske, B; Ponikowski, P; Ristić, A; Ruschitzka, F; Seferović, PM; Skouri, H; Tocchetti, CG; Yilmaz, MB; Zimmermann, WH | 1 |
| Bakkehaug, JP; How, OJ; Kildal, AB; Myrmel, T; Rødland, L; Rønning, L | 1 |
| Andersson, B; Bartfay, SE; Bergh, N; Bollano, E; Dahlberg, P; Gilljam, T; Hjalmarsson, C; Karason, K; Lannemyr, L; Ljungman, C; Ricksten, SE; Rundqvist, B | 1 |
| Bovenzi, F; Coltelli, M; Cortigiani, L; Picano, E; Ramirez, P | 1 |
| Aggeli, C; Couloheri, S; Dilaveris, P; Gatzoulis, K; Giannoulis, E; Kallikazaros, I; Katsaros, A; Koukos, M; Koutagiar, I; Lagoudakou, S; Margioula, E; Poulidakis, E; Sfendouraki, E; Sideris, S; Stefanadis, C; Tousoulis, D | 1 |
| Ishido, H; Iwamoto, Y; Kuwata, S; Masutani, S; Nishida, T; Saiki, H; Senzaki, H; Taketazu, M | 1 |
| Bellagamba, CCA; Bertoluci, C; Bombardini, T; Camarozano, AC; Ciampi, Q; De Nes, M; Junior, AIH; Picano, E; Quevedo, NM; Texeira, TF; Torres, MAR | 1 |
| B Bastos, M; Brugts, JJ; Bunge, JJH; Constantinescu, AA; Daemen, J; den Uil, CA; Engstrom, AE; Jewbali, LS; Lenzen, MJ; Manintveld, OC; Van Mieghem, NM; Wilschut, JM; Zijlstra, F | 1 |
| Caballero, LG; Clausell, N; Domingues, FB; Goldraich, LA; Hastenteufel, LCT; Neyeloff, JL; Silva, ERRD | 1 |
| Khemka, A; Sawada, SG | 1 |
| Izumi, C | 1 |
| Abe, Y; Arai, K; Ashihara, K; Hagiwara, N; Haze, K; Itoh, A; Naruko, T; Shoda, M; Takagi, A; Yagishita, D; Yagishita-Tagawa, Y; Yoshikawa, J | 1 |
| Barbosa, AC; Oliveira, MG; Passos, LC; Santos, EG | 1 |
| Apitz, C; Binder, W; Hofbeck, M; Kerst, G; Latus, H; Sieverding, L | 1 |
| Ayik, F; Balcioglu, O; Baysal, B; Engin, C; Erkul, S; Oguz, E; Ozbaran, M; Ozturk, P; Yagdi, T | 1 |
| Huang, LQ; Huang, X; Jiang, RL; Lei, S; Xia, GL; Zhi, YH; Zhu, MF | 1 |
| C Marboe, C; Mancini, D; Sugiyama Kato, T; Yoshizawa, S | 1 |
| Carll, AP; Cascio, WE; Costa, DL; Farraj, AK; Haykal-Coates, N; Hazari, MS; King, CJ; Krantz, QT; Perez, CM | 1 |
| Hata, N; Kobayashi, N; Okazaki, H; Shinada, T; Shirakabe, A; Tomita, K; Tsurumi, M; Yamamoto, Y; Yokoyama, S | 1 |
| Chłopicki, S; Drelicharz, L; Heinze-Paluchowska, S; Jabłońska, M; Skórka, T; Tyrankiewicz, U; Woźniak, M | 1 |
| McNally, EM | 1 |
| Garcia-Menendez, L; Gong, G; Karamanlidis, G; Kolwicz, SC; Lee, CF; Morgan, PG; Sedensky, MM; Suthammarak, W; Tian, R; Wang, W | 1 |
| Barrett, NA; Berry, WT; Hewson, RW; Langrish, CJ; McKenzie, CA | 1 |
| Bacaksiz, A; Erdogan, E; Ergelen, M; Erturk, M; Karakurt, H; Sonmez, O; Tasal, A; Turfan, M; Uyarel, H; Vatankulu, MA | 1 |
| Balk, AH; Caliskan, K; Constantinescu, AA; Jewbali, L; Manintveld, OC; van Domburg, R | 1 |
| Mitro, P; Murin, P; Simurda, M; Valocik, G | 1 |
| Gu, Y; Niu, HY; Pan, HY; Pan, M; Yu, XH; Zhu, JH | 1 |
| Baleine, J; Cambonie, G; de la Villéon, G; Durand, S; Jacquot, A; Milesi, C; Novais, AR; Roujeau, T | 1 |
| Barretto, AC; Brancalhão, EC; Cardoso, JN; Ochiai, ME; Oliveira, MT; Puig, RS; Vieira, KR | 1 |
| Akturk, IF; Birant, A; Erturk, M; Karakurt, H; Kurtar Mansıroglu, A; Oner, E; Somuncu, MU; Uzun, F; Yalcin, AA; Yildirim, A | 1 |
| Cavusoglu, Y; Mert, U; Morrad, B; Mutlu, F; Nadir, A; Ulus, T | 1 |
| Cepeda, JM; Conthe, P | 1 |
| Chivite, D; Corbella, X; Formiga, F | 1 |
| Mitro, P; Murín, P; Spurný, P; Valocik, G | 1 |
| Butterick, TA; Cabrera, JA; Duffy, CM; Holley, CT; Kelly, RF; Lindsey, ME; Long, EK; McFalls, EO; Ward, HB | 1 |
| Czer, LS; Lee, CC; Luthringer, DJ | 1 |
| Balestra, GM; Eerbeek, O; Mik, EG; Specht, PA; van der Laarse, WJ; Zuurbier, CJ | 1 |
| Abroug, F; Dachraoui, F; Fekih-Hassen, M; Ouanes Besbes, L; Ouanes, I; Souheil, E | 1 |
| Andersen, MJ; Borlaug, BA; Fetterly, K; Hwang, SJ; Kane, GC; Melenovsky, V; Olson, TP | 1 |
| Abdellatif, M; Falcão-Pires, I; Fontoura, D; Leite, S; Leite-Moreira, AF; Lourenço, AP; Oliveira-Pinto, J; Tavares-Silva, M | 1 |
| Arai, M; Horiguchi, J; Koitabashi, N; Kurabayashi, M; Ohyama, Y; Rokutanda, N; Tateno, R | 1 |
| Charles, CJ; Ellmers, LJ; Mark Richards, A; Rademaker, MT | 1 |
| Shan, YX; Wang, XC; Zhu, DM | 1 |
| Mittal, M; Radhakrishnan, M; UmamaheswaraRao, GS | 1 |
| Çavuşoğlu, Y; Demirtaş, S; Gencer, E; Güneş, H; Kalaycı, S; Korkmaz, Ş; Mert, UK; Mutlu, F; Özdemir, S; Şaşmaz, H; Yılmaz, MB | 1 |
| Ban, T; Chen, H; Chen, WR; Fan, Y; Li, BY; Qiao, QF; Sun, HL; Yan, ZY | 1 |
| Al-Hesayen, A; Cherney, DZ; Floras, JS; Gilbert, C; Mak, S; Parker, AB; Parker, JD | 1 |
| Bode, EF; Borland, SJ; Briston, SJ; Dibb, KM; Horn, MA; Kirkwood, GJ; Richards, MA; Trafford, AW | 1 |
| Acharya, D; Hashim, T; Loyaga-Rendon, RY; Morgan, CJ; Pamboukian, SV; Revilla-Martinez, M; Sanam, K; Tallaj, JA | 1 |
| Ertl, G; Pauschinger, M; von Scheidt, W | 1 |
| Harjola, VP; Kivikko, M; Nieminen, MS; Pollesello, P; Sarapohja, T; Tarvasmäki, T | 1 |
| Dupont Birkler, RI; Frederiksen, CA; Heiberg, J; Hyldebrandt, JA; Johannsen, M; Ravn, HB; Schmidt, MR; Støttrup, NB | 1 |
| Bauersachs, J; Bengel, FM; Bogeski, I; Erschow, S; Haghikia, A; Hagl, C; Hilfiker-Kleiner, D; Jauhiainen, M; Kappl, R; Knuuti, J; Kohlhaas, M; Maack, C; Müller, M; Nickel, AG; Pietzsch, S; Ricke-Hoch, M; Roivainen, A; Saar, JA; Saraste, A; Scherr, M; Sieve, I; Silvola, JM; Stapel, B; Thackeray, JT; Tudorache, I | 1 |
| Brugaletta, S; Comerci, G; Di Giannuario, G; Forni, F; Lombardo, A; Loperfido, F; Lotrionte, M; Marchese, N; Natali, R; Pisanello, C; Savino, M; Vigna, C | 1 |
| Anastasiou-Nana, M; Dimopoulos, S; Gerovasili, V; Kaldara, E; Kourtidou, S; Nanas, J; Nanas, S; Pierrakos, C; Roussos, C; Sarafoglou, S; Venetsanakos, J | 1 |
| Bacal, F; Bocchi, EA; Cardoso, LF; Ferreira, SM; Grativvol, PS; Mangini, S; Mocelin, AO; Seguro, LF; Silva, CP; Silveira, FS | 1 |
| Carlson, M; Jones, JA; Ma, YJ; Rajagopalan, V; Zucker, IH | 1 |
| Amour, J; Coriat, P; Ibanez-Esteve, C; Langeron, O; Nicolas-Robin, A; Riou, B | 1 |
| Akyuz, S; Alioglu, E; Bozkaya, YT; Duygu, H; Gunduz, R; Kirilmaz, B; Ozdogan, O; Payzin, S; Turk, U; Turkoglu, C | 1 |
| Bulsara, M; Chamberlain, J; Harding, R; Ho, KM | 1 |
| Bistola, V; Filippatos, G; Ikonomidis, I; Kremastinos, DT; Papadopoulos, C; Paraskevaidis, IA; Parissis, JT | 1 |
| Fischer, G; Stephani, U; van Baalen, A; von Spiczak, S | 1 |
| Blake, SL; Bloch, KD; Brownell, AL; Buys, ES; Derumeaux, G; Kaneki, M; Kuruppu, D; Picard, MH; Raher, MJ; Rieusset, J; Scherrer-Crosbie, M; Shimizu, N; Thibault, HB | 1 |
| Akilli, A; Akin, M; Duygu, H; Ergene, O; Erturk, U; Nalbantgil, S; Nazli, C; Ozerkan, F; Zoghi, M | 1 |
| Donati, A; Elisei, D; Falzetti, G; Pelaia, P; Principi, T | 1 |
| Mebazaa, A; Paraskevaidis, I; Parissis, JT; Rafouli-Stergiou, P | 1 |
| Cleland, JG; Cohen-Solal, A; Filippatos, GS; Huang, B; Mebazaa, A; Nieminen, MS; Padley, RJ; Salon, JE; Thakkar, R | 1 |
| Erdem, A; Karadas, F; Tandogan, I; Turgut, OO; Yalta, K; Yilmaz, A; Yilmaz, MB; Yontar, C | 2 |
| Bonios, M; Drakos, SG; Kaldara, E; Kanakakis, JV; Katsaros, F; Nanas, JN; Nanas, S; Pantsios, C | 1 |
| Blair, JE; Filippatos, GS; Gheorghiade, M; Harinstein, ME; Khan, H; Metra, M; Porchet, H; Sabbah, HN; Valentini, G; Vogel, M | 1 |
| Ciampi, Q; Citro, R; Piacenti, M; Picano, E; Pratali, L; Villari, B | 1 |
| Donlan, SM; Gheorghiade, M; Pang, PS; Quattromani, E | 1 |
| Chay Woodward, T; de Lissovoy, G; Fraeman, K; Salon, J; Sterz, R | 1 |
| Cai, D; Cohen-Solal, A; Huang, B; Logeart, D; Mebazaa, A; Nieminen, MS | 1 |
| Böhm, M; Link, A; Reil, JC; Selejan, S | 1 |
| Boyd, JH; Indrambarya, T; McConechy, M; Walley, KR; Wang, Y | 1 |
| Bodi, V; Chaustre, F; Chorro, FJ; Forteza, MJ; Husser, O; Llacer, A; Lopez-Lereu, MP; Mainar, L; Monmeneu, JV; Nunez, J; Rumiz, E; Sanchis, J; Trapero, I | 1 |
| Wu, KC | 1 |
| Braz, JC; Corbly, AK; Gill, RM; Jin, N; Jones, BD; Shen, W; Vlahos, CJ; Wu, Q | 1 |
| Chughtai, H; Dall'Armellina, E; Hamilton, CA; Hundley, WG; Kitzman, DW; Link, KM; Morgan, TM; Ntim, W; Walsh, TF | 1 |
| Blier, L; Champagne, J; Dubois, M; Dumesnil, JG; Garceau, P; Lancellotti, P; Magne, J; Molin, F; O'Hara, G; Philippon, F; Pierard, L; Sénéchal, M | 1 |
| Kiviniemi, V; Kurola, J; Leppikangas, H; Lindgren, L; Ruokonen, E; Rutanen, J | 1 |
| Chu, EC; Gorodeski, EZ; Hsich, E; Reese, JR; Shishehbor, MH; Starling, RC | 1 |
| Kato, M; Kitakaze, M; Sanada, S | 1 |
| Bilgehan, K; Duman, D; Palit, F; Sacide, A; Simsek, E | 1 |
| Cas, LD; Cotter, G; Gheorghiade, M; Metra, M; Sabbah, HN; Teerlink, JR; Zacà, V | 1 |
| Bertoletti, L; Humbert, M; Jaïs, X; Price, LC; Simonneau, G; Sitbon, O; Souza, R; Sztrymf, B | 1 |
| Bombardini, T; Ciampi, Q; Della Porta, M; Petruzziello, B; Picano, E; Pratali, L; Sicari, R; Villari, B | 1 |
| Lage, SG; Lagudis, S; Mansur, AJ; Medeiros, CC; Vieira, ML; Yamada, AT | 1 |
| Agresti, C; Baroncini, C; Caldi, F; Innocenti, F; Mannucci, E; Monami, M; Pini, R | 1 |
| Omerovic, E; Swedberg, K; Waagstein, F | 1 |
| Andersson, B; Bergh, CH; Dahlström, U; Forfang, K; Kivikko, M; Sarapohja, T; Ullman, B; Wikström, G | 1 |
| Barretto, AC; Cardoso, JN; Morgado, PC; Munhoz, RT; Ochiai, ME; Ramires, JA | 1 |
| Alexander, PM; Butt, WW; Penny, DJ; Ryerson, LM; Shann, FA; Shekerdemian, LS | 1 |
| Azam, S; Berthiaume, JM; Bray, MS; Chandler, MP; Chen, X; Hoit, BD; McElfresh, TA; Young, ME | 1 |
| Campia, U; Gheorghiade, M; Nodari, S | 1 |
| Bauer, R; Blain, A; Bushby, K; Greally, E; Laval, S; Lochmüller, H; MacGowan, GA; Straub, V | 1 |
| Wikström, BG | 1 |
| Ayub-Ferreira, SM; Bacal, F; Bocchi, EA; Mangini, S; Marcondes-Braga, FG | 1 |
| Barretto, AC; Brancalhão, EC; Cardoso, JN; Grativvol, KM; Grativvol, PS; Lima, MV; Morgado, PC; Munhoz, RT; Ochiai, ME; Scipioni, AR | 1 |
| Gjessing, PF; Hermansen, SE; How, OJ; Kildal, AB; Myrmel, T; Røsner, A; Stenberg, TA | 1 |
| Cui, L; Hao, YM; Jiang, DJ; Li, GP; Li, HM; Liu, J; Qi, GX; Wang, L; Wang, WZ; Wei, JP; Zhang, YD | 1 |
| Kawada, T; Sugimachi, M; Sunagawa, K; Uemura, K | 1 |
| Erdem, A; Tandogan, I; Yalta, K; Yilmaz, MB; Yontar, OC | 1 |
| Coons, JC; McGraw, M; Murali, S | 1 |
| Anastasiou-Nana, M; Bistola, V; Ikonomidis, I; Papadopoulos, C; Paraskevaidis, IA; Parissis, J; Stassinos, V | 1 |
| Ata, N; Birdane, A; Cavuşoğlu, Y; Demirüstü, C; Göktekin, Ö; Görenek, B; Tek, M; Ünalır, A | 1 |
| Böhm, M; Cai, D; Cohen Solal, A; Filippatos, GS; Huang, B; Kivikko, M; Link, A; Mebazaa, A; Nieminen, MS; Padley, RJ; Salem, R | 1 |
| Ashley, EA; Denault, AY; Deschamps, A; Haddad, F; Haddad, H; Vrtovec, B | 1 |
| Charoenpanichkit, C; Dall'Armellina, E; Hamilton, CA; Hundley, WG; Little, WC; Mandapaka, S; Morgan, TM | 1 |
| Chiribiri, A; Egnell, C; Fleck, E; Gebker, R; Hamdan, A; Jahnke, C; Kelle, S; Klein, C; Paetsch, I; Vierecke, J; Wellnhofer, E | 1 |
| Garot, J; O h-Ici, D | 1 |
| Cheng, XW; Funahashi, H; Hirashiki, A; Inden, Y; Izawa, H; Murohara, T; Nomura, M | 1 |
| Arai, AE; Schwitter, J | 1 |
| Bettari, L; Bugatti, S; Carubelli, V; Danesi, R; Dei Cas, L; Lazzarini, V; Lombardi, C; Metra, M; Monti, A; Villa, C | 1 |
| Ding, ZM; Hansen, G; Read, RW; Shi, ZZ; Van Sligtenhorst, I; Vogel, P | 1 |
| Altman, RK; Chen-Tournoux, AA; McCarty, D; Orencole, M; Park, MY; Picard, MH; Riedl, L; Singh, JP; Tournoux, FB | 1 |
| Ekholm, S; Germin, BI; Hu, R; Huang, Y; Kolar, B; Liu, X; Tian, W; Zhong, J | 1 |
| Brasolin, B; Bruno, N; Caira, C; D'Ambrosi, A; Fedele, F; Mancone, M | 1 |
| Montalto, M | 1 |
| Barbosa, AC; Passos, LC; Santos, EG | 1 |
| Burger, AJ; Josephson, ME; Mittleman, MA; Nearing, BD; Verrier, RL; Wellenius, GA | 1 |
| Delaney, A; McCaffrey, J; Tacon, CL | 1 |
| Aquaro, GD; Cospite, V; De Marchi, D; Emdin, M; Gallotta, M; L'Abbate, A; Lionetti, V; Lombardi, M; Lorenzoni, V; Molinaro, S; Passino, C; Pingitore, A | 1 |
| Jovicić, B; Kosutić, J; Nikolić, L; Prijić, S; Rakić, S; Stajević, M; Vukomanović, V | 1 |
| Akki, A; Caceres, V; Chacko, VP; Foster, DB; Gerstenblith, G; Gupta, A; Kirk, JA; Lai, S; Leppo, MK; Paolocci, N; Shi, S; Steenbergen, C; Su, J; Wang, Y; Weiss, RG | 1 |
| Borlu, F; Dal, MS; Oztekin, E; Paksoy, F; Tursun, I; Ulaş, T | 1 |
| Bonadei, I; Bugatti, S; Caretta, G; D'Aloia, A; Dei Cas, L; Vizzardi, E; Zanini, G | 1 |
| Nagdev, A; Sivitz, A | 1 |
| Fujiwara, H; Fukuhara, R; Miyamoto, T; Nishi, K; Saijo, S; Sato, Y; Takatsu, Y; Taniguchi, R; Toma, M | 1 |
| Alalawi, R; Alexopoulos, D; Davlouros, P; Jumper, C; Karabinis, A; Karakitsos, D; Papanikolaou, J; Wachtel, M | 1 |
| Besancon, A; de Haro, L; Glaizal, M; Hayek-Lanthois, M; Klouche, K; Schmitt, C; Tichadou, L | 1 |
| An, T; Huang, Y; Lü, R; Qing, EM; Qing, P; Wei, BQ; Zhang, J; Zhang, YH; Zhou, Q; Zou, CH | 1 |
| Bai, XJ; Huang, Y; Jiang, YN; Li, H; Liu, WX; Qing, EM; Qu, P; Sun, YX; Wei, BQ; Zhang, J; Zhang, L; Zhang, YH; Zhou, Q | 1 |
| Amir, O; Zafrir, B | 1 |
| Bonadei, I; Bugatti, S; Curnis, A; D'Aloia, A; Dei Cas, L; Del Magro, F; Rovetta, R; Vizzardi, E | 1 |
| Hirayama, A; Kato, M | 1 |
| Chaanine, AH; Chemaly, ER; Hajjar, RJ; Sakata, S | 1 |
| Cai, D; Cohen-Solal, A; Deye, N; Kivikko, M; Laribi, S; Laterre, PF; Mebazaa, A; Nikolaou, M; Parissis, J; Paugam-Burtz, C; Poder, P; Pohjanjousi, P; Seronde, MF; Yilmaz, MB | 1 |
| Chlopicki, S; Jablonska, M; Petkow-Dimitrow, P; Skorka, T; Tyrankiewicz, U | 1 |
| Apajasalo, M; D'Ambrosi, A; Fedele, F; Lucioni, C; Mazzi, S; Pollesello, P | 1 |
| Abe, T; Kobayashi, S; Misawa, H; Sakata, S; Tabayashi, N; Takaki, M; Takenaka, C; Taniguchi, S; Yoshikawa, Y | 1 |
| Blackburn, B; Chandler, MP; Morita, H; Roth, BA; Sabbah, HN; Stanley, WC; Suzuki, G; Wolff, A | 1 |
| Reek, S | 1 |
| Bristow, MR; D'Aloia, A; Dei Cas, L; Metra, M; Muneretto, C; Nodari, S; Robertson, AD | 1 |
| Himura, Y; Kashiki, M; Liang, CS; Stevens, SY | 1 |
| Corbly, AK; Gill, RM; Jones, BD; Shen, W; Steinberg, MI; Zhang, JP | 1 |
| Böhm, M | 1 |
| Akintürk, H; Benson, M; Bräu, M; Hempelmann, G; Junger, A; Kwapisz, MM; Müller, M; Schindler, E | 1 |
| Duboc, D | 1 |
| Burger, AJ; Cheng, ML; Dennish, G; Dinerman, J; Elkayam, U; Ghali, JK; Horton, DP; Koren, M; LeJemtel, T; Silver, M; Torre, G | 1 |
| Allanic, L; Da Conceiçao, M; Fassassi, M; Favier, JC; Pitti, R; Steiner, T | 1 |
| Asanoi, H; Inoue, H; Ishizaka, S; Joho, S; Kameyama, T | 1 |
| Cerný, J; Frélich, M; Groch, L; Hude, P; Krejcí, J; Meluzín, J; Panovský, R; Rambousková, L; Spinarová, L; Stetka, F; Toman, J | 1 |
| Apajasalo, M; Cleland, JG; Kobelt, G; Takala, A; Zethraeus, N | 1 |
| Gattis, WA; Gheorghiade, M; Jain, P; Klein, L; Massie, BM | 1 |
| Adams, KF; Gheorghiade, M; Mathur, VS | 1 |
| Adams, KF; Gattis, WA; Gheorghiade, M; Jaffe, AS; O'Connor, CM | 1 |
| Felker, GM; O'connor, CM | 1 |
| Aranda, JM; Cleeton, TS; Hill, JA; Leach, D; Lopez, LM; Monroe, VS; Pauly, DF; Schofield, RS; Walker, TC | 1 |
| Bax, JJ; Borghetti, A; De Sutter, J; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; van Domburg, RT; Vourvouri, EC | 1 |
| Edwards, N; Hankins, S; Hauff, H; Lang, CC; Mancini, DM; Maybaum, S | 1 |
| Gronda, E; Mangiavacchi, M | 1 |
| Chatterjee, K; De Marco, T | 1 |
| Aronson, D; Burger, AJ | 3 |
| Rich, MW; Shore, BL | 1 |
| Andersson, B; Bollano, E; Hjalmarson, A; Täng, MS; Waagstein, F | 1 |
| Chana, JS; Kocheril, AG; Moazemi, K; Willard, AM | 1 |
| Aronson, D; Burger, AJ; Burger, MR; Horton, DP | 1 |
| Aranda, JM; Hill, JA; Hsu, K; Pauly, DF; Schofield, R | 1 |
| Castelli, G; Dolara, A; Favilli, S; Mori, F; Olivotto, I; Zuppiroli, A | 1 |
| Stevenson, LW | 1 |
| Adamson, PB; Carminati, P; Gagnol, JP; Germany, R; Mattera, GG; Schwartz, PJ; Vanoli, E | 1 |
| Bender, C; Braun, K; Dittrich, S; Germanakis, I; Hentschel, R; Kececioglu, D | 1 |
| Carron, C; Gibbons, W; López-Candales, A; Schwartz, J; Simmons, P; Vora, T | 1 |
| Burger, AJ; Ciesla, G; de Lissovoy, G; Munger, M; Stier, DM | 1 |
| Boldt, J; Kirchner, J; Lehmann, A | 1 |
| Burger, AJ; Silver, MA | 1 |
| Mak, S; Newton, GE | 1 |
| Somers, VK; van de Borne, P; Velez-Roa, S | 1 |
| Campana, C; Constantin, C; Fontana, A; Ghio, S; Klersy, C; Raineri, C; Tavazzi, L | 1 |
| Appleton, C; DeMaria, A; Eichhorn, EJ; Frantz, R; Grayburn, PA; Greenberg, B; Krause-Steinrauf, H; Mayer, SA; Oh, J; Plehn, J; St John Sutton, M | 1 |
| Degaute, JP; Renard, M; van de Borne, P; Velez-Roa, S | 1 |
| Follath, F | 1 |
| Anifantakis, A; Athanassopoulos, G; Chatzigeorgiou, G; Cokkinos, DV; Iakovis, P; Karatasakis, G; Koutsogiannis, N; Manginas, A; Maounis, T; Papadakis, M; Spargias, KS | 1 |
| Adamopoulos, S; Karatzas, D; Kremastinos, DT; Paraskevaidis, IA; Tsiapras, D | 1 |
| Carron, C; López-Candales, AL; Schwartz, J | 1 |
| Doi, M; Kobayashi, S; Kohno, M; Matsuzaki, M; Oda, T; Ohkusa, T; Okuda, S; Tokuhisa, T; Yamamoto, T; Yano, M | 1 |
| Kaplinsky, EJ; Manito, N; Pujol, R | 1 |
| Airaksinen, KE; Bax, JJ; Engblom, E; Kalliokoski, R; Knuuti, J; Koistinen, J; Naum, A; Nekolla, SG; Stolen, KQ; Sundell, J; Ylitalo, A | 1 |
| Katz, SD; Lee, FA; Nystrom, K; Saldarriaga, C; Sedrakyan, A; Upadya, S; Verma, S | 1 |
| Habet, KJ | 1 |
| Anastasiou-Nana, MI; Kanakakis, J; Moon, T; Nanas, JN; Nanas, SN; Terrovitis, JV; Tsagalou, EP | 1 |
| Sharma, M; Teerlink, JR | 1 |
| Azar, R; Barsumau, J; Decaudin, B; Horrent, S; Odou, P; Vairon, MX; Wierre, L | 1 |
| Doverspike, A; Hentosz, T; Huerbin, R; Mathier, MA; Nikolaidis, LA; Shannon, RP; Shen, YT; Trumble, D | 1 |
| Buttrick, PM; Geenen, DL; Goldspink, PH; McKinney, RD; Montgomery, DE; Solaro, RJ; Urboniene, D; Walker, LA | 1 |
| Ahluwalia, MS; Butany, J; El Demellawy, D; Graba, J; Nair, V; Rao, V; Ross, H | 1 |
| Andrisin, TE; Aquilante, CL; Hamilton, KK; Humma, LM; Johnson, JA; Lewis, JF; Yarandi, HN | 1 |
| Bendall, JK; Damy, T; Heymes, C; Loyer, X; Marotte, F; Marty, I; Milliez, P; Monceau, V; Ratajczak, P; Robidel, E; Samuel, JL | 1 |
| Badagliacca, R; Fedele, F; Sciomer, S; Vizza, CD | 1 |
| Feinberg, MS; Freimark, D; Hochberg, N; Matezky, S; Shechter, M | 1 |
| Agrios, N; Anastasiou-Nana, MI; Christodoulou, K; Dalianis, A; Kanakakis, J; Nanas, JN; Papazoglou, PP; Terrovitis, JV; Tsagalou, EP; Tsolakis, E | 1 |
| Papalia, U; Puddu, PE; Schiariti, M; Usta, C | 1 |
| Barzilai, B; Gage, BF; Gleva, MJ; Katsiyiannis, WT; Lindsay, BD; Rogers, JG; Sanchez, JM; Waggoner, AD | 1 |
| Bove, T; Crivellari, M; Landoni, G; Zangrillo, A | 1 |
| Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Ntalianis, A; Papazoglou, P; Terrovitis, JV; Tsagalou, EP; Tsolakis, E | 1 |
| Hausmann, H; Hennig, F; Hetzer, R; Lehmkuhl, HB; Potapov, EV; Sodian, R; Volk, HD; Wagner, FD | 1 |
| Sackner-Bernstein, JD | 1 |
| Andreadou, I; Androulakis, A; Avgeropoulou, C; Demopoulou, M; Kallikazaros, I; Markantonis-Kyroudis, S; Missovoulos, P | 1 |
| Dean, AS; Gaughan, JP; Libonati, JR; Margulies, KB; Nicholas, JJ; Rubin, S | 1 |
| Buttrick, PM; de Tombe, PP; Geenen, DL; Goldspink, PH; Montgomery, DE; Rundell, VL; Urboniene, D | 1 |
| Bloem, LJ; Gill, RM; Higgins, MA; Ingwall, JS; Jin, N; Ryan, TP; Shen, W; Spindler, M | 1 |
| Abraham, WT; Adams, KF; Berkowitz, RL; Cheng, ML; Costanzo, MR; Fonarow, GC; LeJemtel, TH; Wynne, J | 1 |
| Dec, GW | 1 |
| Mak, S; Newton, GE; Overgaard, CB | 1 |
| Barretto, AC; Canaviera, R; Follador, W; Martins, ML; Oliveira, MT; Scipioni, A; Tsuji, RL | 1 |
| Reingardiene, D | 1 |
| Cittadini, A; Condorelli, G; Di Gianni, A; Di Rella, F; Iaccarino, G; Monti, MG; Peschle, C; Saccà, L; Sorriento, D; Strömer, H; Trimarco, B; Tsichlis, PN | 1 |
| Bax, JJ; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, F; van Domburg, RT | 1 |
| Gortney, JS; Porter, KB | 1 |
| Burger, AJ | 1 |
| Adams, KF; Gattis Stough, W; Gheorghiade, M; Hasselblad, V; Jaffe, AS; O'Connor, CM | 1 |
| Bayram, M; De Luca, L; Gheorghiade, M; Massie, MB | 1 |
| Barraud, D; Mebazaa, A; Welschbillig, S | 1 |
| Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Papazoglou, PD; Terrovitis, JV; Toumanidis, S; Tsagalou, EP; Tsolakis, EJ | 1 |
| Bax, JJ; Boersma, E; de Roos, A; Kaandorp, TA; Lamb, HJ; van der Wall, EE; Viergever, EP | 1 |
| Hidaka, I; Kamiya, A; Kawada, T; Shimizu, S; Shishido, T; Sugimachi, M; Sunagawa, K; Uemura, K; Yoshizawa, M | 1 |
| Ducharme, A; Guertin, MC; He, Y; Ibrahim, R; Lavoie, J; Racine, N; Rouleau, JL; Schiffrin, EL; Touyz, RM; White, M; Whittom, L; Yao, G | 1 |
| Gerhard, T; Hartzema, AG; Winterstein, AG; Zineh, I | 1 |
| Atar, D; Hodt, A; Steine, K | 1 |
| Brodde, OE; Bruck, H; Leineweber, K | 1 |
| Adamopoulos, S; Farmakis, D; Filippatos, GS; Gheorghiade, M; Iliodromitis, EK; Karatzas, D; Kremastinos, DT; Paraskevaidis, I; Parissis, JT; Tsiapras, D | 1 |
| Hennersdorf, M; Müller, K; Peters, A; Strauer, BE; Zeus, T | 1 |
| Arnold, LM; Carroll, NV; Crouch, MA; Oinonen, MJ | 1 |
| Bangalore, S; Chaudhry, FA; Hematpour, K | 1 |
| Brimioulle, S; Demester, JP; Fesler, P; Huez, S; Kerbaul, F; Naeije, R; Rondelet, B | 1 |
| Kurien, S; Miller, WL; Warfield, KT; Wood, CM | 1 |
| Deftereos, D; McKechnie, R; Norton, GR; Osadchii, OE; Woodiwiss, AJ | 1 |
| George, A; Hauptman, PJ; Hoover, R; Mikolajczak, P; Mohr, CJ; Schnitzler, MA; Swindle, J | 1 |
| Gotthardt, M; Granzier, H; Labeit, S; Molkentin, JD; Peng, J; Raddatz, K; Wu, Y | 1 |
| Akilli, A; Akin, M; Duygu, H; Ergene, O; Nalbantgil, S; Nazli, C; Ozerkan, F; Zoghi, M | 1 |
| Khoury, DS; Nagueh, SF; Thohan, V; Torre-Amione, G; Wang, J | 1 |
| Cavusoglu, Y | 1 |
| Barraud, D; Damy, T; Faivre, V; Gayat, E; Heymes, C; Mebazaa, A; Payen, D; Shah, AM; Welschbillig, S | 1 |
| Erdem, A; Karadas, F; Tandogan, I; Yilmaz, MB | 1 |
| Berg, AM; Mahle, WT; Snell, L | 1 |
| Cohen-Solal, A; Kivikko, M; Kleber, FX; Mebazaa, A; Nieminen, MS; Packer, M; Padley, RJ; Pocock, SJ; Põder, P; Thakkar, R | 1 |
| Aaronson, K; Frazier, OH; Mancini, D; Margulies, K; Maybaum, S; McRee, S; Miller, LW; Pagani, FD; Starling, RC; Torre-Amione, G; Xydas, S | 1 |
| Farmakis, D; Nieminen, M; Parissis, JT | 1 |
| Barr, M; Bourge, RC; Jessup, ML; Lilly-Hersley, J; Linde, P; Mancini, D; McCluskey, T; Mehra, MR; Radovancevic, B; Rayburn, B; Taylor, DO | 1 |
| Kagaya, Y | 1 |
| Iino, K; Ito, H | 1 |
| Kajimoto, K; Kawana, M; Watanabe, H | 1 |
| Bars, C; Dubois-Randé, JL; Elbaz, N; Guéret, P; Hamdaoui, B; Lellouche, N; Lim, P; Mitchell-Heggs, L; Roiron, C | 1 |
| Barold, SS; Cutro, R; Dewhurst, R; Herweg, B; Ilercil, A; Krishnan, S; Weston, M | 1 |
| Butler, J; Giamouzis, G; Giannakoulas, G | 1 |
| Hata, K; Hirata, K; Inoue, N; Masai, H; Matsumoto, D; Matsumoto, H; Otake, H; Ozawa, T; Shinke, T; Shite, J; Takaoka, H; Watanabe, S; Yokoyama, M; Yoshikawa, R | 1 |
| Akilli, A; Akin, M; Duygu, H; Ergene, O; Nalbantgil, S; Nazli, C; Ozerkan, F; Yildiz, A; Zoghi, M | 1 |
| Azevedo, CH; Bacal, F; Bocchi, EA; Carneiro, RM; Chizzola, PR; Ferreira, SM; Issa, VS; Mangini, S | 1 |
| Damman, K; Voors, AA | 1 |
| Bax, JJ; Bleeker, GB; Holman, ER; Schalij, MJ; Sieders, A; van der Wall, EE; Ypenburg, C | 1 |
| van der Wall, EE; Verwey, HF; Ypenburg, C | 1 |
| Brügemann, J; de Jonge-Weber, AT; Rienstra, M; van den Broek, SA; van Veldhuisen, DJ; Zijlstra, F | 1 |
| Bartunek, J; de Bruyne, B; Delrue, L; Goethals, M; Mullens, W; Vanderheyden, M; Verstreken, S; Wijns, W | 1 |
| Chu, AL; Chun, J; Elsherif, L; Huang, MS; Kaufman, SJ; Li, RY; Mekany, MA; Ross, RS; Shai, SY; Yang, Y | 1 |
| Komamura, K; Matsuo, H; Sasaki, T | 1 |
| Alamgir, MF; Chattopadhyay, S; Clark, AL; Cleland, JG; Fraser, AG; Nikitin, NP | 1 |
| Haritakis, CN; Nyktari, EG; Parthenakis, FI; Patrianakos, AP; Vardas, PE; Zacharis, EA | 1 |
| Dalampiras, P; Kelepeshis, G; Sitafidis, G; Skoularigis, J; Triposkiadis, F | 1 |
| Al-Hesayen, A; Parker, JD | 1 |
| Du, J; Feng, HZ; Gobara, N; Hossain, MM; Huang, XP; Jean-Charles, PY; Jin, JP; Li, Y; Liu, J; Zhang, C | 1 |
| Agha, SA; Butler, J; Georgiopoulou, V; Giamouzis, G; Giannakoulas, G; Kalogeropoulos, A; Karvounis, H; Tsarpalis, K | 1 |
| Celik, T; Iyisoy, A; Kardesoglu, E; Yuksel, UC | 1 |
| Roberts, R | 2 |
| Carlier, J; Cremers, S; D'Orio, V; el Allaf, D | 1 |
| Sharpe, DN | 1 |
| Baumann, G; Permanetter, B; Wirtzfeld, A | 1 |
| Klein, G; Schnelle, K; Wirtzfeld, A | 1 |
| Shevchenko, VA | 1 |
| Storstein, L; Taylor, SH | 1 |
| Bodem, G; Ochs, HR | 1 |
| Goldberg, LI; Rajfer, SI | 2 |
| Brandt, D; Klein, W | 1 |
| Artman, M; Graham, TP; Parrish, MD | 1 |
| Doherty, JU; Hood, WB; Lee, VW; Liang, CS; Sherman, LG; Wellington, K | 1 |
| Grom, E; Hauf, GF | 1 |
| Cohn, JN | 2 |
| Awan, NA; Beattie, JM; Evenson, MK; Mason, DT; Needham, KE | 1 |
| Bernard, R; Jacobs, P; Renard, M; Vainsel, H | 1 |
| Benjamin, GC | 1 |
| Pachinger, O | 1 |
| Brandt, D; Klein, W; Pristautz, H | 1 |
| Bernard, R; Englert, M; Jacobs, P; Melot, C; Renard, M | 1 |
| Hashimoto, K; Mori, T; Yabuuchi, Y; Yamashita, S | 1 |
| Ye, JM | 1 |
| Leier, CV; Unverferth, DV | 1 |
| Chodera, A; Chodera-Otuszewska, R; Pieczyńska, A | 1 |
| Bernard, R; Renard, M | 1 |
| Hermiller, JB; Leier, CV; Leithe, ME; Magorien, RD; Unverferth, DV | 1 |
| Jüngst, BK; Schranz, D; Stopfkuchen, H | 1 |
| Ferraro, N; Martin, JL; Wilson, JR | 1 |
| Cohn, JN; Levine, TB; Petein, M | 1 |
| Bendersky, R; Chatterjee, K; Parmley, WW | 1 |
| Boucher, R; David, A; Fortin, L; Gagnon, RM; Gilbert, S; Lemire, J; Morrisette, M; Present, S | 1 |
| Applefeld, MM; Grove, WR; Linberg, SE; Newman, KA; Reed, WP; Roffman, DS; Sutton, FJ | 1 |
| Brown, GP; Leier, CV; Magorien, RD; Unverferth, DV | 1 |
| Hutton, I; Rae, AP; Tweddel, AC | 1 |
| Kadota, K; Kambara, H; Kawai, C; Kawashita, K; Saimyoji, H | 1 |
| Bödigheimer, K; Delius, W; Ischinger, T; Nowak, FG | 1 |
| Forman, R; Frishman, WH; LeJemtel, TH; Maskin, CS; Sonnenblick, EH | 1 |
| Altschuld, R; Kolibash, AJ; Leier, CV; Lewis, RP; Magorien, RD; Unverferth, DV | 1 |
| Gürtler-Krawczyńska, E; Pałko, T; Pietrzyk, E | 1 |
| Smith-Collins, A | 1 |
| Gunnar, RM | 1 |
| Ikram, H; Maslowski, AH; Nicholls, MG | 1 |
| Andrews, V; Janicki, JS; Weber, KT | 1 |
| Huss, P; Leier, CV; Lewis, RP; Unverferth, DV | 1 |
| Bleifeld, W; Hanrath, P; Kupper, W; Waller, D | 1 |
| Clemens, R; Emmrich, P; Jüngst, BK; Schranz, D; Stopfkuchen, H | 1 |
| Chierchia, S; Crea, F; Distante, A; L'Abbate, A; Maseri, A; Moscarelli, E; Parodi, O; Pesola, A | 1 |
| Bauer, R; Klein, G; Sauer, E; Sebening, H; Wirtzfeld, A | 1 |
| Dirschinger, J; Rudolph, W | 1 |
| Bortz, R; DiBianco, R; Fletcher, RD; Katz, RJ; Myerburg, RJ; Pozen, RG | 1 |
| Frishman, WH; Klein, NA; LeJemtel, TH; Siskind, SJ; Sonnenblick, EH | 1 |
| Doenecke, P; Schmengler, K | 1 |
| Awan, NA; DeMaria, AN; Evenson, MK; Hermanovich, J; Joye, JA; Mason, DT; Needham, K | 1 |
| Bendersky, R; Brundage, BH; Chatterjee, K; Parmley, WW; Ports, TA | 1 |
| Kopman, EA | 1 |
| Bodem, G; Spannbrucker, N; Vogel, F | 1 |
| Alepuz Ferrer, R; Montero Benzo, R; Vicente Sánchez, JL | 1 |
| Segal, BL | 1 |
| Leier, CV; Magorien, RD; Unverferth, DV | 1 |
| Blanford, M; Kates, RE; Leier, CV; Unverferth, DA | 1 |
| Goldstein, RA; Passamani, ER; Roberts, R | 1 |
| Baba, N; Croskery, R; Dick, MR; Kolibash, AJ; Leier, CV; Magorien, RD; Meacham, JA; Svirbely, JR; Unverferth, DV | 1 |
| Leier, CV | 2 |
| Awan, NA; Evenson, MK; Mason, DT; Needham, KE | 1 |
| Mercadante, S; Simonetti, MT | 1 |
| Adamopoulos, S; Bernardi, L; Coats, AJ; Piepoli, M; Sleight, P | 1 |
| Berkland, D | 1 |
| Giesen, G; Kersting, F; Kupp, M | 1 |
| Marks, R | 1 |
| Sherman, A | 1 |
| Berger, R; Frey, B; Hülsmann, M; Ioannides, C; Pacher, R; Stanek, B; Wutte, M | 1 |
| Beanlands, RS; Schwaiger, M | 1 |
| Buser, PT; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, SY | 1 |
| Kamijo, T; Kido, H; Miwa, AY; Nakamura, F; Sugimoto, T; Tomaru, T; Uchida, Y | 1 |
| Iwase, M; Nagata, K; Sobue, T; Yokota, M | 1 |
| Adamopoulos, S; Bernardi, L; Coats, A; Davies, M; Forfar, C; Piepoli, M; Pissimissis, E; Qiang, F; Sleight, P | 1 |
| Barbarash, R; Beckham, V; Coulter, L; Davila-Roman, VG; Kurz, H; Morello, PJ; Rich, MW; Sperry, J; Spinner, L; Woods, WL | 1 |
| Norris, RM | 1 |
| Martin, C; Papazian, L; Perrin, G | 1 |
| Lie, KI; van Zwieten, PA | 1 |
| Gorrie, M; Nicholls, A | 1 |
| Domínguez de Rozas, JM; Guindo Soldevila, J; Martínez Vílchez, R; Rodríguez Font, E | 1 |
| da Silva, MA | 1 |
| Arnal, JF; Bourdarias, JP; Chikli, F; Delorme, G; Dubourg, O; Dumas, C; Jondeau, G; Kamoun, L | 1 |
| Berger, R; Globits, S; Heinz, G; Kreiner, G; Pacher, R; Presch, I; Radosztics, S; Rödler, S; Weber, H; Wutte, M | 1 |
| Fedel, FJ; Kataoka, T; Keteyian, SJ; Levine, AB; Levine, TB; Marks, CR | 1 |
| Hasenfuss, G; Holubarsch, C; Just, H; Pieske, B | 1 |
| Ohizumi, Y | 1 |
| Armstrong, PW; Grima, EA; Howard, RJ; Moe, GW; Seth, R | 1 |
| Bonijoly, S; Favre, E; Marcon, JL | 1 |
| Gheorghiade, M; Sy, J; Vitarelli, A | 1 |
| Bashchinskiĭ, SE; Osipov, MA; Volkov, GV | 1 |
| Alam, M; Goldstein, S; Kono, T; Rosman, H; Sabbah, HN; Shimoyama, H | 1 |
| Bersin, RM; Chatterjee, K; de Marco, T; Henderson, GN; Khorrami, P; Klinski, C; Kwasman, M; Lau, D; Tanaka, K; Wolfe, C | 1 |
| Scrima, DA | 1 |
| Faggiano, P; Ghizzoni, G; Lombardi, C; Rusconi, C; Sorgato, A; Spedini, C | 1 |
| Chang, WC; Chen, JH; Cheng, JT; Kwan, CM; Lin, LJ; Teng, JK; Tsai, LM | 1 |
| Agostini, A; Angelucci, E; Cesaroni, P; Lucarelli, G; Mariotti, E; Sgarbi, E | 1 |
| Bain, RJ; Davies, MK; Lawson, N; Qiang, FX; Townend, JN; Virk, SJ | 1 |
| Gheorghiade, M; Goldstein, S; Kono, T; Levine, TB; Sabbah, HN | 1 |
| Berton, C; Boujdaria, R; Graini, L; Richard, C; Teboul, JL | 1 |
| Cannon, MA; Povlow, MJ | 1 |
| Annane, D; Auzepy, P; Bellissant, E; Giudicelli, JF; Richard, C; Teboul, JL; Thuillez, C | 1 |
| van der Giessen, WJ; van Woerkens, LJ; Verdouw, PD | 1 |
| Szatmari, A; Terlouw, JF; Umans-Eckenhausen, MA; van den Anker, JN | 1 |
| Jolobe, OM | 1 |
| Caldicott, LD; Channer, KS; Hawley, K; Heppell, R; Woodmansey, PA | 1 |
| Coddens, J; Delooft, T; Vandenbroucke, G | 1 |
| Doi, Y; Hori, M; Kamada, T; Kondo, H; Mano, T; Masuyama, T; Nagano, R; Naito, J; Yamamoto, K | 1 |
| Izumi, T; Kodama, M; Koyama, S; Shibata, A | 1 |
| Christmann, G; Fleischer, F; Haussmann, R; Lange, R; Martin, E | 1 |
| Hess, ML; Shipley, JB | 1 |
| Manetti, A; Pipitone, S | 1 |
| Ishihara, H; Kanda, H; Kato, R; Nagata, K; Sobue, T; Yokota, M | 1 |
| Berder, V; Cherrier, F; Danchin, N; Feldmann, L; Juillière, Y; Perrin, O | 1 |
| Barbe, F; Crozatier, B; Hittinger, L; Laplace, M; Su, JB | 1 |
| Goldberg, D; Goldstein, S; Lesch, M; Levine, AB; Levine, TB; Narins, B | 1 |
| Berger, R; Hülsmann, M; Pacher, R; Siegel, A; Stanek, B; Wutte, M | 1 |
| Adamopoulos, S; Bemardi, L; Coats, AJ; Piepoli, M; Ponikowski, P; Radaelli, A; Sleight, P | 1 |
| Clark, WA; Denes, P; Fernandez, RN; Heaney, L; Marius-Nunez, AL; Ranganini, A; Silber, E | 1 |
| Berk, MR; DeMaria, AN; DeWood, MA; Karlsberg, RP; Lasher, KP | 1 |
| Hogan, PM; Novotny, MJ | 1 |
| Colucci, WS; Landzberg, JS; Newton, GE; Parker, AB; Parker, JD | 1 |
| Counihan, PJ; Gorcsan, J; Kormos, RL; Mandarino, WA; Murali, S | 1 |
| Campa, PP; Dawodu, AA; De Biase, L; Gentile, C; Lilla Della Monica, PL; Monti, F; Puddu, PE; Schiariti, M; Vaccaro, M | 1 |
| Bedogni, F; Bottero, M; Centofante, P; Cera, A; Fortunato, A; La Vecchia, L; Ometto, R | 1 |
| Assmann, G; Breithardt, G; Brisse, B; Deng, MC; Erren, M; Lütgen, A; Scheld, HH; Schmitz, W; Zimmermann, P | 1 |
| Hanzawa, K; Kamiyama, Y; Murayama, K; Shiraishi, M; Warabi, K | 1 |
| Berger, R; Daneschvar, H; Frey, B; Grimm, M; Hülsmann, M; Laufer, G; Pacher, R; Rödler, S; Siegel, A; Stanek, B | 1 |
| Bareiss, P; Roul, G | 1 |
| Erdmann, E | 1 |
| Benoit, T; Gillain, D; Limet, R; Piérard, L; Rigo, P; Van Damme, H | 1 |
| Kapoor, C; Mehra, MR; Smart, FW; Stapleton, DD; Ventura, HO; Zimmerman, D | 1 |
| Benhalima, B; Chauvel, C; Cohen, A; Desert, I; Guyon, P; Valty, J | 1 |
| Harjai, KJ; Lapeyre, YM; Mehra, MR; Murgo, JP; Smart, FW; Stapleton, DD; Ventura, HO | 1 |
| Heyman, S; Ozdemir, S; Zucker, I | 1 |
| Kaan, AF; Keogh, AM; Macdonald, PS; McCosker, CJ; Sindone, AP | 1 |
| Bauce, B; Boffa, GM; Cacciavillani, L; Cannas, S; Grassi, G; Livi, U; Maddalena, F; Marzari, A | 1 |
| Abraham, WT; Bristow, MR; Ferguson, DA; Lindenfeld, J; Lowes, BD; Scheffel, CA; White, M; Wolfel, EE | 1 |
| Capomolla, S; Cobelli, F; Febo, O; Maestri, R; Opasich, C; Pozzoli, M; Riccardi, G; Salvucci, F; Sisti, M; Tavazzi, L | 1 |
| Drew, BJ; Ide, B | 1 |
| Dernellis, JM; Toutouzas, PK; Vyssoulis, GP; Zacharoulis, AA | 1 |
| Matsuzaki, M; Nakamura, Y; Ohkusa, T; Ryoke, T; Tanaka, N | 1 |
| Appleby, S; Johnson, RG; Kivilghn, SD; Krause, SM; Lynch, JJ; Prahalada, S; Shen, YT; Siegl, PK; Woltmann, RF | 1 |
| Fujii, H; Ishizu, T; Kousogabe, Y; Kurasaka, N; Otani, S; Tanaka, T; Tokioka, H | 1 |
| Asano, M; Maehara, J; Momose, K; Saitoh, C; Saitoh, M; Sato, S; Taguchi, K; Tanaka, H; Usuda, S | 1 |
| Belardinelli, R; Georgiou, D; Purcaro, A | 1 |
| Agliata, S; Bosimini, E; Cavagnino, A; Corrà, U; Giannuzzi, P; Sacco, A; Schweiger, K | 1 |
| Maisel, A; Nuñez, S | 1 |
| McCloskey, WW | 1 |
| Bonser, RS; Camici, PG; Lorenzoni, R; Ordoubadi, F; Pagano, D; Townend, JN | 1 |
| Chen, CK; Chen, CP; Chen, YT; Ho, HY; Hsueh, CW; Huang, DS; Huang, JL; Lee, WL; Ting, CT | 1 |
| Berton, C; Lenique, F; Mercat, A; Richard, C; Teboul, JL | 1 |
| Bental, T; Elis, A; Kimchi, O; Lishner, M; Ravid, M | 1 |
| Anzai, T; Gao, M; Hammond, HK; Lai, NC | 1 |
| Baumann, G; Iven, H; Kieback, AG; Stolzenburg, K | 1 |
| Anthopoulos, L; Filippatos, G; Kappos, K; Kranidis, A | 1 |
| Ambrosino, N; D'Aloia, A; Faggiano, P; Giordano, A; Gualeni, A; Pagani, M | 1 |
| Cocozza, M; De Vecchis, R; Imperatore, F; Nocerino, L; Pucciarelli, G; Setaro, A; Torre, G | 1 |
| Bermúdez-Cañete, R; Díez-Balda, JI; Domínguez, F; Gómez, R; Martínez, A; Ramos, A; Vellibre, D | 1 |
| Crilley, JG; Dark, JH; Hall, JA | 1 |
| Lauer, MS; Lytle, BW; Marwick, TH; Secknus, MA; Williams, J; Zuchowski, C | 1 |
| Finocchi, G; Ometto, R; Vecchia, L; Vincenzi, M | 1 |
| Junger, E; Liziczai, I; Nagy, L; Tarján, J | 1 |
| Delehanty, J; Liang, CS; Odorisi, ML | 1 |
| Berger, R; Bojic, A; Frey, B; Grimm, M; Hülsmann, M; Laufer, G; Locker, G; Pacher, R; Rödler, S; Stanek, B; Sturm, B | 1 |
| Dukić, M; Gradinac, S; Hercog, D; Jovanović, I; Jovović, L; Kokai, G; Simeunović, S; Stajević, M | 1 |
| Mutnick, AH; Souney, PF | 1 |
| Boldt, J; Faust, K; Lang, J; Lehmann, A; Thaler, E; Werling, C | 1 |
| Kaul, S; Lahiri, A; Senior, R | 1 |
| Liu, L; Zhao, SP | 1 |
| Adams, KF; Califf, RM; Gattis, WA; Gheorghiade, M; Grossman, SH; McKenna, WJ; McNulty, SE; O'Connor, CM; Swedberg, K; Uretsky, BF; Zannad, F | 1 |
| Bax, JJ; Boersma, E; Cornel, JH; Elhendy, A; Fioretti, PM; Poldermans, D; Rambaldi, R; Roelandt, JR | 1 |
| Silver, MA | 1 |
| Latini, R; Maggioni, AP; Mauri, F; Nicolis, E; Oliva, F; Politi, A; Staszewsky, L | 1 |
| Fujiwara, A; Hirota, Y; Kawamura, K; Kono, T; Morita, H; Nishina, T | 1 |
| Frey, B; Hartter, E; Kos, T; Kubecova, L; Pacher, R; Spinar, J; Stanek, B; Vitovec, J; Wimmer, A; Yilmaz, N | 1 |
| Drazner, MH; Solomon, MA; Thompson, B; Yancy, CW | 1 |
| Cherng, WJ; Hung, MJ; Wang, CH | 1 |
| Blankenship, JS | 1 |
| Karas, SM; Kefalas, CG; Mentzikof, DG; Parissis, JT; Venetsanou, KF; Ziras, NG | 1 |
| Bristow, MR; Lindenfeld, J; Lowes, BD | 1 |
| Bonser, RS; Camici, PG; Pagano, D; Parums, DV; Townend, JN | 1 |
| Mingrone, R; Opasich, C; Russo, A; Tavazzi, L; Zambelli, M | 1 |
| Bristow, MR; Lowes, BD; Simon, MA; Tsvetkova, TO | 1 |
| Borzak, S; Goldstein, S; Mishima, T; Sabbah, HN; Steinberg, MI; Tanimura, M | 1 |
| Delle-Karth, G; Haumer, M; Heinz, G; Koller-Strametz, J; Koreny, M; Siostrzonek, P | 1 |
| Hata, K; Kawai, H; Kijima, Y; Murata, T; Okubo, H; Shinke, T; Takaoka, H; Takeuchi, M; Yokoyama, M | 1 |
| Armstrong, WF; Avelar, E; Grossman, PM; Nicklas, JM; Oral, H; Sachdev, V; Sherman, HL | 1 |
| Duncan, KF; Newberry, JW; Rauch, ED; Stammers, AH; Willett, LD | 1 |
| Lagioia, R; Napoli, V; Passantino, A; Ricci, A; Rizzon, P; Scrutinio, D | 1 |
| Das, MK; Mahoney, DW; McCully, RB; Oh, JK; Pellikka, PA; Roger, VL; Seward, JB | 1 |
| Bojic, A; Frey, B; Hartter, E; Locker, G; Pacher, R; Stanek, B; Woloszczuk, W | 1 |
| Diehl, JL; Faisy, C; Guerot, E; Labrousse, J; Rezgui, N | 1 |
| Cianfrone, N; De Rito, V; Fanelli, R; Fusilli, S; Lombardo, A; Loperfido, F; Natali, R; Russo, A; Siena, GP; Vigna, C | 1 |
| Bommer, WJ; Dhond, MR; Donnell, K; Nguyen, T; Whitley, TB | 1 |
| Moen, EK; Young, JB | 1 |
| Agricola, E; Alfieri, O; La Canna, G | 1 |
| Atsumi, H; Endoh, M; Nakada, S; Sakurai, K; Sugawara, H; Tomoike, H | 1 |
| Dienesch, C; Haase, A; Leupold, A; Neubauer, S; Rommel, E; Ruff, J; Wiesmann, F | 1 |
| Kahn, JH; Starling, MR; Supiano, MA | 1 |
| Elliott, WG; Levine, AB; Levine, TB; Narins, B; Stomel, RJ | 1 |
| Alexopoulos, GP; Anastasiou-Nana, MI; Kontoyannis, DA; Moulopoulos, SD; Nanas, JN; Stamatelopoulos, SF; Tsagalou, EP | 1 |
| Cadariu, AR; Carolan, S; Longo, MD; Ramahi, TM; Rohlfs, K; Slade, M; Vallejo, E; Wackers, FJ | 1 |
| Burnett, JC; Hahn, EL; Hart, CY; Meyer, DM; Redfield, MM | 1 |
| Aronson, D; Burger, AJ; Elkayam, U; Ghali, J; Haught, H; Horton, DP; Neibaur, MT | 1 |
| De la Peña-Almaguer, E; Desai, MY; Mannting, F | 1 |
| Durand, JB; Kobrin, I; Nagueh, S; Pratt, C; Torre-Amione, G; Vooletich, MT | 1 |
| Bache, RJ; Godinot, C; Gong, G; Ishibashi, Y; Liu, J; Murakami, Y; Ochiai, K; Prody, C; Wang, C; Zhang, J | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF | 1 |
| Capomolla, S; Caporotondi, A; Cobelli, F; Febo, O; Gnemmi, M; Guazzotti, G; La Rovere, MT; Maestri, R; Mortara, A; Opasich, C; Pinna, GD; Vona, M | 1 |
| Borghetti, V; Ceconi, C; Coletti, G; La Canna, G; Lorusso, R; Minzioni, G; Parrinello, G; Totaro, P | 1 |
| Frantz, S; Kelly, RA; Paulus, WJ | 1 |
| Albert, N; Haji, SA; Kelly, L; Knack, DL; Starling, RC; Yamani, MH; Young, JB | 1 |
| Bristow, MR; Eichhorn, EJ; Gilbert, EM; Lowes, BD; Tsvetkova, T | 1 |
| Van Besouw, J | 1 |
| Elkayam, U; Ghali, JK; Horton, DP; Silver, MA | 1 |
| Al-Hesayen, A; Azevedo, ER; Newton, GE; Parker, JD | 1 |
| Gorski, LA | 1 |
| Diakakis, GF; Filippou, OK; Kanakaraki, MK; Kanoupakis, EM; Parthenakis, FI; Skalidis, EI; Vardas, PE | 1 |
| Anagnostopoulos, P; Chaudhry, PA; Emala, CW; Gupta, RC; Kass, DA; Mishima, T; Paolocci, N; Saavedra, WF; Sabbah, HN; Suzuki, G; Tunin, RS | 1 |
| Kübler, W; Mäurer, W; Tillmanns, H | 1 |
| Bredakis, J; Gunner, RM; Loeb, HS | 1 |
| Bolen, JL; Harrison, DC; Stoner, JD | 1 |
| Frishman, WH; LeJemtel, TH; Sonnenblick, EH | 1 |
| Kates, RE; Leier, CV; Unverferth, DV | 1 |
| Armstrong, PW | 1 |
| Bolte, HD; Cyran, J | 2 |
| Lundman, T; Rehnqvist, N | 1 |
| Codecà, L; De Lorenzi, E; Pradella, A | 1 |
| Bush, CA; Heban, PT; Huss, P; Leier, CV; Lewis, RP | 1 |
| Cohn, JN; Franciosa, JA | 1 |
| Jackson, PG; Jennings, K; Jewitt, D | 1 |
| Bleifeld, W; Hanrath, P; Kupper, W; Mathey, D | 1 |
| Kates, RE; Leier, CV | 1 |
| Davidson, J; Delius, W; Himmler, C; Klein, G; Volger, E; Wirtzfeld, A | 1 |
| Ambrosioni, E; Branzi, A; Capitanucci, P; Magnani, B; Picchio, F | 1 |
| Ali, N; Andy, JJ; Curry, CL; Mehrotra, PP | 1 |
| Bush, CA; Leier, CV; Webel, J | 1 |
| Bardet, J; Boschat, J; Bourdarias, JP; Ferreira, A; Rigaud, M; Rocha, P | 1 |
| Cohn, JN; Franciosa, JA; Mikulic, E | 1 |
| Delius, W; Mathes, P; Sebening, H; Wirtzfeld, A | 1 |
| Delius, W; Sebening, H; Wirtzfeld, A | 1 |
| Anderson, FL; Bristow, MR; Hanson, G; Hershberger, RE; Kralios, AC; Port, JD; Reid, BB | 1 |
| Bier, S; Burkhoff, D; de Tombe, PP; Gerstenblith, G; Harasawa, Y; Hunter, WC; Kass, DA; Wolff, MR | 1 |
| Quaale, S | 1 |
| Amano, M; Kanamori, T; Kinoshita, M; Shichiri, G; Takahashi, M | 1 |
| Qi, WH | 1 |
| Adnot, S; Benvenuti, C; Bourguignon, MH; Castaigne, A; Dubois-Randé, JL; Loisance, D; Merlet, P; Syrota, A; Valette, H | 1 |
| Reynolds, GW; Richmond, A; Silke, B; Taylor, SH; Verma, SP | 1 |
| Benvenuti, C; Bohuon, C; Carville, C; Castaigne, A; Comoy, E; Dubois-Randé, JL; Hittinger, L; Macquin-Mavier, I; Merlet, P | 1 |
| Elis, A; Lishner, M; Ravid, M | 1 |
| Sleight, P | 1 |
| Cleland, JG; Frost, G; Good, J; Oakley, CM | 1 |
| Bleifeld, W; Erlemeier, HH; Kupper, W | 2 |
| Asanoi, H; Ishizaka, S; Sasayama, S | 2 |
| Bossan, P; Drici, M; Ferrari, E; Gibelin, P; Morand, P | 1 |
| Bubik, JS; Robison-Strane, SR | 1 |
| Asanoi, H; Ishizaka, S; Kameyama, T; Sasayama, S | 2 |
| Honda, H; Hoshi, N; Kikuchi, J; Koiwa, Y; Takagi, T; Takishima, T | 1 |
| Annane, D; Bellissant, E; Depret, J; Richard, C; Teboul, JL; Thuillez, C | 1 |
| Brown, G; Douglas, I; Herkes, R; O'Leary, M | 1 |
| Araghi, A; Dietrich, KA; Dooley, F; Landau, SW; Mene, M; Sacher, HL; Sacher, ML | 1 |
| Pickworth, KK | 1 |
| Gerdesmeyer, L; Herrmann, G; Meissner, A; Simon, R | 1 |
| Bittl, JA; Colucci, WS; Landzberg, JS; Mirsky, I; Parker, JD | 1 |
| Baumann, G; Gerzer, R; Stangl, K; Weil, J | 1 |
| Frey, MJ; Lanoce, V; Liang, BT; Manning, DR; Marzo, KP; Molinoff, PB; Wilson, JR | 1 |
| Hilleman, DE; Mohiuddin, SM | 1 |
| Hua, J; Uretsky, BF | 1 |
| Fan, TM; Frantz, RP; Guthinger, L; Liang, CS; Sakamoto, S; Suematsu, M; Sullebarger, JT | 1 |
| Asanoi, H; Fujita, M; Miyagi, Y; Nakajima, H; Sasayama, S | 1 |
| Budzinski, D; Goldberg, AD; Jafri, SM; Levine, TB; Pilla, A; Reddy, BR | 1 |
| Debets, JJ; Schoemaker, RG; Smits, JF; Struyker-Boudier, HA | 1 |
| Costa, R; De Marino, V; Marino, A | 1 |
| Keller, N; Larsen, J; Sykulski, R | 1 |
| Boldt, J; Hempelmann, G | 1 |
| Zeplin, HE | 1 |
| Peters, P; Saborowski, F; Schneider, M | 1 |
| Brichant, C; Cauwe, F; De Coster, P; Gonzalez, M; Installe, E; Lessire, H | 1 |
| Hilger, HH; Höpp, HW; Klocke, RK; Kux, A; Mager, G | 1 |
| Paccagnella, A; Simini, G; Valfré, C | 1 |
| Gofman, AM; Ol'binskaia, LI; Poptsov, VN | 1 |
| Guy, S; Silke, B | 1 |
| Adamopoulos, S; Coats, AJ | 1 |
| Binkley, PF; Hammer, DF; Leier, CV; Starling, RC | 1 |
| Camous, JP; Drici, M; Gibelin, P; Lapalus, P; Morand, P; Sbirrazzuoli, V | 1 |
| Arter, WJ; Field, MJ; Kiyingi, A; Lawrence, JR; Pawsey, CC; Yiannikas, J | 1 |
| Bristow, MR; Gilbert, EM; Ginsburg, R; Hershberger, RE; Larrabee, P; Mealey, P; Murray, J; Port, JD; Volkman, K | 1 |
| Fournier, P; Fraysse, JB; Grosgogeat, Y; Komajda, M; Landault, C; Lechat, P; Richaud, M | 1 |
| Baumann, G; Felix, SB; Filcek, SA | 1 |
| Lewis, RP | 1 |
| van Zwieten, PA | 1 |
| Buttrick, P; Geenen, D; Lahorra, M; Malhotra, A; Perla, C; Scheuer, J | 1 |
| Littler, WA; Murray, RG; Tan, LB | 2 |
| Hilger, HH; Höpp, HW; Klocke, RK; Kux, A; Mager, G; Volkmann, A | 1 |
| Baumann, G; Cremer, G; Joder-Ohlenbusch, AM; Ningel, K; Vieweg, J | 1 |
| Schoemaker, RG; Smits, JF | 1 |
| Benvenuti, C; Cachera, JP; Castaigne, A; Deleuze, P; Dubois-Randé, JL; Duval-Moulin, AM; Lellouche, D; Loisance, D; Merlet, P; Saal, JP | 1 |
| Annane, D; Bellissant, E; Richard, C; Teboul, JL; Thuillez, C | 1 |
| Bounhoure, JP; Edouard, P; Fauvel, JM; Fourcade, J; Galinier, M; Massabuau, P; Puel, J; Rochiccioli, JP | 1 |
| Besse, P; Coste, P; Durrieu, C; Le Goff, G; Rochoux, G | 1 |
| Allal, J; Barraine, R; Bouton, S; Couetil, JP; Dreyfus, G; Farge, D; Ourbak, P; Pornin, M; Prevost, D; Sarkis, A | 1 |
| Liu, ZQ; Ma, AQ; Yang, DY; Zhang, L | 1 |
| Gunnar, RM; Stecy, P | 1 |
| Applefeld, MM; Sohl, LL | 1 |
| Marcus, RH; Mitha, A; Patel, J; Raw, K; Sareli, P | 1 |
| Herrmann, V; Merkle, EJ; Miller, LW | 1 |
| Follath, F; Ha, HR; Ritz, R; Schmidlin, O; Weiss, P | 1 |
| Imburgia, M; Rich, MW | 1 |
| Campbell, CA; Held, AC; Johnson, V; Lavine, SJ | 1 |
| Chance, B; Ferraro, N; Mancini, DM; Schwartz, M; Seestedt, R; Wilson, JR | 1 |
| De Backer, D; Kahn, RJ; Roman, A; Vincent, JL | 1 |
| Demedts, M; Van den Brande, P; Van Mieghem, W | 1 |
| Keren, G; LeJemtel, TH; Reis, D; Sonnenblick, EH | 1 |
| Bayliss, J; Poole-Wilson, P; Thomas, L | 1 |
| Hood, WB; Imai, N; Kawashima, S; Liang, CS; Stone, CK; Thomas, A | 1 |
| Baumann, G; Ningel, K; Permanetter, B | 2 |
| Gilfrich, HJ; Römer, A; Witzke-Gross, J | 1 |
| Gans, SJ; Zwaveling, JH | 1 |
| Katz, S; Keren, G; LeJemtel, TH; Sonnenblick, EH; Strom, J | 1 |
| Kahn, RJ; Madhoun, P; Primo, G; Vincent, JL | 1 |
| Carey, RA; Jacob, L | 1 |
| Drexler, H; Just, H; Meinertz, T | 1 |
| Aïtkaciali, F; Cupa, M; Fosse, JP; Fournier, JL; Hoang, P; Pourriat, JL | 1 |
| Buser, PT; Camacho, SA; Higgins, CB; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, ST | 1 |
| Bhatt-Mehta, V; Nahata, MC | 1 |
| Bain, RJ; Littler, WA; Tan, LB | 1 |
| Dieckelmann, A; Haan, J; Haupts, M; Kaliwoda, A; Rembs, E; Zumtobel, V | 1 |
| Keren, G; Laniado, S; Lejemtel, TH; Sonnenblick, EH | 1 |
| Banerjee, SP; Fan, TH; Kawashima, S; Liang, CS | 1 |
| Colucci, WS; Denniss, AR; Gauthier, DF; Leatherman, GF; Ludmer, PL; Marsh, JD; Quigg, RJ | 1 |
| Matoba, M | 1 |
| Fukuzaki, H; Nakanishi, M; Yokota, Y | 1 |
| Acar, J; Le Potier, J; Michel, PL; Sergent, J; Vahanian, A | 1 |
| Braunwald, E; Colucci, WS; Wright, RF | 1 |
| Kopia, GA; Ruffolo, RR | 1 |
| Andersson, KE | 1 |
| Ruffolo, RR; Shebuski, RJ; Smith, JM | 1 |
| Dhainaut, JF | 1 |
| Colucci, WS | 2 |
| Sonoki, H; Sugimoto, T; Tomaru, T; Uchida, Y | 1 |
| Cohn, JN; Goldenberg, IF; Levine, TB; Olivari, MT | 1 |
| Reddy, PS; Uretsky, BF; Valdes, AM | 1 |
| Hakki, A; Iskandrian, AS; Likoff, MJ; Ulrich, S | 1 |
| Generalovich, T; Reddy, PS; Uretsky, BF; Valdes, AM; Verbalis, JG | 1 |
| Jain, MC; Janicki, JS; Weber, KT | 1 |
| Uretsky, BF | 1 |
| Collard, P; Gonzalez, M; Installé, E; Jacquemart, JL; Pourbaix, S; Roulette, F; Tremouroux, J | 1 |
| LeJemtel, TH; Mancini, DM; Sonnenblick, EH | 1 |
| Kleinschmidt, R; Spannbrucker, N; Vogel, F | 1 |
| Applefeld, MM; Roffman, DS | 1 |
| Ruggie, N | 1 |
| Bristow, MR; Fowler, MB; Hopkins, GL; Laser, JA; Minobe, W | 1 |
| Halon, DA; Hardoff, R; Lewis, BS; Merdler, A; Rodeanu, ME; Saggie, Y | 1 |
| Autenrieth, G | 1 |
| Amin, DK; Brandon, G; Hulse, S; Shah, PK; Shellock, FG; Spangenberg, R; Swan, HJ | 1 |
| Keren, G; LeJemtel, TH; Mancini, D; Sonnenblick, EH | 1 |
| Crawford, MV; Schactman, M | 1 |
| Marshall, LE; Thomas, RL; Watson, D | 1 |
| Kolesar, JA; Lawless, CE; Reddy, PS; Uretsky, BF; Valdes, AM; Verbalis, JG | 1 |
| Ruffolo, RR | 1 |
| Hattori, R; Kawai, C; Sakaguchi, K; Susawa, T; Takatsu, Y; Yui, N; Yui, Y | 1 |
| Drexler, H; Faude, F; Freudenberg, N; Just, H; Winterer, H; Wollschläger, H | 1 |
| Anand, IS; Gurden, J; Harris, P; Poole-Wilson, PA; Wanless, RB | 1 |
| Casanegra, P; Chamorro, G; Corbalán, R; Illanes, G; Jalil, J; Martínez, A | 1 |
| Jaski, BE; Peters, C | 1 |
| Kindler, M; Kramer, W; Kremer, P; Schlepper, M; Thormann, J | 1 |
| Martínez Martínez, A; Salvati, A; Suárez, LD | 1 |
| Baim, DS; Lanoue, AS; Monrad, ES; Smith, HS | 1 |
| Braunwald, E; Colucci, WS; Fifer, MA; Jaski, BE; Wright, RF | 1 |
| Riemenschneider, TA; Tiefenbrunn, LJ | 1 |
| Mauro, LS; Mauro, VF | 1 |
| Huth, R; Jüngst, BK; Schranz, D; Stopfkuchen, H | 1 |
| Benotti, JR; Biddle, TL; Creager, MA; Faxon, DP; Firth, BG; Fitzpatrick, PG; Kershner, RP; Konstam, MA; Krebs, C; Walton, L | 1 |
| Agmon, J; Davidson, E; Hellman, C; Lewin, RF; Sclarovsky, S; Strasberg, B; Zafrir, N | 1 |
| Bache, RJ; Cohn, JN; Heppner, B; Petein, M; Pierpont, GL | 1 |
| Iwasaki, T; Komasa, N; Mihata, S; Mori, S; Nishian, K; Tateishi, J; Yasutomi, N | 1 |
| Applefeld, MM; Grove, WR; Newman, KA; Reed, WP; Roffman, DS; Sutton, FJ; Talesnick, BS | 1 |
| Margolis, J; Puram, B; Puram, V | 1 |
| Hagège, HH | 1 |
| Colucci, WS; Gauthier, DF; Leatherman, GF; Ludmer, PL | 1 |
| Baerman, JM; de Buitleir, M; DiCarlo, LA; Krol, RB; Morady, F; Schork, MA; Schurig, L; Sereika, SM | 1 |
| Cornyn, J; Loge, D; Massie, BM; Podolin, RA; Topic, N | 1 |
| Eichhorn, EJ; Konstam, MA; Martin, TT; Roberts, DJ; Salem, DN; Stransky, NB; Weiland, DS | 1 |
| Aiba, S; Nakazawa, M; Ohta, H; Okuda, H; Takahashi, Y; Takao, A | 1 |
| Bleifeld, W; Erlemeier, HH; Hamm, CW; Kupper, W | 1 |
| Gage, J; LeJemtel, TH; Lucido, D; Rutman, H | 1 |
| Hayakawa, H; Katoh, T; Koh, M; Munakata, K; Nejima, J; Seino, Y; Shimai, S; Takada, K; Takano, T; Tanaka, K | 1 |
| Bates, ER; Dilworth, LR; Hodgson, JM; Kline, EM; Krell, MJ; Laufer, N; Pitt, B; Vogel, RA | 1 |
| Seino, Y; Takano, T; Tanaka, K | 1 |
| Geraets, DR | 1 |
| Applefeld, MM; Hassan, E; Roffman, DS | 1 |
| McGuirk, SM; Muir, WW | 1 |
| Domenech, R; Goich, J; Thumala, A | 1 |
| Beck, OA | 1 |
| Ferraro, N; Fink, LI; Wilson, JR | 1 |
| Applefeld, MM | 1 |
| David, S; Zaks, JM | 1 |
| Elert, O; Pomer, S; Sarai, K; Satter, P | 1 |
| Greenberg, M; Grose, R; LeJemtel, TH; Strain, J | 1 |
| Berger, M; McSherry, CK | 1 |
| Alpert, JS; Benotti, JR; McCue, JE | 1 |
| Janicki, JS; Maskin, CS; Weber, KT | 1 |
| Fukuzaki, H; Hayakawa, M; Inoh, T; Kubo, M; Kumaki, T; Maehashi, N; Seo, T; Takarada, A; Toh, S; Yokota, Y | 1 |
105 review(s) available for dobutamine and Cardiac Failure
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone | 2022 |
Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Randomized Controlled Trials as Topic; Retrospective Studies; Shock, Cardiogenic | 2023 |
Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure.
Topics: Cardiac Output, Low; Diuretics; Dobutamine; Heart Failure; Humans; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Water-Electrolyte Imbalance | 2022 |
Comparison of milrinone with dobutamine in patients undergoing cardiac surgery: a systematic review and meta-analysis.
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone | 2023 |
[The Role of Pharmacists in Home Medical Care of Patients with Heart Failure].
Topics: Catecholamines; Chronic Disease; Dobutamine; Furosemide; Heart Failure; Home Care Services; Humans; Injections; Patient Care Team; Pharmacists; Professional Role | 2020 |
An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.
Topics: Adrenergic beta-Antagonists; Cardiac Surgical Procedures; Cardiotonic Agents; Critical Care; Dobutamine; Heart Failure; Hemodynamics; Humans; Shock, Cardiogenic; Simendan | 2021 |
Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan; Treatment Outcome | 2021 |
Calcium and Heart Failure: How Did We Get Here and Where Are We Going?
Topics: Adenosine Triphosphatases; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Ca(2+) Mg(2+)-ATPase; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Sarcoplasmic Reticulum | 2021 |
Left ventricular contractile reserve by stress echocardiography as a predictor of response to cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis.
Topics: Aged; Aged, 80 and over; Cardiac Resynchronization Therapy; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Odds Ratio; Predictive Value of Tests; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2017 |
Dobutamine echocardiography for assessment of viability in the current era.
Topics: Cardiotonic Agents; Dobutamine; Echocardiography; Echocardiography, Stress; Heart Failure; Humans; Myocardial Contraction; Myocardial Ischemia; Prognosis; Tissue Survival; Ventricular Dysfunction, Left | 2019 |
Is there evidence favoring the use of beta-blockers and dobutamine in acute heart failure?
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Heart Failure; Humans | 2013 |
Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.
Topics: Arrhythmias, Cardiac; Cardiotonic Agents; Comorbidity; Critical Illness; Dobutamine; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Hypotension; Pyridazines; Randomized Controlled Trials as Topic; Risk Factors; Simendan; Survival Rate; Treatment Outcome | 2013 |
[Possibilities of clinical echocardiography in patients with heart failure: some examples from clinical practice].
Topics: Acute Coronary Syndrome; Acute Disease; Aged; Arrhythmias, Cardiac; Counterpulsation; Diagnostic Errors; Dobutamine; Dyspnea; Echocardiography; Gastroenteritis; Heart Failure; Humans; Male; Middle Aged; Myocarditis; Norepinephrine; Point-of-Care Systems; Pulmonary Embolism; Radiography; Respiration, Artificial; Shock, Cardiogenic; Stroke Volume; Systole | 2014 |
[Organ-protection therapy. A new therapeutic approach for acute heart failure?].
Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan | 2014 |
Scorpion-related cardiomyopathy: Clinical characteristics, pathophysiology, and treatment.
Topics: Animals; Cardiomyopathies; Cardiotonic Agents; Combined Modality Therapy; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Oxygen Inhalation Therapy; Pulmonary Edema; Respiration, Artificial; Scorpion Stings; Scorpion Venoms; Scorpions; Time Factors; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 2015 |
Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.
Topics: Acute Disease; Cardiotonic Agents; Cohort Studies; Dobutamine; Heart Failure; Hospital Mortality; Humans; Natriuretic Peptide, Brain; Patient Readmission; Survival Analysis | 2015 |
Long-term intravenous inotropes in low-output terminal heart failure?
Topics: Administration, Intravenous; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Chi-Square Distribution; Dobutamine; Drug Administration Schedule; Heart Failure; Heart Transplantation; Humans; Hydrazones; Milrinone; Odds Ratio; Practice Guidelines as Topic; Pyridazines; Risk Factors; Simendan; Time Factors; Treatment Outcome; Waiting Lists | 2016 |
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?
Topics: Acute Disease; Animals; Cardiotonic Agents; Dobutamine; Etiocholanolone; Heart Failure; Hemodynamics; Humans; Pulmonary Wedge Pressure; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Potassium-Exchanging ATPase | 2009 |
Therapy for acute heart failure syndromes.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Milrinone; Mineralocorticoid Receptor Antagonists; Morphine; Nitroprusside; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Analysis; Syndrome; Treatment Outcome | 2009 |
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.
Topics: Acute Disease; Cardiotonic Agents; Digoxin; Dobutamine; Etiocholanolone; Exercise Test; Heart Failure; Hemodynamics; Hospitals, Group Practice; Humans; Hydrazones; Prognosis; Pyrazines; Pyridazines; Quinolines; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Treatment Outcome; Urea; Vasodilator Agents | 2009 |
Pharmacotherapy for acute heart failure syndromes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Heart Failure; Humans; Milrinone; Morphine; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Practice Guidelines as Topic; Vasodilator Agents | 2011 |
The concept of ventricular reserve in heart failure and pulmonary hypertension: an old metric that brings us one step closer in our quest for prediction.
Topics: Coronary Artery Disease; Dobutamine; Exercise Test; Health Status Indicators; Heart Failure; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Myocardial Contraction; Prognosis; Stroke Volume; Tissue Survival; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2011 |
Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance.
Topics: Cardiotonic Agents; Chronic Disease; Contrast Media; Coronary Artery Disease; Death, Sudden, Cardiac; Diagnosis, Differential; Dobutamine; Feasibility Studies; Heart Failure; Humans; Magnetic Resonance Angiography; Myocardial Infarction; Myocardial Ischemia; Patient Safety; Prognosis | 2011 |
Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials.
Topics: Adult; Cardiotonic Agents; Databases, Bibliographic; Dobutamine; Heart Failure; Humans; Mortality; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2012 |
Beta blocker therapy, decompensated heart failure, and inotropic interactions: current perspectives.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Heart Failure; Hospitalization; Humans; Hydrazones; Phosphodiesterase Inhibitors; Practice Guidelines as Topic; Pyridazines; Simendan | 2012 |
[Combination therapy; dobutamine and milrinone].
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Milrinone; Myocardial Ischemia; Phosphodiesterase 3 Inhibitors | 2011 |
[Are cardiac glycosides still needed in the treatment of cardiac insufficiency?].
Topics: Cardiac Glycosides; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Dobutamine; Heart Failure; Humans; Multicenter Studies as Topic; Odds Ratio; Risk; Severity of Illness Index; Treatment Failure; Treatment Outcome | 2002 |
[Cardiac insufficiency of ischemic origin].
Topics: Cardiotonic Agents; Dobutamine; Echocardiography; Heart Failure; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Thallium Radioisotopes; Tomography, Emission-Computed | 2002 |
Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.
Topics: Aged; Diuretics; Dobutamine; Enalaprilat; Female; Heart Failure; Hemodynamics; Hospitalization; Humans; Hydrazones; Injections, Intravenous; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroprusside; Pulmonary Wedge Pressure; Pyridazines; Renal Agents; Simendan; Vasodilator Agents | 2003 |
B-type natriuretic peptide: from bench to bedside.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Cardiotonic Agents; Diuretics; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Randomized Controlled Trials as Topic; Receptors, Atrial Natriuretic Factor; Vasodilator Agents | 2003 |
[Inotropic agents in advanced and refractory heart failure].
Topics: Cardiotonic Agents; Dobutamine; Dopamine; Drug Administration Schedule; Heart Failure; Humans; Hydrazones; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Treatment Failure; Treatment Outcome | 2003 |
Role of nonglycosidic inotropic agents: indications, ethics, and limitations.
Topics: Adrenergic beta-Antagonists; Cardiac Glycosides; Cardiotonic Agents; Dobutamine; Ethics, Clinical; Heart Failure; Humans; Milrinone; Myocardial Infarction; Nitroprusside; Quality of Life; Sympathomimetics; Vasodilator Agents | 2003 |
Intravenous vasodilator therapy in congestive heart failure.
Topics: Dobutamine; Endothelin Receptor Antagonists; Heart Failure; Humans; Injections, Intravenous; Nitroglycerin; Phosphodiesterase Inhibitors; Thrombocytopenia; Vasodilator Agents | 2003 |
Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure.
Topics: Acute Disease; Age Distribution; Aged; Cardiotonic Agents; Dobutamine; Drug Costs; Female; Heart Failure; Hospital Costs; Humans; Life Expectancy; Male; Middle Aged; Models, Econometric; Monte Carlo Method; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Admission; Predictive Value of Tests; Sex Distribution; Survival Analysis; Treatment Outcome; United States; Value of Life | 2003 |
The role of Ca++-sensitizers for the treatment of heart failure.
Topics: Calcium; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Myocardial Ischemia; Pyridazines; Simendan | 2003 |
[Inotropic therapy in heart failure: general aspects and clinical results].
Topics: Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Heart Failure; Humans; Milrinone; Treatment Outcome | 2004 |
A rational approach for the treatment of acute heart failure: current strategies and future options.
Topics: Acute Disease; Adenosine; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Drug Therapy; Endothelins; Forecasting; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Vasopressins | 2004 |
[Echocardiography in aortic stenosis: new insights into challenging scenarios].
Topics: Aged; Aortic Valve Stenosis; Cardiotonic Agents; Clinical Trials as Topic; Death, Sudden, Cardiac; Diagnosis, Differential; Disease Progression; Dobutamine; Echocardiography; Heart Failure; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Myocardial Contraction; Prognosis; Risk Factors; Severity of Illness Index; Time Factors; Ventricular Dysfunction, Left | 2004 |
Management of diuretic-refractory, volume-overloaded patients with acutely decompensated heart failure.
Topics: Cardiotonic Agents; Diuretics; Dobutamine; Edema; Heart Failure; Hemofiltration; Humans; Patient Care Management; Renal Dialysis; Treatment Outcome; Vasodilator Agents | 2005 |
[The novelty in the treatment of heart failure].
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Multicenter Studies as Topic; Pyridazines; Randomized Controlled Trials as Topic; Retrospective Studies; Simendan; Vasodilator Agents | 2005 |
Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Dopamine; Heart Failure; Humans; Milrinone; Syndrome | 2005 |
Randomized clinical trials with levosimendan.
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Syndrome | 2005 |
[Medical and ventilatory treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Continuous Positive Airway Pressure; Diuretics; Dobutamine; Furosemide; Heart Failure; Humans; Hydrazones; Isosorbide Dinitrate; Natriuretic Agents; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxygen Inhalation Therapy; Practice Guidelines as Topic; Pyridazines; Simendan; Vasodilator Agents | 2006 |
Cardiac adrenoceptors: physiological and pathophysiological relevance.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Dose-Response Relationship, Drug; GTP-Binding Proteins; Heart; Heart Failure; Heart Rate; Myocardium; Physical Conditioning, Animal; Polymorphism, Genetic; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Terbutaline | 2006 |
Dobutamine stress echocardiography: does it predict response to beta-blockers in patients with heart failure?
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Dobutamine; Echocardiography, Stress; Heart Failure; Humans; Predictive Value of Tests | 2006 |
The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
Topics: Aged; Biological Availability; Calcium Channels; Cardiotonic Agents; Dobutamine; Half-Life; Heart Failure; Hospitalization; Humans; Hydrazones; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Tissue Distribution; Treatment Outcome | 2007 |
Classical inotropes and new cardiac enhancers.
Topics: Algorithms; Cardiotonic Agents; Dobutamine; Dopamine; Heart Failure; Humans; Hydrazones; Milrinone; Practice Guidelines as Topic; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Treatment Outcome | 2007 |
[Catecholamines--characteristics, mechanisms of action, pharmacokinetics, indications, contraindications, clinical trials, and side effects].
Topics: Acute Disease; Cardiotonic Agents; Catecholamines; Clinical Trials as Topic; Contraindications; Dobutamine; Dopamine; Heart Failure; Humans; Norepinephrine | 2007 |
[Catecholamines use in patients with heart failure].
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Epinephrine; Heart Failure; Humans; Norepinephrine | 2007 |
[Combination therapy with PDE III inhibitor for heart failure].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Chronic Disease; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Hydrazones; Milrinone; Phosphodiesterase Inhibitors; Pyridazines; Simendan | 2007 |
The role of diuretics and inotropic therapy in failure associated with myocardial infarction.
Topics: Acute Disease; Blood Pressure; Cardiac Complexes, Premature; Cardiotonic Agents; Chronic Disease; Digoxin; Diuretics; Dobutamine; Heart Failure; Hemodynamics; Humans; Isoproterenol; Myocardial Infarction | 1984 |
Newer inotropic agents.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Ethanolamines; Heart Failure; Humans; Practolol; Prenalterol; Receptors, Adrenergic, beta | 1984 |
[Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
Topics: Adrenergic beta-Agonists; Captopril; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Isoproterenol; Isosorbide Dinitrate; Nitroprusside; Nonachlazine; Phentolamine; Practolol; Prazosin; Prenalterol; Vasodilator Agents | 1983 |
[Catecholamines in the therapy of chronic cardiac insufficiency].
Topics: Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Epinephrine; Heart Failure; Humans; Isoproterenol; Metaproterenol; Myocardial Contraction; Norepinephrine; Practolol; Prenalterol; Receptors, Adrenergic, alpha; Vasoconstriction; Vasodilation | 1982 |
Congestive heart failure in childhood and adolescence: recognition and management.
Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Electrocardiography; Endocarditis, Bacterial; Furosemide; Heart; Heart Defects, Congenital; Heart Diseases; Heart Failure; Humans; Hydralazine; Isoproterenol; Nitroprusside; Physical Examination; Radionuclide Imaging; Rheumatic Heart Disease | 1983 |
[Currently used positive inotropic substances].
Topics: Cardiotonic Agents; Chemical Phenomena; Chemistry; Coronary Disease; Dobutamine; Dopamine; Epinephrine; Heart Failure; Hemodynamics; Humans; Isoproterenol; Norepinephrine | 1984 |
Assessment of vasodilatation in man.
Topics: Arterioles; Blood Pressure; Dobutamine; Heart Failure; Humans; Microcirculation; Nitroprusside; Pressoreceptors; Regional Blood Flow; Vascular Resistance; Vasodilation | 1984 |
Dobutamine in heart failure.
Topics: Catecholamines; Digoxin; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Nitroprusside; Oxygen Consumption | 1982 |
Vasodilator therapy of congestive heart failure.
Topics: Aortic Valve Insufficiency; Captopril; Dobutamine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Mitral Valve Insufficiency; Nitroglycerin; Nitroprusside; Phentolamine; Physical Exertion; Piperazines; Prazosin; Quinazolines; Time Factors; Vasodilator Agents | 1980 |
The role of vasodilating agents in the treatment of chronic heart failure.
Topics: Cardiac Output; Chronic Disease; Dobutamine; Heart Failure; Humans; Muscle Contraction; Nitroprusside; Phentolamine; Prazosin; Pulmonary Edema; Vascular Resistance; Vasodilator Agents | 1980 |
Creative solutions: home dobutamine infusions.
Topics: Dobutamine; Heart Failure; Home Infusion Therapy; Humans; Patient Care Planning | 1995 |
Critical care management of the heart failure patient in the home.
Topics: Aged; Critical Care; Dobutamine; Heart Failure; Home Care Services; Humans; Male | 1995 |
[Dopexamine: a new dopaminergic agonist].
Topics: Adrenergic Agonists; Animals; Dobutamine; Dogs; Dopamine; Glomerular Filtration Rate; Heart; Heart Conduction System; Heart Failure; Hemodynamics; Humans; Natriuresis; Rats; Receptors, Dopamine; Shock, Septic; Splanchnic Circulation | 1993 |
[Neurohormonal compensation processes in chronic heart failure: the effect of drugs].
Topics: Adrenergic beta-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Deoxyepinephrine; Diuretics; Dobutamine; Heart Failure; Humans; Receptors, Cell Surface; Renin-Angiotensin System; Sympathetic Nervous System | 1994 |
[Tendency of development on novel type of cardiotonic drugs].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Amrinone; Animals; Calcium; Catechols; Dobutamine; Dopamine; Fatty Alcohols; Heart Failure; Humans; Pyridazines; Troponin | 1993 |
[Intermittent infusions of dobutamine in the treatment of chronic cardiac failure in the terminal stage].
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged | 1993 |
Nicardipine in heart failure: distinguishing its acute beneficial from its chronic effects.
Topics: Acute Disease; Calcium Channel Blockers; Chronic Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Nicardipine; Renin-Angiotensin System; Time Factors | 1993 |
[Application of non-glycoside inotropic agents in newborn infants].
Topics: Cardiotonic Agents; Dobutamine; Dopamine; Heart Failure; Humans; Infant, Newborn; Infant, Newborn, Diseases; Isoproterenol; Myocardial Contraction; Oxygen; Oxygen Consumption | 1993 |
Inotropic therapy for the failing myocardium.
Topics: Adrenergic beta-Agonists; Cardiac Output; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Vasodilator Agents; Ventricular Dysfunction, Left | 1995 |
[Terminal heart failure; therapeutic strategies. Drug therapy in cases of absence of possibility of heart transplantation: dobutamine therapy, aspects of compassion?].
Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Dobutamine; Heart Failure; Hemofiltration; Humans; Infusions, Intravenous; Phosphodiesterase Inhibitors; Quality of Life; Terminal Care; Vasodilator Agents | 1996 |
Reversed ventilation-perfusion mismatch involving a pediatric patient in congestive heart failure.
Topics: Adolescent; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Lung; Male; Milrinone; Pulmonary Circulation; Pulmonary Ventilation; Pyridones; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Ventilation-Perfusion Ratio | 1997 |
Use of intravenous inotropic therapy in the home.
Topics: Amrinone; Cardiotonic Agents; Dobutamine; Heart Failure; Home Infusion Therapy; Humans; Infusions, Intravenous; Milrinone; Pyridones | 1998 |
Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?
Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Critical Care; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Intensive Care Units; Phosphodiesterase Inhibitors | 2000 |
Outpatient parenteral inotropic therapy for advanced heart failure.
Topics: Adrenergic beta-Agonists; Aged; Ambulatory Care; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Prognosis; Severity of Illness Index; Survival Rate; Treatment Outcome | 2000 |
[Evaluation of hibernating myocardium in patients with heart insufficiency].
Topics: Cardiotonic Agents; Coronary Circulation; Dobutamine; Heart Failure; Heart Function Tests; Humans; Myocardial Contraction; Myocardial Revascularization; Myocardial Stunning; Prognosis; Tomography, Emission-Computed; Ultrasonography, Doppler; Ventricular Dysfunction, Left | 2000 |
Cardiovascular phenotype characterization in mice by high resolution magnetic resonance imaging.
Topics: Adrenergic beta-Agonists; Animals; Cardiovascular Physiological Phenomena; Cardiovascular System; Disease Models, Animal; Dobutamine; Heart Failure; Humans; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Phenotype; Ventricular Function, Left | 2000 |
[Anesthesia for heart transplantation].
Topics: Anesthesia, General; Animals; Cardiovascular Agents; Combined Modality Therapy; Dobutamine; Forecasting; Heart Failure; Heart Transplantation; Heart-Assist Devices; Hemodynamics; Humans; Phosphodiesterase Inhibitors; Preanesthetic Medication; Preoperative Care; Swine; Tissue and Organ Procurement; Transplantation, Heterologous; Transplantation, Homologous | 2001 |
Dobutamine: a new synthetic cardioactive sympathetic amine.
Topics: Animals; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Myocardial Infarction; Sympathomimetics | 1979 |
Exercise and the heart.
Topics: Blood Pressure; Dobutamine; Exercise Therapy; Heart Diseases; Heart Failure; Humans; Hypertension; Myocardial Infarction; Risk | 1992 |
[Treatment of chronic heart insufficiency with dobutamine. Value and limitations].
Topics: Chronic Disease; Dobutamine; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous | 1992 |
Outpatient dobutamine therapy: the rhyme and the riddle.
Topics: Ambulatory Care; Arrhythmias, Cardiac; Cardiomyopathies; Dobutamine; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Oxygen Consumption | 1992 |
Long-term dobutamine therapy for refractory congestive heart failure.
Topics: Dobutamine; Heart Failure; Humans | 1992 |
Changing strategies in the management of chronic congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Phosphodiesterase Inhibitors; Receptors, Adrenergic, beta | 1991 |
[Physiological bases and therapeutic uses of inodilator drugs].
Topics: Amrinone; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Sympathomimetics; Vasodilator Agents | 1991 |
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol | 1990 |
Pharmacology of modalities of treatment.
Topics: Adrenergic beta-Antagonists; Digitalis Glycosides; Diuretics; Dobutamine; Heart Failure; Humans; Vasodilator Agents | 1990 |
[Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
Topics: Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Myocardial Contraction; Vasodilation | 1990 |
Is intermittent dobutamine infusion useful in the treatment of patients with refractory congestive heart failure?
Topics: Dobutamine; Drug Administration Schedule; Heart Failure; Heart Ventricles; Humans; Infusions, Intravenous | 1990 |
The role of novel inotropic agents in the treatment of heart failure.
Topics: Amrinone; Animals; Cardiotonic Agents; Dobutamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Physical Exertion; Pyridazines; Pyridones; Time Factors | 1986 |
The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
Topics: Benzazepines; Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1989 |
Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?
Topics: Adrenergic Agonists; Animals; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Nitroprusside | 1989 |
Dopamine and dobutamine in pediatric therapy.
Topics: Child; Child, Preschool; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn; Shock | 1989 |
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Calcium; Cardiotonic Agents; Cyclic AMP; Dobutamine; Dopamine; Drug Tolerance; Glucagon; Heart Failure; Histamine; Humans; Levodopa; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Receptors, Adrenergic; Receptors, Adrenergic, beta; Stimulation, Chemical; Sympathomimetics; Theophylline; Xanthines | 1986 |
Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; Guinea Pigs; Heart Failure; Heart Rate; Heart Ventricles; Humans; Isoproterenol; Metoprolol; Myocardial Contraction; Norepinephrine; Propranolol; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Cell Surface; Receptors, Glucagon; Receptors, Histamine H2 | 1986 |
Some new positive inotropic agents.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Drug Tolerance; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practolol; Prenalterol; Pyridones | 1986 |
Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
Topics: Administration, Oral; Animals; Cardiomyopathies; Cardiotonic Agents; Dobutamine; Dogs; Enoximone; Heart Failure; Heart Rate; Hemodynamics; Hormones; Humans; Imidazoles; Injections, Intravenous; Kinetics; Lactates; Myocardial Contraction; Time Factors; Vasodilation | 1986 |
[Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Renal Circulation; Shock, Cardiogenic; Vascular Resistance; Vasodilation | 1985 |
Digitalis and other positive catecholamine-like inotropic agents in the management of congestive heart failure.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Glycosides; Cardiotonic Agents; Digitalis Glycosides; Digoxin; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Middle Aged; Myocardial Contraction; Random Allocation; Risk; Sodium-Potassium-Exchanging ATPase; Stroke Volume | 1986 |
Congestive heart failure.
Topics: Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Milrinone; Nitrates; Nitroprusside; Prazosin; Pyridones; Sympathomimetics; Vasodilator Agents | 1986 |
Review of intermittent dobutamine infusions for congestive cardiomyopathy.
Topics: Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Outpatients | 1987 |
The pharmacology of dobutamine.
Topics: Dobutamine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction | 1987 |
Persistent pulmonary hypertension of the newborn.
Topics: Animals; Cardiomyopathies; Catheterization; Diagnosis, Differential; Disease Models, Animal; Dobutamine; Echocardiography; Heart Failure; Humans; Hyperventilation; Infant, Newborn; Muscle Development; Muscle, Smooth, Vascular; Persistent Fetal Circulation Syndrome; Positive-Pressure Respiration; Pulmonary Circulation; Tolazoline | 1986 |
Use of intermittent dobutamine infusion in congestive heart failure.
Topics: Dobutamine; Heart Failure; Humans; Infusions, Intravenous | 1986 |
[Pump failure syndrome].
Topics: Cardiac Output; Catecholamines; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Nitroprusside | 1985 |
137 trial(s) available for dobutamine and Cardiac Failure
| Article | Year |
|---|---|
The use of peripherally inserted central catheter reduced the incidence of phlebitis in heart failure patients: A randomized trial.
Topics: Catheterization, Central Venous; Catheterization, Peripheral; Catheters, Indwelling; Central Venous Catheters; Dobutamine; Heart Failure; Humans; Incidence; Middle Aged; Phlebitis; Retrospective Studies | 2023 |
Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial.
Topics: Aged; Cardio-Renal Syndrome; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamic Monitoring; Hemodynamics; Humans; Male; Middle Aged; p-Aminohippuric Acid; Renal Circulation; Renal Insufficiency; Renal Plasma Flow; Simendan | 2018 |
Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Heart-Assist Devices; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Treatment Outcome | 2019 |
Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levels.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Blood Pressure; Cardiotonic Agents; China; Dobutamine; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Natriuretic Peptide, Brain; Recombinant Proteins; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2014 |
Short-term add-on therapy with angiotensin receptor blocker for end-stage inotrope-dependent heart failure patients: B-type natriuretic peptide reduction in a randomized clinical trial.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Cardiac Output, Low; Dobutamine; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Time Factors; Treatment Outcome | 2014 |
Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
Topics: Aged; Biomarkers; Cardiotonic Agents; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Pyridazines; Recovery of Function; Simendan; Stroke Volume; Systole; Time Factors; Treatment Outcome; Turkey; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2015 |
Global myocardial contractile reserve assessed by high-dose dobutamine stress echocardiography predicts response to the cardiac resynchronization therapy.
Topics: Cardiac Resynchronization Therapy; Dobutamine; Echocardiography, Stress; Exercise Test; Female; Fractional Flow Reserve, Myocardial; Heart Failure; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2015 |
Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Aged, 80 and over; Arterial Pressure; Diagnostic Techniques, Cardiovascular; Dobutamine; Female; Heart Failure; Humans; Hypertension, Pulmonary; Infusions, Parenteral; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Artery; Stroke Volume; Vasodilation; Ventricular Dysfunction, Right; Ventricular Function, Left; Ventricular Function, Right | 2015 |
Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.
Topics: Adolescent; Adult; Aged; Biomarkers; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyridazines; Serum Albumin; Serum Albumin, Human; Simendan; Treatment Outcome; Turkey; Young Adult | 2015 |
Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patients.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Dobutamine; Drug Therapy, Combination; Female; Finland; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Proportional Hazards Models; Pyridazines; Retrospective Studies; Simendan; Survival Analysis; Treatment Outcome | 2016 |
Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Propanolamines; Pyridazines; Simendan; Time Factors; Treatment Outcome | 2008 |
Effects of levosimendan on left atrial functions in patients with ischemic heart failure.
Topics: Aged; Atrial Function, Left; Blood Pressure; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Myocardial Ischemia; Pyridazines; Simendan; Stroke Volume; Ventricular Function, Left; Ventricular Pressure | 2008 |
Behavior of B-type natriuretic peptide during mechanical ventilation and spontaneous breathing after extubation.
Topics: Adult; Aged; Biomarkers; Cell Size; Critical Illness; Dobutamine; Dyspnea; Female; Heart Failure; Humans; Intensive Care Units; Male; Middle Aged; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Respiration, Artificial; Sensitivity and Specificity; Ventilator Weaning; Ventricular Dysfunction, Left; Water-Electrolyte Balance | 2009 |
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Cause of Death; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Simendan; Stroke Volume; Survival Rate; Treatment Outcome | 2009 |
Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure.
Topics: Aged; Cardiotonic Agents; Diastole; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Simendan; Stroke Volume; Systole; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Right | 2009 |
The costs of treating acute heart failure: an economic analysis of the SURVIVE trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Female; Health Expenditures; Heart Failure; Humans; Hydrazones; Length of Stay; Male; Middle Aged; Patient Admission; Pyridazines; Simendan | 2008 |
Usefulness and limitation of dobutamine stress echocardiography to predict acute response to cardiac resynchronization therapy.
Topics: Cardiac Pacing, Artificial; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2010 |
Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
Topics: Adult; Aged; Aged, 80 and over; Atrial Function, Left; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan; Single-Blind Method; Treatment Outcome; Young Adult | 2009 |
The effect of dobutamine without and with L-arginine on arterial compliance in heart failure patients.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Brachial Artery; Dobutamine; Drug Therapy, Combination; Elastic Modulus; Elasticity Imaging Techniques; Female; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2009 |
Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Analysis of Variance; Antihypertensive Agents; Cardiotonic Agents; Confidence Intervals; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Myocardial Perfusion Imaging; Natriuretic Peptide, Brain; Odds Ratio; Perfusion; Pulmonary Wedge Pressure; Pyridazines; Simendan; Vasodilator Agents | 2010 |
[Is it necessary to suspend betablockers in decompensated heart failure with low output?].
Topics: Adrenergic beta-Antagonists; Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Prospective Studies; Withholding Treatment | 2010 |
[Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Injections, Intravenous; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome | 2010 |
Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure.
Topics: Aged; Cardiotonic Agents; Chi-Square Distribution; Dobutamine; Female; Heart Conduction System; Heart Failure; Humans; Hydrazones; Male; Muscle Contraction; Pyridazines; Simendan; Statistics, Nonparametric | 2010 |
[Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiotonic Agents; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Parenteral; Male; Middle Aged; Pyridazines; Risk Factors; Simendan; Tachycardia, Ventricular; Ventricular Premature Complexes | 2010 |
Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiotonic Agents; Confidence Intervals; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Hospital Mortality; Humans; Hydrazones; Infusions, Intravenous; International Cooperation; Kaplan-Meier Estimate; Male; Middle Aged; Patient Discharge; Proportional Hazards Models; Pyridazines; Reference Values; Risk Assessment; Severity of Illness Index; Simendan; Survival Analysis; Treatment Outcome | 2011 |
Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure.
Topics: Cardiotonic Agents; Disease Progression; Dobutamine; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Prognosis; Prospective Studies; Tachycardia, Ventricular | 2012 |
[The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].
Topics: Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Prospective Studies; Pyridazines; Simendan; Treatment Outcome | 2012 |
Acute effect of sildenafil on central hemodynamics in mechanically ventilated patients with WHO group III pulmonary hypertension and right ventricular failure necessitating administration of dobutamine.
Topics: Adrenergic beta-1 Receptor Agonists; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Purines; Respiration, Artificial; Sildenafil Citrate; Sulfones; Time Factors; Treatment Outcome; Ventricular Dysfunction, Right | 2013 |
[Hemodynamic and efficacies of domestic levosimendan versus dobutamine in patients with acute decompensated heart failure].
Topics: Adolescent; Adult; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome; Young Adult | 2012 |
[Comparison on efficacy and safety between domestic levosimendan versus dobutamine for patients with acute decompensated heart failure].
Topics: Aged; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome | 2012 |
Effect of short-term infusive dobutamine therapy on thyroid hormone profile and hemodynamic parameters in patients with acute worsening heart failure and low-triiodothyronine syndrome.
Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Euthyroid Sick Syndromes; Heart Failure; Hemodynamics; Humans; Thyroid Hormones; Time Factors; Triiodothyronine | 2012 |
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Angiography; Severity of Illness Index; Time Factors; Treatment Outcome | 2002 |
Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
Topics: Aged; Cardiotonic Agents; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Tachycardia, Ventricular | 2002 |
Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Double-Blind Method; Europe; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Length of Stay; Life Expectancy; Male; Middle Aged; Patient Admission; Pyridazines; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Simendan; Survival Analysis; Treatment Outcome | 2003 |
Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
Topics: Cardiotonic Agents; Disease Progression; Dobutamine; Double-Blind Method; Endpoint Determination; Heart Failure; Hospitalization; Humans; Multicenter Studies as Topic; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Selection; Pilot Projects; Randomized Controlled Trials as Topic; Troponin I; Troponin T | 2003 |
Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Drug Costs; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Prospective Studies; Statistics as Topic | 2003 |
Neurohumoral activation and ventricular arrhythmias in patients with decompensated congestive heart failure: role of endothelin.
Topics: Arrhythmias, Cardiac; Cardiotonic Agents; Cytokines; Dobutamine; Electrocardiography, Ambulatory; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Natriuretic Agents; Natriuretic Peptide, Brain; Neurotransmitter Agents; Ventricular Premature Complexes | 2003 |
Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Cross-Over Studies; Dobutamine; Dopamine; Echocardiography, Stress; Heart Failure; Humans; Metoprolol; Middle Aged; Propanolamines; Single-Blind Method; Treatment Outcome | 2003 |
Comparison of the effects of dobutamine and nesiritide (B-type natriuretic peptide) on ventricular ectopy in acutely decompensated ischemic versus nonischemic cardiomyopathy.
Topics: Aged; Arrhythmias, Cardiac; Cardiomyopathies; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Agents; Natriuretic Peptide, Brain; Prospective Studies; Treatment Outcome; Ventricular Premature Complexes | 2003 |
Therapeutic implications of contractile reserve elicited by dobutamine echocardiography in symptomatic, low-gradient aortic stenosis.
Topics: Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Dobutamine; Echocardiography, Stress; Feasibility Studies; Female; Heart Failure; Humans; Male; Middle Aged; Mortality; Myocardial Contraction; Survival Analysis; Ventricular Dysfunction, Left | 2003 |
Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study.
Topics: Aged; Cardiotonic Agents; Cross-Over Studies; Dobutamine; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Pilot Projects; Quality of Life; Time Factors | 2002 |
Dobutamine potentiates the peripheral chemoreflex in patients with congestive heart failure.
Topics: Adult; Aged; Chemoreceptor Cells; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hypoxia; Male; Middle Aged; Pulmonary Ventilation | 2003 |
Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Chronic Disease; Dobutamine; Echocardiography; Enoximone; Exercise Test; Female; Heart Failure; Humans; Image Enhancement; Male; Middle Aged; Myocardial Infarction; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Peripheral sympathetic control during dobutamine infusion: effects of aging and heart failure.
Topics: Adrenergic beta-Agonists; Age Factors; Blood Pressure; Dobutamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Pressoreceptors; Sympathetic Nervous System; Vasodilation | 2003 |
Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Topics: Adrenergic beta-Agonists; Calcium Channels, L-Type; Cardiac Output, Low; Cardiotonic Agents; Death, Sudden, Cardiac; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Morbidity; Myocardial Contraction; Pulmonary Wedge Pressure; Pyridazines; Risk Factors; Severity of Illness Index; Shock, Cardiogenic; Simendan; Stroke Volume; Survival Analysis; Time; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Prognostic usefulness of echocardiographic dobutamine in younger (14 to 25 years) and older (40 to 55 years) patients with idiopathic dilated cardiomyopathy.
Topics: Adolescent; Adult; Age Factors; Cardiomyopathy, Dilated; Cardiotonic Agents; Case-Control Studies; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Humans; Male; Middle Aged; Oxygen Consumption; Prognosis; Prospective Studies; Risk Factors | 2004 |
Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
Topics: Aged; Ambulatory Care; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Hospice Care; Humans; Infusions, Intravenous; Male; Milrinone; Needs Assessment; New York; Palliative Care; Patient Acceptance of Health Care; Quality of Life; Terminally Ill | 2004 |
Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study.
Topics: Administration, Oral; Amiodarone; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Survival Rate; Vasodilator Agents | 2004 |
Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Sympathomimetics | 2004 |
Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure.
Topics: Adrenergic beta-Agonists; Adult; Aged; Brachial Artery; Dobutamine; Drug Therapy, Combination; Endothelium, Vascular; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Prospective Studies; Ultrasonography; Vasodilation; Vasodilator Agents | 2004 |
Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
Topics: Administration, Oral; Cardiac Output; Cardiotonic Agents; Diuretics; Dobutamine; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Pyridazines; Simendan | 2004 |
Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
Topics: Aged; Chronic Disease; Confidence Intervals; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Probability; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Survival Analysis; Tachycardia, Ventricular; Treatment Outcome | 2004 |
The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Interleukin-6; Male; Malondialdehyde; Middle Aged; Natriuretic Peptide, Brain; Oxidative Stress; Pyridazines; Simendan; Time Factors; Tumor Necrosis Factor-alpha | 2005 |
Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure.
Topics: Ascorbic Acid; Blood Pressure; Cardiotonic Agents; Dobutamine; Drug Combinations; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Remodeling | 2006 |
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
Topics: Biomarkers; C-Reactive Protein; Cardiotonic Agents; Case-Control Studies; Cell Adhesion Molecules; Chemokine CCL2; Colorimetry; Cytokines; Dinoprost; Disease Progression; Dobutamine; E-Selectin; Enzyme-Linked Immunosorbent Assay; Exercise Test; Female; Heart Failure; Humans; Inflammation; Interleukin-18; Interleukin-6; Male; Middle Aged; Milrinone; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Tyrosine | 2006 |
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.
Topics: Cardiotonic Agents; Cost-Benefit Analysis; Decision Trees; Dobutamine; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Models, Economic; Models, Statistical; Monte Carlo Method; Natriuretic Agents; Natriuretic Peptide, Brain | 2006 |
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Topics: Aged; Apoptosis; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography; Fas Ligand Protein; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Interleukin-6; Male; Membrane Glycoproteins; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Pulmonary Wedge Pressure; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Tumor Necrosis Factor-alpha; Tumor Necrosis Factors | 2006 |
Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Pyridazines; Simendan; Single-Blind Method | 2008 |
Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aminoglycosides; Animals; Cardiac Catheterization; Cardiotonic Agents; Diastole; Dobutamine; Dogs; Echocardiography, Doppler; Enediynes; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Mitral Valve; Models, Cardiovascular; Predictive Value of Tests; Propanolamines; Pulmonary Wedge Pressure; Ventricular Function, Left; Ventricular Pressure | 2007 |
Improvement in Doppler alternans in patients with severe heart failure: Levosimendan versus dobutamin.
Topics: Adult; Aged; Cardiotonic Agents; Dobutamine; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Ventricular Function, Left | 2008 |
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Simendan; Survival Analysis | 2007 |
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
Topics: Cardiovascular Agents; Combined Modality Therapy; Cytokines; Dobutamine; Exercise Test; Exercise Tolerance; Female; Fibrosis; Heart Failure; Heart Function Tests; Heart Transplantation; Heart-Assist Devices; Humans; Hypertrophy; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Prospective Studies; Single-Blind Method; Stroke Volume; Treatment Outcome; Ultrasonography | 2007 |
Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
Topics: Cardiotonic Agents; Dobutamine; Double-Blind Method; Echocardiography; Eligibility Determination; Heart Failure; Heart Transplantation; Humans; Infusions, Intravenous; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Selection; Preoperative Care; Research Design; Sample Size; Severity of Illness Index; Survival Rate; Treatment Outcome | 2007 |
Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Female; Follow-Up Studies; Heart Conduction System; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Severity of Illness Index; Treatment Outcome; Ventricular Dysfunction, Left | 2007 |
Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome; Ventricular Function, Right | 2008 |
Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine.
Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hydrazones; Kidney; Male; Middle Aged; Pyridazines; Simendan; Urination | 2007 |
Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure.
Topics: Biomarkers; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Female; Furosemide; Heart Failure; Humans; Hypokalemia; Hyponatremia; Male; Middle Aged; Potassium; Renal Insufficiency; Saline Solution, Hypertonic; Severity of Illness Index; Sodium; Time Factors; Treatment Outcome; Urea | 2007 |
Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.
Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Oxygen Consumption; Physical Exertion | 1984 |
Drug-induced conditioning in congestive heart failure.
Topics: Adult; Aged; Ambulatory Care; Cardiac Output; Catecholamines; Dobutamine; Drug Administration Schedule; Female; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Random Allocation; Time Factors | 1982 |
Sympathetic stimulations by exercise-stress testing and by dobutamine infusion induce similar changes in heart rate variability in patients with chronic heart failure.
Topics: Aged; Blood Pressure; Chronic Disease; Cross-Over Studies; Dobutamine; Exercise; Exercise Test; Heart Failure; Heart Rate; Humans; Middle Aged; Reproducibility of Results; Sympathetic Nervous System | 1995 |
Preliminary evidence for the mechanism underlying the development of tolerance to prazosin in congestive heart failure: the alpha-agonistic properties of dobutamine unmasked by prazosin treatment.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prazosin; Up-Regulation; Vasodilator Agents | 1993 |
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program.
Topics: Alprostadil; Angiotensin-Converting Enzyme Inhibitors; Death, Sudden, Cardiac; Digoxin; Dobutamine; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Life Tables; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome | 1995 |
Changes in myocardial oxygen consumption and efficiency with heart failure therapy measured by 11C acetate PET.
Topics: Acetates; Animals; Carbon Radioisotopes; Cardiomyopathy, Dilated; Dobutamine; Heart Failure; Humans; Myocardium; Nitroprusside; Oxygen Consumption; Tomography, Emission-Computed | 1995 |
Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure.
Topics: Administration, Oral; Blood Flow Velocity; Cardiac Catheterization; Coronary Circulation; Diastole; Dobutamine; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isoquinolines; Male; Middle Aged; Phosphodiesterase Inhibitors; Tetrahydroisoquinolines; Ventricular Function, Left | 1995 |
Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure.
Topics: Aged; Dobutamine; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Lymphocytes; Male; Middle Aged; Norepinephrine; Receptors, Adrenergic, beta; Up-Regulation; Vascular Resistance | 1995 |
A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
Topics: Aged; Aged, 80 and over; Amrinone; Analysis of Variance; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Prospective Studies; Treatment Outcome; Ventricular Function, Left | 1995 |
[The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
Topics: Adult; Aged; Analysis of Variance; Dobutamine; Dopamine; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Nitroprusside; Phosphodiesterase Inhibitors; Pyridones | 1994 |
Oral enoximone as a substitute for intravenous catecholamine support in end-stage congestive heart failure.
Topics: Administration, Oral; Aged; Cardiac Output, Low; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged | 1994 |
Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
Topics: Alprostadil; Analysis of Variance; Chronic Disease; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Single-Blind Method; Time Factors | 1994 |
[An outpatient study by stress echocardiography with dobutamine of myocardial function in patients with congestive heart failure (the first trial in Russia of the use of the dobutamine-echocardiography test)].
Topics: Adult; Aged; Ambulatory Care; Dobutamine; Echocardiography, Doppler; Exercise Test; Heart; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Moscow; Myocardial Contraction | 1993 |
Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Output; Dobutamine; Double-Blind Method; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left | 1993 |
Effects of dobutamine and/or nitroprusside on the pulmonary circulation in patients with pulmonary hypertension secondary to end-stage heart failure.
Topics: Blood Pressure; Cardiac Catheterization; Cardiac Output, Low; Dobutamine; Drug Combinations; Electrocardiography; Heart Failure; Heart Rate; Heart Transplantation; Humans; Hypertension, Pulmonary; Middle Aged; Nitroprusside; Pulmonary Artery; Pulmonary Circulation; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Ventricular Function, Right | 1993 |
A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
Topics: Cardiotonic Agents; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Middle Aged; Oxygen Consumption; Prospective Studies; Quinolones; Vascular Resistance; Vasodilator Agents; Ventricular Function, Left | 1996 |
Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Premedication; Prognosis; Prospective Studies; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Right | 1995 |
Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Echocardiography; Electrocardiography, Ambulatory; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Myocardial Infarction; Pyridones; Treatment Outcome | 1996 |
Interleukin-6 correlates with hemodynamic impairment during dobutamine administration in chronic heart failure.
Topics: Adult; Chronic Disease; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Interleukin-6; Male; Middle Aged; Pilot Projects; Prognosis; Sensitivity and Specificity; Severity of Illness Index; Stroke Volume; Vascular Resistance | 1996 |
Safety and clinical utility of long-term intravenous milrinone in advanced heart failure.
Topics: Adult; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hypotension; Injections, Intravenous; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Prospective Studies; Pyridones; Survival Rate; Tachycardia, Supraventricular; Tachycardia, Ventricular; Thrombocytopenia; Treatment Outcome | 1997 |
Low dose dobutamine echocardiography predicts improvement in functional capacity after exercise training in patients with ischemic cardiomyopathy: prognostic implication.
Topics: Adult; Aged; Cardiotonic Agents; Dobutamine; Exercise Test; Exercise Therapy; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Stunning; Oxygen Consumption; Predictive Value of Tests; Prognosis; Ultrasonography; Ventricular Dysfunction, Left | 1998 |
Dopamine and dobutamine have different effects on heart rate variability in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Sympathomimetics | 1998 |
Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.
Topics: Adrenergic beta-Agonists; Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Humans; Injections, Intravenous; Male; Myocardial Ischemia; Severity of Illness Index; Survival Analysis; Treatment Outcome | 1998 |
Saterinone, dobutamine, and sodium nitroprusside: comparison of cardiovascular profiles in patients with congestive heart failure.
Topics: Adult; Aged; Antihypertensive Agents; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroprusside; Oxygen Consumption; Phosphodiesterase Inhibitors; Piperazines; Pyridones | 1998 |
Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
Topics: Alprostadil; Ambulatory Care; Antihypertensive Agents; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Disease Progression; Dobutamine; Epoprostenol; Female; Heart Failure; Heart Transplantation; Hospitalization; Humans; Infusions, Intravenous; Lung; Male; Middle Aged; Pilot Projects; Prospective Studies; Pulmonary Wedge Pressure; Risk Factors; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 1999 |
The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Tumor Necrosis Factor-alpha | 1999 |
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Risk; Severity of Illness Index; Survival Analysis; Treatment Outcome | 1999 |
Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
Topics: Adult; Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Treatment Outcome | 1999 |
Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
Topics: Alprostadil; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Dobutamine; Endothelins; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prospective Studies; Renal Circulation; Vasodilator Agents | 1999 |
Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
Topics: Aged; Cardiotonic Agents; Catecholamines; Critical Illness; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Prospective Studies | 2000 |
Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Volume; Cardiomyopathy, Dilated; Diastole; Dobutamine; Energy Metabolism; Enzyme Inhibitors; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Oxygen Consumption; Pulmonary Wedge Pressure; Systole | 2000 |
Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
Topics: Adult; Aged; Alprostadil; Ambulatory Care; Cardiotonic Agents; Dobutamine; Endothelin-1; Endothelins; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Long-Term Care; Male; Middle Aged; Prognosis; Prospective Studies; Protein Precursors; Survival Rate; Vascular Resistance; Vasodilator Agents | 2000 |
Effect of diabetes mellitus on heart rate variability in patients with congestive heart failure.
Topics: Atrial Natriuretic Factor; Cardiotonic Agents; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Signal Processing, Computer-Assisted | 2001 |
Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure.
Topics: Administration, Oral; Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Creatinine; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pulmonary Wedge Pressure; Sodium; Stroke Volume; Survival Rate | 2001 |
Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy.
Topics: Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Natriuretic Peptide, Brain; Statistics, Nonparametric; Tachycardia, Ventricular; Treatment Outcome | 2001 |
A pilot safety trial of prolonged (48 h) infusion of the dual endothelin-receptor antagonist tezosentan in patients with advanced heart failure.
Topics: Acute Disease; Aged; Dobutamine; Double-Blind Method; Drug Tolerance; Echocardiography, Doppler; Endothelin Receptor Antagonists; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Pyridines; Safety; Tetrazoles | 2001 |
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Cardiotonic Agents; Dobutamine; Female; Health Care Costs; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Readmission; Prospective Studies; Survival Rate; Time Factors; Treatment Outcome | 2002 |
Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
Topics: Aged; Blood Gas Analysis; Blood Pressure; Cardiac Output; Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Drug Evaluation; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Pulmonary Circulation; Vascular Resistance | 1977 |
Comparison of dobutamine and dopamine in treatment of severe heart failure.
Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Drug Evaluation; Heart Failure; Hemodynamics; Humans | 1977 |
[Combined infusion of nitroprusside and dobutamine in the treatment of severe congestive heart failure (author's transl)].
Topics: Adult; Catecholamines; Coronary Disease; Dobutamine; Drug Synergism; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Humans; Infusions, Parenteral; Male; Middle Aged; Nitroprusside | 1979 |
[Dopamine and dobutamine in the treatment of severe cardiac failure (author's transl)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Dopamine; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Oxygen Consumption; Pulmonary Circulation; Pulmonary Edema; Stroke Volume | 1978 |
Modulation of inotropic therapy by venodilation in acute heart failure: a randomised comparison of four inotropic agents, alone and combined with isosorbide dinitrate.
Topics: Adult; Aged; Amrinone; Cardiotonic Agents; Digoxin; Dobutamine; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Prenalterol; Prospective Studies; Single-Blind Method; Vasodilation | 1992 |
The renal effects of dopamine and dobutamine in stable chronic heart failure.
Topics: Aged; Chronic Disease; Diuresis; Dobutamine; Dopamine; Drug Interactions; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Kidney; Male; Middle Aged; Single-Blind Method | 1992 |
Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.
Topics: Adult; Aged; Blood Pressure; Body Weight; Dobutamine; Drug Tolerance; Exercise Test; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Oxygen; Physical Exertion; Random Allocation | 1992 |
Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Bucladesine; Cardiac Output; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Vascular Resistance | 1990 |
[Hemodynamic effects of enoximone--comparative studies of heart surgery patients].
Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Drug Therapy, Combination; Enoximone; Epinephrine; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusion Pumps; Myocardial Contraction; Phosphodiesterase Inhibitors; Postoperative Complications | 1991 |
[The effect of enoximone and catecholamines on renal function after open heart surgery].
Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Diuresis; Dobutamine; Enoximone; Heart Failure; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Imidazoles; Kidney Function Tests; Middle Aged; Myocardial Contraction; Phosphodiesterase Inhibitors; Postoperative Complications; Prospective Studies; Vascular Resistance | 1991 |
[The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Topics: Aged; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors | 1991 |
Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Topics: Adult; Aged; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pulmonary Wedge Pressure; Pyridones; Receptors, Adrenergic, beta; Stroke Volume; Time Factors | 1991 |
Metolazone in treatment of severe refractory congestive cardiac failure.
Topics: Aged; Aged, 80 and over; Body Weight; Clinical Trials as Topic; Diuresis; Diuretics; Dobutamine; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Male; Metolazone; Middle Aged; Prognosis | 1990 |
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol | 1990 |
Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure.
Topics: Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Vasodilator Agents | 1991 |
Piroximone, dobutamine and nitroprusside: comparative effects on haemodynamics in patients with congestive heart failure.
Topics: Adult; Aged; Analysis of Variance; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside; Random Allocation | 1991 |
[Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
Topics: Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged | 1990 |
[Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
Topics: Adult; Aged; Angiography, Digital Subtraction; Cardiomyopathy, Dilated; Cardiotonic Agents; Cineangiography; Dobutamine; Enoximone; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Vasodilation | 1990 |
[Enoximone in the hemodynamic evaluation before heart transplantation. A new test].
Topics: Adult; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside | 1990 |
Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.
Topics: Adult; Amrinone; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Water-Electrolyte Balance | 1990 |
Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Topics: Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Nitroprusside; Pulmonary Circulation; Pyridazines; Receptors, Adrenergic, beta; Stroke Volume; Time Factors; Vascular Resistance; Vasodilator Agents | 1989 |
Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
Topics: Adult; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Chronic Disease; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Myocardial Contraction; Nitroprusside; Pulmonary Artery; Pulmonary Wedge Pressure; Pyridazines; Receptors, Adrenergic, beta; Stroke Volume; Time Factors; Vascular Resistance | 1989 |
Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
Topics: Aged; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Enoximone; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside | 1987 |
[Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Renal Circulation; Shock, Cardiogenic; Vascular Resistance; Vasodilation | 1985 |
Hemodynamic effect of oral TA-064 after dobutamine in congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors | 1987 |
[Clinical effects of the infusion of dobutamine and amrinone in patients with refractory cardiac insufficiency].
Topics: Aged; Aged, 80 and over; Amrinone; Body Weight; Clinical Trials as Topic; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged | 1987 |
An analytical method to separate inotropic and vasodilatory drug effects in patients with heart failure.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Felodipine; Female; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Male; Middle Aged; Nitrendipine; Vasodilator Agents | 1987 |
Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
Topics: Clinical Trials as Topic; Dobutamine; Ferricyanides; Heart Failure; Hemodynamics; Humans; Milrinone; Myocardial Contraction; Nitroprusside; Oxygen Consumption; Pyridones | 1986 |
Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Topics: Aged; Blood Pressure; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Myocardial Contraction; Nitroprusside; Norepinephrine; Pyridones; Stimulation, Chemical; Vascular Resistance; Vasodilation | 1986 |
Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Coronary Disease; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Milrinone; Pyridones | 1987 |
Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Pyridones; Systole | 1987 |
496 other study(ies) available for dobutamine and Cardiac Failure
| Article | Year |
|---|---|
Identification of a Hydroxypyrimidinone Compound (
Topics: Animals; Apelin Receptors; Dogs; Drug Discovery; Heart Failure; Humans; Pyrimidinones; Rats; Structure-Activity Relationship | 2021 |
Renal Hemodynamics and Renin-Angiotensin-Aldosterone System Profiles in Patients With Heart Failure.
Topics: Aldosterone; Biomarkers; Dobutamine; Heart Failure; Hemodynamics; Humans; Nitroprusside; Renin; Renin-Angiotensin System | 2022 |
Incidence and Predictors of Eosinophilic Myocardial Hypersensitivity in Patients Receiving Home Dobutamine.
Topics: Adult; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Milrinone; Myocardium | 2022 |
Prognostic Role of Cardiac Power in a Large Cohort of Patients with Normal Ejection Fraction Referred for Dobutamine Stress Echocardiography.
Topics: Aged; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Stroke Volume; Ventricular Function, Left | 2022 |
Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
Topics: Adrenergic beta-Antagonists; Adult; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Retrospective Studies | 2022 |
Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Retrospective Studies; Stroke Volume; Ventricular Function, Left | 2022 |
[Comparative assessment of the effects of dobutamine and levosimendan on right ventricular ejection fraction in patients with biventricular heart failure].
Topics: Cardiovascular Agents; Cross-Sectional Studies; Dobutamine; Heart Failure; Humans; Prospective Studies; Simendan; Stroke Volume; Ventricular Function, Left; Ventricular Function, Right | 2023 |
Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
Topics: Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone; Retrospective Studies; Shock, Cardiogenic | 2023 |
Preoperative Levosimendan Administration in Heart Transplant Patients with Severe Hepatic and Renal Impairment: A Retrospective Study.
Topics: Dobutamine; Dopamine; Heart Failure; Heart Transplantation; Humans; Renal Insufficiency; Retrospective Studies; Simendan | 2023 |
Successful echocardiography-guided medical management of severe early post-implant right ventricular failure in a patient with left ventricular assist device support: a case report.
Topics: Adolescent; Dobutamine; Echocardiography; Female; Heart Failure; Heart-Assist Devices; Humans; Milrinone; Retrospective Studies | 2023 |
Myocardial Energetics in Heart Failure With Preserved Ejection Fraction.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Case-Control Studies; Coronary Circulation; Dobutamine; Echocardiography, Stress; Energy Metabolism; Female; Heart Failure; Humans; Male; Microcirculation; Middle Aged; Myocardium; Oxygen Consumption; Positron-Emission Tomography; Prospective Studies; Stroke Volume; Ventricular Function, Left | 2019 |
Combined Therapy With Dobutamine and Omecamtiv Mecarbil in Pigs With Ischemic Acute Heart Failure Is Attributed to the Effect of Dobutamine.
Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Energy Metabolism; Heart Failure; Male; Myocardial Contraction; Myocardial Ischemia; Oxygen Consumption; Sus scrofa; Urea; Ventricular Function, Left | 2020 |
Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
Topics: Aged; Cardiotonic Agents; Cause of Death; Disease Progression; Dobutamine; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Milrinone; Recovery of Function; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2020 |
Levosimendan with other inotropes or vasopressors: Should you combine them?
Topics: Acute Disease; Aged; Aged, 80 and over; Arterial Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Hospital Mortality; Humans; Hypotension; Length of Stay; Male; Middle Aged; Norepinephrine; Simendan; Tachycardia, Supraventricular; Treatment Outcome; Vasoconstrictor Agents | 2020 |
Feasibility and value of two-dimensional volumetric stress echocardiography.
Topics: Aged; Dobutamine; Echocardiography; Echocardiography, Stress; Feasibility Studies; Heart Failure; Humans; Male; Middle Aged | 2022 |
COVID-19 infection in left ventricular assist device patients.
Topics: Aged; Cardiotonic Agents; COVID-19; Dobutamine; Furosemide; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Simendan; Ventricular Dysfunction, Right | 2020 |
Comparison of cardiac output estimates by echocardiography and bioreactance at rest and peak dobutamine stress test in heart failure patients with preserved ejection fraction.
Topics: Cardiac Output; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Stroke Volume; Ventricular Function, Left | 2020 |
Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Outpatients; Retrospective Studies | 2020 |
Application of dopamine combined with dobutamine in children with pneumonia and heart failure.
Topics: Adrenergic beta-1 Receptor Agonists; Age Factors; Cardiotonic Agents; Case-Control Studies; Child, Preschool; Dobutamine; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Female; Heart Failure; Humans; Infant; Length of Stay; Male; Pneumonia; Recovery of Function; Time Factors; Treatment Outcome | 2020 |
Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Milrinone; Mortality; Retrospective Studies | 2017 |
Is the mechanism of re-expansion pulmonary oedema in a heart-lung interaction?
Topics: Aged; Blood Pressure; Cardiotonic Agents; Dobutamine; Drainage; Echocardiography; Heart; Heart Failure; Heart Ventricles; Humans; Hypertension, Pulmonary; Lung; Male; Mitral Valve Insufficiency; Pleural Effusion; Pulmonary Edema; Respiratory Insufficiency; Stroke Volume; Ventricular Function, Left | 2017 |
Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
Topics: Acute Disease; Aged; Cardio-Renal Syndrome; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Incidence; Male; Middle Aged; Pyridazines; Retrospective Studies; Simendan | 2017 |
Successful Withdrawal from Dobutamine by Canagliflozin in a Diabetic Patient with Stage D Heart Failure.
Topics: Aged; Canagliflozin; Cardiotonic Agents; Diabetes Complications; Dobutamine; Female; Heart Failure; Humans; Hypoglycemic Agents | 2017 |
Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Home Care Services; Humans; Infusions, Intravenous; Male; Palliative Care; Quality of Life; Retrospective Studies; Stroke Volume; Treatment Outcome | 2018 |
Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality.
Topics: Aged; Aged, 80 and over; Cardiac Surgical Procedures; Cardiotonic Agents; Cohort Studies; Denmark; Dobutamine; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Milrinone; Prospective Studies; Retrospective Studies | 2018 |
Stability of dobutamine in continuous ambulatory delivery devices.
Topics: Dobutamine; Drug Delivery Systems; Drug Packaging; Drug Stability; Heart Failure; Humans; Infusion Pumps; Temperature | 2018 |
Remote Left Ventricular Hemodynamic Monitoring Using a Novel Intracardiac Sensor.
Topics: Animals; Cardiac Catheterization; Cardiac Pacing, Artificial; Disease Models, Animal; Dobutamine; Dogs; Echocardiography; Equipment Design; Heart Failure; Hemodynamics; Male; Miniaturization; Predictive Value of Tests; Remote Sensing Technology; Reproducibility of Results; Time Factors; Transducers, Pressure; Vasopressins; Ventricular Function, Left | 2018 |
Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
Topics: Adolescent; Adult; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Infant; Infusions, Intravenous; Male; Milrinone; Retrospective Studies; Simendan; Survival Rate; Treatment Outcome; Young Adult | 2018 |
Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition.
Topics: Animals; Calcium; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dogs; Heart Failure; Heart Rate; Hemodynamics; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Rabbits; Receptors, Adrenergic, beta-2; Signal Transduction | 2018 |
Treatments targeting inotropy.
Topics: Acute Disease; Animals; Antioxidants; Calcium; Cardiotonic Agents; Case-Control Studies; Catecholamines; Clinical Trials as Topic; Diastole; Dobutamine; Dogs; Energy Metabolism; Excitation Contraction Coupling; Heart Failure; Humans; Mitochondria; Models, Animal; Myocardial Contraction; Nitrogen Oxides; Oxidation-Reduction; Phosphodiesterase Inhibitors; Placebos; Receptors, Adrenergic; Sarcomeres; Shock, Cardiogenic; Simendan; Swine; Systole; Urea | 2019 |
Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co-treatment in pigs with acute ischemic heart failure.
Topics: Animals; Cardiotonic Agents; Cardiovascular Agents; Diastole; Dobutamine; Drug Therapy, Combination; Heart Failure; Ivabradine; Male; Myocardial Ischemia; Swine; Treatment Outcome; Urea | 2018 |
Drop-off in positivity rate of stress echocardiography based on regional wall motion abnormalities over the last three decades.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Coronary Artery Disease; Dipyridamole; Dobutamine; Echocardiography, Stress; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Time Factors; Vasodilator Agents; Ventricular Function, Left | 2019 |
Echocardiography for prediction of 6-month and late response to cardiac resynchronization therapy: implementation of stress echocardiography and comparative assessment along with widely used dyssynchrony indices.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Cardiac Resynchronization Therapy; Dobutamine; Echocardiography, Doppler, Color; Echocardiography, Stress; Female; Heart Failure; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Recovery of Function; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Function, Right | 2019 |
Fenestration in the Fontan circulation as a strategy for chronic cardioprotection.
Topics: Adrenergic beta-1 Receptor Agonists; Child; Child, Preschool; Dobutamine; Echocardiography; Echocardiography, Stress; Female; Fontan Procedure; Heart Defects, Congenital; Heart Failure; Heart Rate; Hemodynamics; Humans; Hyperemia; Male; Myocardial Contraction | 2019 |
The value of a simplified approach to end-systolic volume measurement for assessment of left ventricular contractile reserve during stress-echocardiography.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Coronary Artery Disease; Dipyridamole; Dobutamine; Echocardiography, Stress; Feasibility Studies; Female; Heart Failure; Humans; Italy; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Stroke Volume; Systole; Vasodilator Agents; Ventricular Function, Left | 2019 |
Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol.
Topics: Adult; Aged; Cardiotonic Agents; Clinical Protocols; Critical Care; Dobutamine; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Milrinone; Patient Discharge; Retrospective Studies; Treatment Outcome | 2019 |
Ventricular dyssynchrony; it is a dynamic phenomenon.
Topics: Cardiac Resynchronization Therapy; Clinical Trials as Topic; Dobutamine; Echocardiography; Exercise Test; Heart Failure; Humans; Prognosis; Ventricular Dysfunction, Left; Ventricular Function, Left | 2013 |
Low-dose dobutamine induces left ventricular mechanical dyssynchrony in patients with dilated cardiomyopathy and a narrow QRS: a study using real-time three-dimensional echocardiography.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Echocardiography, Three-Dimensional; Electrocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Ventricular Dysfunction, Left | 2013 |
Right ventricular-pulmonary arterial coupling in patients after repair of tetralogy of Fallot.
Topics: Adolescent; Cardiac Catheterization; Cardiac Surgical Procedures; Cardiotonic Agents; Child; Compliance; Dobutamine; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Myocardial Contraction; Predictive Value of Tests; Pulmonary Artery; Tetralogy of Fallot; Treatment Outcome; Vascular Stiffness; Ventricular Dysfunction, Right; Ventricular Function, Right; Young Adult | 2013 |
Left ventricular assist device implantation in heart failure patients with a left ventricular thrombus.
Topics: Dobutamine; Dopamine; Heart Failure; Heart-Assist Devices; Humans; Thrombosis; Ventricular Dysfunction, Left | 2013 |
Characteristics of patients with advanced heart failure having eosinophilic infiltration of the myocardium in the recent era.
Topics: Biopsy; Dobutamine; Eosinophils; Heart Failure; Heart Transplantation; Humans; Milrinone; Myocarditis; Myocardium; Prognosis; Retrospective Studies; Survival Analysis; Survival Rate | 2013 |
An autonomic link between inhaled diesel exhaust and impaired cardiac performance: insight from treadmill and dobutamine challenges in heart failure-prone rats.
Topics: Animals; Dobutamine; Electrocardiography; Heart Failure; Male; Rats; Rats, Inbred SHR; Vehicle Emissions; Walking | 2013 |
Usefulness of a surface cooling device (Arctic Sun®) for therapeutic hypothermia following cardiac arrest.
Topics: Aged; Body Temperature; Cardiotonic Agents; Dobutamine; Female; Heart Arrest; Heart Failure; Humans; Hypothermia, Induced; Infusions, Intravenous; Male; Middle Aged | 2014 |
The effect of the renin-angiotensin-aldosterone system inhibition on myocardial function in early and late phases of dilated cardiomyopathy in Tgaq*44 mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Canrenone; Cardiovascular Agents; Dobutamine; Heart Failure; Mice; Mice, Transgenic; Models, Animal; Perindopril; Renin-Angiotensin System | 2013 |
Can we do better than dobutamine?
Topics: Arrhythmias, Cardiac; Cardiac Output; Cardiotonic Agents; Dobutamine; Drug Discovery; Heart Failure; Humans; Myocardial Contraction; Risk Factors; Treatment Outcome | 2013 |
Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure.
Topics: Acetylation; Animals; Cardiotonic Agents; Dobutamine; Electron Transport Complex I; Female; Heart Failure; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Mitochondrial Diseases; Myocardium; NAD; Oxidative Stress; Pregnancy; Reactive Oxygen Species; Sirtuin 3 | 2013 |
Levosimendan: a retrospective single-center case series.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Hospital Mortality; Humans; Hydrazones; Intensive Care Units; Male; Milrinone; Norepinephrine; Pyridazines; Retrospective Studies; Simendan; Sympathomimetics; Treatment Outcome | 2013 |
Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Disease Progression; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Hydrazones; Infusions, Intravenous; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neutrophils; Predictive Value of Tests; Pyridazines; Retrospective Studies; Simendan | 2014 |
Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Echocardiography; Enoximone; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Prognosis; Propanolamines; Retrospective Studies; Survival Rate; Ventilator Weaning | 2014 |
Regional myocardial contractile reserve assessed by strain echocardiography and the response to cardiac resynchronization therapy.
Topics: Cardiac Resynchronization Therapy; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Prospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2014 |
[Takotsubo cardiomyopathy in an adolescent girl].
Topics: Adolescent; Cerebellum; Dobutamine; Echocardiography; Female; Heart Failure; Heart Failure, Systolic; Hematoma; Humans; Intracranial Arteriovenous Malformations; Prognosis; Rupture, Spontaneous; Takotsubo Cardiomyopathy | 2014 |
Expression of uncoupling protein-2 remains increased within hibernating myocardium despite successful coronary artery bypass grafting at 4 wk post-revascularization.
Topics: Animals; Cardiac Imaging Techniques; Cardiotonic Agents; Cell Respiration; Chronic Disease; Coronary Artery Bypass; Coronary Circulation; Disease Models, Animal; Dobutamine; Echocardiography, Doppler; Heart Failure; Ion Channels; Mitochondria; Mitochondrial Proteins; Myocardial Stunning; Oxidative Stress; Swine; Tomography, X-Ray Computed; Uncoupling Protein 2 | 2015 |
Dobutamine-induced fever and isolated eosinophilic myocarditis in a 66-year-old male awaiting heart transplantation: a case report.
Topics: Aged; Cardiotonic Agents; Dobutamine; Eosinophilia; Fever; Heart Failure; Heart Transplantation; Humans; Male; Myocarditis; Waiting Lists | 2014 |
Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Topics: Administration, Inhalation; Animals; Arterial Pressure; Cardiotonic Agents; Disease Models, Animal; Disease Progression; Dobutamine; Energy Metabolism; Heart Failure; Hexokinase; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; L-Lactate Dehydrogenase; Male; Mitochondria, Heart; Monocrotaline; Oxygen; Oxygen Consumption; Protoporphyrins; Pulmonary Artery; Rats, Wistar; Ventricular Dysfunction, Right; Ventricular Function, Right | 2015 |
Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study.
Topics: Animals; Area Under Curve; Cardiac Catheterization; Disease Models, Animal; Dobutamine; Echocardiography, Doppler; Echocardiography, Stress; Exercise Tolerance; Feasibility Studies; Head-Down Tilt; Heart Failure; Hemodynamics; Male; Obesity; Oxygen Consumption; Phenylephrine; Predictive Value of Tests; Rats, Inbred WKY; Rats, Zucker; Reproducibility of Results; ROC Curve; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2015 |
Reversible Cardiomyopathy After Epirubicin Administration.
Topics: Aged; Antibiotics, Antineoplastic; Atrial Natriuretic Factor; Breast Neoplasms; Cardiomyopathies; Cardiotonic Agents; Diuretics; Dobutamine; Echocardiography; Electrocardiography; Epirubicin; Female; Heart Failure; Heart Ventricles; Humans; Magnetic Resonance Imaging, Cine; Respiration, Artificial; Severity of Illness Index; Treatment Outcome | 2015 |
Urocortin 2 protects heart and kidney structure and function in an ovine model of acute decompensated heart failure: Comparison with dobutamine.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Biomarkers; Collagen; Disease Models, Animal; Dobutamine; Female; Gene Expression; Heart; Heart Failure; Kidney; Kidney Diseases; Real-Time Polymerase Chain Reaction; Sheep; Transforming Growth Factor beta1; Urocortins | 2015 |
Management of catecholamine-induced stunned myocardium--a case report.
Topics: Blood Pressure; Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Female; Fluid Therapy; Heart Failure; Humans; Intraoperative Complications; Middle Aged; Milrinone; Myocardial Stunning; Neurosurgical Procedures; Norepinephrine; Subarachnoid Hemorrhage; Vasodilator Agents | 2015 |
Na+-induced Ca2+ influx through reverse mode of Na+-Ca2+ exchanger in mouse ventricular cardiomyocyte.
Topics: Action Potentials; Animals; Calcium; Dobutamine; Dose-Response Relationship, Drug; Electrophysiology; Heart; Heart Failure; Heart Ventricles; Male; Mice; Myocytes, Cardiac; Patch-Clamp Techniques; Receptors, Adrenergic, beta; Sodium-Calcium Exchanger; Thiourea | 2015 |
Hemodynamic and neurochemical determinates of renal function in chronic heart failure.
Topics: Aged; Aged, 80 and over; Arterial Pressure; Atrial Function, Right; Atrial Pressure; Cardiac Catheterization; Case-Control Studies; Chronic Disease; Dobutamine; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Models, Cardiovascular; Nitroprusside; Renal Plasma Flow; Sympathetic Nervous System; Sympathomimetics; Vasodilator Agents; Ventricular Function, Left | 2016 |
Temporal Development of Autonomic Dysfunction in Heart Failure: Effects of Age in an Ovine Rapid-pacing Model.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Age Factors; Animals; Autonomic Nervous System; Biomarkers; Cardiac Pacing, Artificial; Disease Models, Animal; Dobutamine; Echocardiography; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Female; Heart Failure; Heart Rate; Hemodynamics; Norepinephrine; Sheep, Domestic; Time Factors | 2016 |
Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.
Topics: Administration, Intravenous; Adult; Aged; Alabama; Atrial Fibrillation; Bacteremia; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Female; Follow-Up Studies; Heart Arrest; Heart Conduction System; Heart Failure; Home Care Services; Hospitals, University; Humans; Male; Middle Aged; Milrinone; Pacemaker, Artificial; Patient Readmission; Retrospective Studies; Tachycardia, Ventricular; Treatment Outcome | 2016 |
Citric Acid Cycle Metabolites Predict the Severity of Myocardial Stunning and Mortality in Newborn Pigs.
Topics: Animals; Biomarkers; Cardiotonic Agents; Chromatography, Liquid; Citric Acid Cycle; Dobutamine; Drug Therapy, Combination; Epinephrine; Female; Heart Failure; Microdialysis; Milrinone; Myocardial Stunning; Random Allocation; Severity of Illness Index; Sodium Chloride; Spectrometry, Mass, Electrospray Ionization; Swine; Tandem Mass Spectrometry; Treatment Outcome | 2016 |
Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.
Topics: Adrenergic beta-1 Receptor Agonists; Adult; Animals; Blood Glucose; Cardiomyopathies; Dobutamine; Female; Heart Failure; Humans; Isoproterenol; Male; Mice, Knockout; MicroRNAs; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Peripartum Period; Puerperal Disorders; Purine Nucleotides; Random Allocation; Reactive Oxygen Species; Receptor, ErbB-4; STAT3 Transcription Factor; Ventricular Dysfunction, Left | 2017 |
Prediction of functional capacity by low-dose dobutamine stress echocardiography in chronic heart failure.
Topics: Adrenergic beta-Agonists; Aged; Chronic Disease; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Prospective Studies; Respiratory Function Tests; Ventricular Dysfunction, Left | 2008 |
Inotropic agents improve the peripheral microcirculation of patients with end-stage chronic heart failure.
Topics: Adrenergic beta-Agonists; Brachial Artery; Cardiotonic Agents; Case-Control Studies; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Microcirculation; Middle Aged; Muscle, Skeletal; Myocardial Reperfusion; Oxygen Consumption; Prognosis; Prospective Studies; Pyridazines; Simendan; Spectroscopy, Near-Infrared; Vasodilator Agents | 2008 |
Decompensated heart failure in the emergency department of a cardiology hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Brazil; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Dopamine; Emergency Service, Hospital; Epidemiologic Methods; Female; Heart Failure; Hospitalization; Humans; Infant; Infant, Newborn; Length of Stay; Male; Middle Aged; Young Adult | 2008 |
Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction.
Topics: Adenylyl Cyclases; Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Colforsin; Dobutamine; ErbB Receptors; Female; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Mutation; Myocardial Contraction; Myocytes, Cardiac; Phenotype; Phosphorylation; Receptor, ErbB-2; Signal Transduction; Time Factors; Ventricular Dysfunction, Left | 2008 |
Effect of glucose-insulin-potassium in severe acute heart failure after brain death.
Topics: Adult; Brain Death; Confidence Intervals; Dobutamine; Drug Therapy, Combination; Echocardiography, Doppler; Echocardiography, Transesophageal; Female; Follow-Up Studies; Glucose; Heart Failure; Heart Rate; Heart Transplantation; Humans; Infusions, Intravenous; Insulin; Male; Middle Aged; Organ Preservation; Potassium; Probability; Prospective Studies; Risk Factors; Severity of Illness Index; Stroke Volume; Tissue Donors; Treatment Outcome; Ventricular Remodeling | 2008 |
A comparison of central and mixed venous oxygen saturation in circulatory failure.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Female; Heart Failure; Heart Function Tests; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Norepinephrine; Oxygen; Respiration, Artificial; ROC Curve; Sample Size; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents | 2010 |
Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Heart Ventricles; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Severity of Illness Index; Simendan; Stroke Volume | 2008 |
Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
Topics: Adolescent; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Humans; Infusions, Intravenous; Male; Muscular Dystrophy, Duchenne; Time Factors | 2008 |
A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload.
Topics: Acetylcholine; Animals; Apoptosis; Blood Glucose; Capillaries; Coronary Circulation; Dietary Fats; Disease Models, Animal; Dobutamine; Fibrosis; Heart Failure; Hemodynamics; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Risk Factors; Time Factors; Ultrasonography; Vasodilation; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2008 |
Levosimendan: from basic science to clinical practice.
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Kidney; Myocardial Contraction; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Quality of Life; Simendan; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Right | 2009 |
Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan; Survival Rate; Treatment Outcome | 2009 |
Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echocardiography.
Topics: Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Contraction; Prospective Studies; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Randomized Controlled Trials as Topic; Retrospective Studies; Simendan | 2009 |
Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.
Topics: Acute Disease; Benzazepines; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Tachycardia, Sinus; Treatment Outcome | 2009 |
Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice.
Topics: Animals; Arginine Vasopressin; Cardiotonic Agents; Dobutamine; Heart Failure; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Shock; Stroke Volume; Survival Analysis; Vasoconstrictor Agents; Ventricular Dysfunction, Left | 2009 |
Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction.
Topics: Adrenergic beta-Agonists; Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Vessels; Dobutamine; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Microvessels; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardium; Necrosis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Thrombolytic Therapy; Time Factors; Treatment Outcome | 2009 |
Variation on a theme: CMR as the "one-stop shop" for risk stratification after infarction?
Topics: Adrenergic beta-Agonists; Angioplasty, Balloon, Coronary; Coronary Vessels; Dobutamine; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Microvessels; Myocardial Contraction; Myocardial Infarction; Myocardium; Necrosis; Predictive Value of Tests; Prognosis; Recurrence; Risk Assessment; Risk Factors; Thrombolytic Therapy; Time Factors; Treatment Outcome | 2009 |
Selective activation of PI3Kalpha/Akt/GSK-3beta signalling and cardiac compensatory hypertrophy during recovery from heart failure.
Topics: Analysis of Variance; Animals; Dobutamine; Dogs; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; Hemodynamics; Hypertrophy, Left Ventricular; Longitudinal Studies; Male; Models, Animal; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction | 2009 |
Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Angina, Unstable; Cardiovascular Diseases; Dobutamine; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Observer Variation; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Ventricular Dysfunction, Left | 2009 |
Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Overdose; Heart Failure; Hemodynamics; Hydrazones; Propranolol; Pyridazines; Random Allocation; Simendan; Survival Analysis; Swine | 2009 |
Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
Topics: Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2009 |
Should we use outpatient dobutamine or milrinone?
Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Injections, Intravenous; Milrinone; Outpatients; Treatment Outcome | 2009 |
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Pressure; C-Reactive Protein; Cardiotonic Agents; Creatinine; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Hypertension, Pulmonary; Intensive Care Units; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Sodium; Survival Analysis; Vasoconstrictor Agents; Young Adult | 2010 |
Pressure-volume relationship during dobutamine stress echocardiography predicts exercise tolerance in patients with congestive heart failure.
Topics: Aged; Blood Pressure; Dobutamine; Echocardiography; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Stroke Volume; Vasodilator Agents | 2010 |
Prognostic value of dobutamine stress echocardiography in diabetic patients.
Topics: Aged; Cardiotonic Agents; Chi-Square Distribution; Comorbidity; Coronary Disease; Diabetic Angiopathies; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Myocardial Infarction; Predictive Value of Tests; Prognosis; Rest; Risk Factors; Statistics, Nonparametric; Survival Analysis | 2010 |
Is levosimendan better than dobutamine in acute heart failure in patients on beta-blockade treatment? What is the evidence?
Topics: Acute Disease; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan | 2010 |
[Angiotensin II receptor blocker add-on therapy for low cardiac output in decompensated heart failure].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Dobutamine; Drug Therapy, Combination; Epidemiologic Methods; Female; Heart Failure; Humans; Kidney; Male; Middle Aged; Stroke Volume | 2010 |
Rotating inotrope therapy in a pediatric population with decompensated heart failure.
Topics: Adolescent; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Hydrazones; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Milrinone; Pyridazines; Retrospective Studies; Simendan; Treatment Outcome | 2011 |
The myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Output; Dietary Fats; Disease Models, Animal; Dobutamine; Energy Metabolism; Fatty Acids; Gene Expression Profiling; Gene Expression Regulation; Heart Failure; Male; Myocardial Contraction; Myocardial Infarction; Oligonucleotide Array Sequence Analysis; Rats; Rats, Wistar; Recovery of Function; Signal Transduction; Stress, Physiological; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 2010 |
Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events?
Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Dobutamine; Etiocholanolone; Genetic Therapy; Heart Failure; Humans; Hydrazones; Pyridazines; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Sodium-Potassium-Exchanging ATPase; Urea | 2010 |
Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Dobutamine; Heart Failure; Hemodynamics; Metoprolol; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, Inbred Strains; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophy, Duchenne; Papillary Muscles | 2010 |
Correspondence concerning the article: is levosimendan better than dobutamine in acute heart failure in patients on beta blockade treatment? What is the evidence?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan | 2010 |
How to treat acute decompensated heart failure in the 'beta-blocker era'?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan; Vasodilator Agents | 2010 |
Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Male; Norepinephrine; Orchiectomy; Shock, Cardiogenic; Swine; Vasodilator Agents; Vasopressins; Ventricular Function, Left | 2010 |
Automated drug delivery system for the management of hemodynamics and cardiac energetic in acute heart failure.
Topics: Acute Disease; Animals; Automation; Bradycardia; Cardiac Output; Computer Simulation; Dextrans; Dobutamine; Dogs; Drug Delivery Systems; Embolization, Therapeutic; Heart Failure; Heart Function Tests; Heart Rate; Hemodynamics; Nitroprusside; Systole; Time Factors | 2010 |
Dobutamine-induced changes of left atrial two-dimensional deformation predict clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensated chronic heart failure.
Topics: Aged; Atrial Function, Left; Biomarkers; Chronic Disease; Dobutamine; Echocardiography; Echocardiography, Stress; Female; Forecasting; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Pyridazines; Simendan; Treatment Outcome | 2012 |
Impaired left ventricular stroke volume reserve during clinical dobutamine stress predicts future episodes of pulmonary edema.
Topics: Aged; Atropine; Dobutamine; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pulmonary Edema; Risk Factors; Stroke Volume | 2011 |
Long-term prognostic value of dobutamine stress CMR.
Topics: Aged; Chi-Square Distribution; Coronary Artery Disease; Disease-Free Survival; Dobutamine; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Ventricular Function, Left | 2011 |
Dobutamine stress CMR: can we predict outcome?
Topics: Coronary Artery Disease; Disease-Free Survival; Dobutamine; Heart Failure; Humans; Magnetic Resonance Imaging; Myocardial Contraction; Myocardial Infarction; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Ventricular Function, Left | 2011 |
Altered microRNA expression associated with reduced catecholamine sensitivity in patients with chronic heart failure.
Topics: Cardiac Catheterization; Cardiomyopathy, Dilated; Catecholamines; Chronic Disease; Dobutamine; Female; Gene Expression Regulation; Heart Failure; Humans; Male; Microarray Analysis; MicroRNAs; Middle Aged; Myocardial Contraction; Myocardium; Norepinephrine; Receptors, Adrenergic; Ventricular Function | 2011 |
[Treatment of heart failure patients with inotropic drugs: beyond traditional agents].
Topics: Adrenergic beta-1 Receptor Agonists; Cardiotonic Agents; Dobutamine; Guidelines as Topic; Heart Failure; Hydrazones; Meta-Analysis as Topic; Phosphodiesterase Inhibitors; Pyridazines; Retrospective Studies; Risk Assessment; Simendan | 2010 |
Cardiomyopathy in α-kinase 3 (ALPK3)-deficient mice.
Topics: Animals; Cardiomyopathies; Diastole; Dobutamine; Female; Heart; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Mice; Mice, Knockout; Muscle Proteins; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Phosphotransferases; Sequence Deletion; Stroke Volume; Systole | 2012 |
Usefulness of low-dose dobutamine echocardiography to predict response and outcome in patients undergoing cardiac resynchronization therapy.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Cardiac Pacing, Artificial; Defibrillators, Implantable; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Hospitalization; Humans; Male; Myocardial Ischemia; Pacemaker, Artificial; Prospective Studies; Stroke Volume; Systole; Ventricular Dysfunction, Left | 2011 |
MR perfusion-weighted imaging may help in differentiating between nonenhancing gliomas and nonneoplastic lesions in the cervicomedullary junction.
Topics: Animals; Aorta; Brain Neoplasms; Cardiac Output; Dobutamine; Glioma; Heart Failure; Heart Ventricles; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Perfusion; Swine | 2011 |
Cost-effectiveness of levosimendan in patients with acute heart failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Patient Readmission; Pyridazines; Retrospective Studies; Simendan; Survival Rate | 2011 |
Hospital in the home.
Topics: Australia; Cardiotonic Agents; Dobutamine; Heart Failure; Home Care Services; Humans; Infusions, Intravenous; Milrinone; Palliative Care | 2011 |
Beta-blockers and dobutamine in heart failure: a safe combination?
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Male; Withholding Treatment | 2011 |
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: a cardiac MR study.
Topics: Aged; Dobutamine; Exercise Test; Female; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Ischemia; Stroke Volume | 2013 |
[Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
Topics: Acute Disease; Adolescent; Cardiotonic Agents; Child, Preschool; Dobutamine; Heart Failure; Humans; Hydrazones; Male; Milrinone; Pyridazines; Simendan | 2011 |
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved.
Topics: Adenosine Triphosphate; Animals; Creatine Kinase, MM Form; Disease Models, Animal; Dobutamine; Energy Metabolism; Gene Expression; Heart Failure; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Contraction; Perfusion; Recombinant Proteins | 2012 |
Heart failure syndrome due to dobutamine stress echocardiography: Tako-Tsubo induced-cardiomiopathy.
Topics: Adrenergic beta-1 Receptor Agonists; Dobutamine; Echocardiography, Stress; Electrocardiography; Female; Heart Failure; Humans; Middle Aged; Myocardial Ischemia; Takotsubo Cardiomyopathy | 2012 |
Heart failure secondary to dilated cardiomyopathy: a role for emergency physician bedside ultrasonography.
Topics: Abdominal Pain; Acute Disease; Cardiomyopathy, Dilated; Child, Preschool; Diagnostic Errors; Dobutamine; Dopamine; Dyspnea; Echocardiography; Edema; Electrocardiography; Emergency Service, Hospital; Female; Gastroenteritis; Gastrointestinal Hemorrhage; Heart Failure; Heart Transplantation; Humans; Point-of-Care Systems; Vomiting | 2012 |
Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.
Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Female; Follow-Up Studies; Heart Failure; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Outpatients; Pyridones; Severity of Illness Index; Survival Rate; Systole; Treatment Outcome | 2012 |
[Occurrence of severe cardiac alterations in Amanita proxima poisoning: two original observations].
Topics: Adrenergic beta-Agonists; Adult; Amanita; Diuretics; Dobutamine; Electrocardiography; Female; Furosemide; Heart Failure; Hemodiafiltration; Hemodynamics; Humans; Long QT Syndrome; Male; Middle Aged; Mushroom Poisoning; Nausea; Resuscitation; Shock, Cardiogenic; Ultrasonography; Ventricular Dysfunction, Left | 2012 |
Stroke volume-to-wall stress ratio as a load-adjusted and stiffness-adjusted indicator of ventricular systolic performance in chronic loading.
Topics: Animals; Arteries; Body Weight; Dobutamine; Echocardiography; Heart; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Male; Pressure; Rats; Rats, Sprague-Dawley; Stroke; Stroke Volume; Systole; Ventricular Function, Left | 2012 |
Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure.
Topics: Acute Disease; Aged; Alkaline Phosphatase; Cardiotonic Agents; Cholestasis; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Liver Diseases; Liver Function Tests; Male; Prognosis; Prospective Studies; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Transaminases | 2013 |
Characterization of the cardiac response to a low and high dose of dobutamine in the mouse model of dilated cardiomyopathy by MRI in vivo.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Cardiomyopathy, Dilated; Disease Models, Animal; Dobutamine; Electrocardiography; Heart; Heart Failure; Heart Rate; Magnetic Resonance Imaging; Mice; Myocardium; Receptors, Adrenergic, beta; Software; Ventricular Function, Left | 2013 |
Economic evaluation of levosimendan versus dobutamine for the treatment of acute heart failure in Italy.
Topics: Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Heart Failure; Hospitalization; Humans; Hydrazones; Pyridazines; Retrospective Studies; Rome; Simendan; Treatment Outcome | 2012 |
Oxygen costs of left ventricular contractility for dobutamine and Ca(2+) in normal rat hearts and the cost for dobutamine in Ca(2+) overload-induced failing hearts.
Topics: Animals; Calcium Chloride; Cardiotonic Agents; Dobutamine; Heart Failure; Male; Myocardial Contraction; Myocardial Stunning; Myocardium; Oxygen Consumption; Rats; Rats, Wistar; Ventricular Function, Left | 2002 |
Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure.
Topics: Acetanilides; Animals; Cardiotonic Agents; Chronic Disease; Coronary Circulation; Disease Models, Animal; Dobutamine; Dogs; Drug Administration Schedule; Fatty Acids, Nonesterified; Glucose; Heart; Heart Failure; Heart Rate; Lactic Acid; Myocardium; Oxygen Consumption; Piperazines; Ranolazine; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
[How is catecholamine therapy carried out in heart failure?].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Catecholamines; Chronic Disease; Dobutamine; Drug Therapy, Combination; Epinephrine; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Treatment Outcome | 2002 |
Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Blood Pressure; Cardiotonic Agents; Desipramine; Dobutamine; Dogs; Heart Failure; Immunohistochemistry; Myocardial Contraction; Myocardium; Neuropeptide Y; Norepinephrine; Organ Size; Presynaptic Terminals; Receptors, Adrenergic, beta; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Ventricular Dysfunction, Right | 2002 |
Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
Topics: Animals; Azetidines; Cardiotonic Agents; Chronic Disease; Coronary Circulation; Cyclic AMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Failure; Heart Rate; Male; Myocardial Contraction; Myocardium; Oxygen Consumption; Sodium Channel Agonists; Ventricular Function, Left | 2002 |
Incidence and risk calculation of inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anaesthesia record-keeping system.
Topics: Aged; Anesthesia; Cardiopulmonary Bypass; Cardiotonic Agents; Dobutamine; Enoximone; Epinephrine; Female; Heart Failure; Humans; Male; Medical Records Systems, Computerized; Middle Aged; Myocardial Infarction; Preoperative Care; Retrospective Studies; Risk Factors; Time Factors | 2002 |
Successful resuscitation of serious bupivacaine intoxication in a patient with pre-existing heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Anesthetics, Local; Bupivacaine; Clonidine; Dobutamine; Female; Heart Failure; Humans; Injections, Intravenous; Middle Aged; Resuscitation | 2003 |
Disparate force-frequency effects of pimobendan and dobutamine in conscious dogs with tachycardia-induced cardiomyopathy.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Cardiotonic Agents; Dobutamine; Dogs; Heart Failure; Heart Rate; Myocardial Contraction; Pyridazines; Stimulation, Chemical; Stroke Volume; Tachycardia; Ventricular Pressure | 2002 |
Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures; Cell Survival; Chronic Disease; Coronary Artery Disease; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardium; Postoperative Complications; Prognosis; Severity of Illness Index; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
A bridge for the 21st century in heart transplantation?
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Heart Transplantation; Humans; Milrinone; Prospective Studies; Randomized Controlled Trials as Topic | 2003 |
Prognostic value of dobutamine stress echocardiography in patients with diabetes.
Topics: Adrenergic beta-Agonists; Coronary Disease; Diabetic Angiopathies; Disease-Free Survival; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Hypercholesterolemia; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Survival Analysis; Time Factors; Treatment Outcome | 2003 |
Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home.
Topics: Adult; Aged; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Electric Countershock; Female; Heart Failure; Heart Transplantation; Home Care Services; Humans; Male; Middle Aged; Milrinone; Outcome Assessment, Health Care; Retrospective Studies; Severity of Illness Index; Waiting Lists | 2003 |
Dobutamine for patients with end-stage heart failure in a hospice program?
Topics: Aged; Cardiotonic Agents; Dobutamine; Heart Failure; Hospice Care; Humans; Male; Palliative Care; Treatment Outcome; United States | 2003 |
Sustained use of nesiritide to aid in bridging to heart transplant.
Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Preoperative Care; Time Factors; Treatment Outcome; Waiting Lists | 2003 |
The cul-de-sac at the end of the road.
Topics: Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Palliative Care | 2003 |
Hemodynamic effects of a new inotropic compound, PST-2744, in dogs with chronic ischemic heart failure.
Topics: Animals; Cardiotonic Agents; Dobutamine; Dogs; Etiocholanolone; Heart Failure; Hemodynamics; Ventricular Dysfunction, Left | 2003 |
Hypercontractile heart failure caused by catecholamine therapy in premature neonates.
Topics: Adrenergic Agonists; Adrenergic beta-Agonists; Dobutamine; Drug Therapy, Combination; Epinephrine; Female; Heart Failure; Heart Rate; Humans; Hypertrophy, Left Ventricular; Hypotension; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Myocardial Contraction; Norepinephrine; Ultrasonography | 2003 |
Nesiritide in acute heart failure.
Topics: Acute Disease; Cardiac Output, Low; Clinical Trials as Topic; Comorbidity; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Treatment Outcome | 2003 |
Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure.
Topics: Ascorbic Acid; Cardiotonic Agents; Dobutamine; Female; Heart; Heart Failure; History, Early Modern 1451-1600; Humans; Male; Middle Aged; Myocardial Contraction; Oxidation-Reduction; Reference Values; Ventricular Dysfunction, Left | 2004 |
Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Dobutamine; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Propanolamines; Prospective Studies; Radionuclide Imaging; Stroke Volume; Ventricular Function, Left | 2003 |
Preliminary clinical experience with the repetitive administration of levosimendan in patients with end-stage heart failure.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Pressure; Calcium Channels, L-Type; Cardiac Output, Low; Cardiotonic Agents; Diastole; Dobutamine; Dopamine; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Greece; Heart Failure; Heart Ventricles; Hematocrit; Hemoglobins; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Potassium; Pyridazines; Severity of Illness Index; Simendan; Stimulation, Chemical; Survival Analysis; Systole; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Signaling; Calcium-Transporting ATPases; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Dogs; Drug Evaluation, Preclinical; Heart Failure; Myocardial Contraction; Norepinephrine; Phosphorylation; Protein Processing, Post-Translational; Receptors, Adrenergic, beta; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Tachycardia, Ventricular; Tacrolimus Binding Proteins; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2004 |
The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
Topics: Carbon Radioisotopes; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Coronary Circulation; Dobutamine; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Regional Blood Flow; Stroke Volume; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure.
Topics: Adult; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Dopamine; Empirical Research; Female; Health Care Costs; Heart Failure; Heart Transplantation; Home Infusion Therapy; Humans; Longitudinal Studies; Male; Middle Aged; Milrinone; Survival Rate; Waiting Lists | 2004 |
To infuse or not?
Topics: Aged; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infusions, Intravenous | 2004 |
Dobutamine-induced myoclonia in severe renal failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Myoclonus | 2004 |
Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure).
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Catecholamines; Coronary Circulation; Disease Models, Animal; Dobutamine; Dogs; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Heart Ventricles; Male; Models, Cardiovascular; Myocardial Contraction; Norepinephrine; Oxygen Consumption; Severity of Illness Index; Stroke Volume; Vasodilation | 2004 |
Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure.
Topics: Actin Cytoskeleton; Animals; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Disease Progression; Dobutamine; Drug Resistance; Enzyme Induction; Heart Failure; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Myosin Heavy Chains; Myosin Light Chains; Osteopontin; Phosphorylation; Protein Kinase C; Protein Kinase C-epsilon; Protein Processing, Post-Translational; Recombinant Fusion Proteins; RNA, Messenger; Sialoglycoproteins | 2004 |
Hypersensitivity myocarditis complicating hypertrophic cardiomyopathy heart.
Topics: Adrenergic beta-Agonists; Cardiomyopathy, Hypertrophic; Dobutamine; Drug Hypersensitivity; Echocardiography; Female; Heart Failure; Humans; Middle Aged; Mitral Valve Insufficiency; Myocarditis; Myocardium; Stroke Volume; Ventricular Dysfunction, Left | 2004 |
Influence of gender and race on hemodynamic response to dobutamine during dobutamine stress echocardiography.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Stress; Electrocardiography; Ethnicity; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Mathematical Computing; Middle Aged; Prospective Studies; Reference Values | 2004 |
Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
Topics: Adrenergic beta-Agonists; Animals; Autocrine Communication; Caveolin 3; Caveolins; Dobutamine; Enzyme Induction; Heart Failure; Isoproterenol; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Ryanodine Receptor Calcium Release Channel; Sarcolemma; Ventricular Dysfunction, Left | 2004 |
Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failure.
Topics: Case-Control Studies; Defibrillators, Implantable; Dobutamine; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Ventricular Dysfunction, Left | 2005 |
Heart failure after Caesarean section for twin delivery.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Cardiotonic Agents; Catheterization, Swan-Ganz; Cesarean Section; Diagnosis, Differential; Digoxin; Diuretics; Dobutamine; Electrocardiography; Female; Furosemide; Heart Failure; Humans; Hydralazine; Intubation, Intratracheal; Nitroprusside; Pulmonary Edema; Twins; Vasodilator Agents | 2004 |
Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
Topics: Adult; Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Multivariate Analysis; Pyridazines; Radionuclide Ventriculography; Risk; Simendan; Survival Rate | 2005 |
Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Dobutamine; Dopamine; Drug Administration Schedule; Drug Therapy, Combination; E-Selectin; Enoximone; Epidemiologic Methods; Epinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptides; Nerve Tissue Proteins; Norepinephrine; Peptide Fragments; Prognosis; Shock, Cardiogenic | 2005 |
Impaired vasoreactivity in end-stage heart failure patients on intravenous inotropic support.
Topics: Blood Flow Velocity; Brachial Artery; Cardiac Catheterization; Cardiotonic Agents; Dobutamine; Echocardiography; Exercise Test; Follow-Up Studies; Forearm; Heart Failure; Humans; Injections, Intravenous; Isometric Contraction; Male; Middle Aged; Milrinone; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler; Vasoconstriction; Ventricular Function, Right | 2005 |
Protein kinase C epsilon induces systolic cardiac failure marked by exhausted inotropic reserve and intact Frank-Starling mechanism.
Topics: Actin Cytoskeleton; Adenosine Triphosphatases; Animals; Animals, Genetically Modified; Cardiotonic Agents; Dobutamine; Electrophoresis, Polyacrylamide Gel; Heart Failure; Mice; Myocardial Contraction; Myocardium; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Sarcomeres; Systole; Ultrasonography | 2005 |
The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system.
Topics: Animals; Blotting, Western; Cardiac Pacing, Artificial; Cardiotonic Agents; Creatine; Creatine Kinase; Creatine Kinase, BB Form; Creatine Kinase, MM Form; Dobutamine; Dogs; Dose-Response Relationship, Drug; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Isoenzymes; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Retrospective Studies | 2005 |
Acute decompensated heart failure: the shrinking role of inotropic therapy.
Topics: Acute Disease; Cardiovascular Agents; Dobutamine; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Treatment Outcome | 2005 |
[Cost analysis of the treatment of acute decompensated heart failure. Levosimendan versus dobutamine].
Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Health Care Costs; Heart Failure; Hospital Costs; Humans; Hydrazones; Length of Stay; Pyridazines; Simendan | 2005 |
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling.
Topics: Adenoviridae; Adrenergic beta-Agonists; Animals; Calcium; Calcium-Transporting ATPases; Dobutamine; Echocardiography; Genetic Therapy; Genetic Vectors; Heart Failure; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxygen Consumption; Perfusion; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Transduction, Genetic | 2006 |
Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy.
Topics: Blood Pressure; Cardiotonic Agents; Death, Sudden, Cardiac; Dobutamine; Echocardiography, Stress; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Netherlands; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Survival Rate | 2005 |
Risk of death with nesiritide.
Topics: Adrenergic beta-Antagonists; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain | 2005 |
Risk of death with nesiritide.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Research Design | 2005 |
The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).
Topics: Adrenergic beta-Agonists; Aged; Biomarkers; Dobutamine; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Agents; Natriuretic Peptide, Brain; Pilot Projects; Predictive Value of Tests; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Troponin I; Troponin T | 2005 |
Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Dobutamine; Feasibility Studies; Heart Failure; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Myocardial Ischemia; Propanolamines; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Automated drug delivery system to control systemic arterial pressure, cardiac output, and left heart filling pressure in acute decompensated heart failure.
Topics: Animals; Antihypertensive Agents; Atrial Function, Left; Automation; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; Drug Delivery Systems; Drug Therapy, Combination; Furosemide; Heart Failure; Infusions, Intravenous; Models, Cardiovascular; Nitroprusside | 2006 |
[Therapy of acute decompensated heart failure with levosimendan].
Topics: Adult; Aged; Calcium Channel Agonists; Cardiotonic Agents; Conscious Sedation; Critical Care; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Norepinephrine; Pyridazines; Shock, Cardiogenic; Simendan | 2006 |
Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Health Care Costs; Heart Failure; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Odds Ratio; Patient Readmission; Regression Analysis; Retrospective Studies; Treatment Outcome | 2006 |
Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
Topics: Animals; Cardiotonic Agents; Dobutamine; Dogs; Heart Failure; Hydrazones; Hypertension, Pulmonary; Prospective Studies; Pulmonary Artery; Pulmonary Circulation; Pyridazines; Random Allocation; Simendan; Ventricular Dysfunction, Right | 2006 |
Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Topics: Aged; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Kidney; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Survival Rate; Urine | 2006 |
Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; Apoptosis; Cardiomyopathy, Dilated; Dobutamine; Down-Regulation; Heart Failure; Male; Myocardial Contraction; Myocardium; Norepinephrine; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Systole; Ventricular Dysfunction, Left | 2007 |
Chronic inotropic therapy in end-stage heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Drug Administration Schedule; Drug Costs; Female; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Male; Medicare; Middle Aged; Milrinone; Severity of Illness Index; Time Factors | 2006 |
Cardiac hypertrophy and reduced contractility in hearts deficient in the titin kinase region.
Topics: Animals; Calcium; Cardiomegaly; Connectin; Dobutamine; Heart Failure; Mice; Mice, Knockout; Muscle Proteins; Myocardial Contraction; Protein Kinase C; Protein Kinases; Signal Transduction; Tamoxifen; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2007 |
Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Topics: Animals; Cardiotonic Agents; Diastole; Disease Models, Animal; Dobutamine; Heart Failure; Hydrazones; Lipopolysaccharides; Milrinone; Pyridazines; Rabbits; Sepsis; Simendan; Systole; Ventricular Function, Left | 2007 |
Home inotropic therapy in children.
Topics: Adolescent; Cardiotonic Agents; Child; Dobutamine; Female; Health Care Costs; Heart Failure; Heart Transplantation; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Time Factors; Treatment Outcome; Waiting Lists | 2007 |
Importance of contractile reserve for CRT.
Topics: Aged; Cardiac Pacing, Artificial; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Ischemia; Male; Middle Aged; Myocardial Contraction; Pacemaker, Artificial; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2007 |
A struggle to SURVIVE: to abandon or not to abandon levosimendan?
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; Pyridazines; Simendan; Survival Rate; Treatment Outcome | 2007 |
Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Cardiac Catheterization; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Reactive Oxygen Species; Thermodilution; Ventricular Function, Left | 2007 |
Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Editorial to: "Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et al."
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Glomerular Filtration Rate; Heart Failure; Humans; Hydrazones; Kidney; Pyridazines; Simendan | 2007 |
Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy.
Topics: Cardiac Pacing, Artificial; Dobutamine; Echocardiography; Heart Failure; Humans; Myocardial Contraction; Regression Analysis; Sensitivity and Specificity; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2007 |
[Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner].
Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Health Care Costs; Heart Failure; Home Infusion Therapy; Humans; Nursing; Quality of Life | 2007 |
[Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Female; Health Care Costs; Heart Failure; Heart Transplantation; Hemodynamics; Home Infusion Therapy; Humans; Male; Middle Aged; Nursing; Quality of Life; Retrospective Studies; Treatment Outcome; Waiting Lists | 2007 |
Endomyocardial upregulation of beta1 adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy.
Topics: Aged; Cardiac Output, Low; Cardiac Pacing, Artificial; Dobutamine; Endocardium; Exercise Tolerance; Female; Gene Expression; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Muscle Contraction; Myocardial Contraction; Myocardium; Receptors, Adrenergic; Stroke Volume; Ventricular Function, Left | 2008 |
Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification.
Topics: Adrenergic beta-Agonists; Animals; Calcinosis; Calcium-Binding Proteins; Cardiomyopathies; Cell Adhesion Molecules; Core Binding Factor Alpha 1 Subunit; Decorin; Disease Models, Animal; Dobutamine; Dystrophin; Extracellular Matrix Proteins; Female; Fibrosis; Heart Failure; Integrin beta1; Isoproterenol; Male; Matrix Gla Protein; Mice; Mice, Inbred mdx; Mice, Knockout; Myocytes, Cardiac; Necrosis; Phenotype; Pregnancy; Proteoglycans; RNA, Messenger; Severity of Illness Index; Time Factors; Up-Regulation; Ventricular Function | 2008 |
Comparison of the initial hospitalization costs between the patients treated with dobutamine and the patients treated with amrinone for acute decompensated heart failure in a Japanese institute.
Topics: Aged; Amrinone; Cardiotonic Agents; Chi-Square Distribution; Cost-Benefit Analysis; Dobutamine; Drug Costs; Economics, Pharmaceutical; Female; Heart Failure; Hospital Costs; Humans; Japan; Length of Stay; Male; Statistics, Nonparametric | 2008 |
The effect of pharmacological stress on intraventricular dyssynchrony in left ventricular systolic dysfunction.
Topics: Aged; Cardiac Pacing, Artificial; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Doppler, Color; Echocardiography, Stress; Electrocardiography; Female; Heart Failure; Heart Ventricles; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Stroke Volume; Systole; Ventricular Dysfunction, Left; Ventricular Function, Left | 2008 |
NT-proBNP response to dobutamine stress echocardiography predicts left ventricular contractile reserve in dilated cardiomyopathy.
Topics: Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Natriuretic Peptide, Brain; Peptide Fragments | 2008 |
Hemodynamic effects of dobutamine in patients with an exacerbation of chronic systolic heart failure treated with low doses of carvedilol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Stroke Volume | 2008 |
The effects of dobutamine on renal sympathetic activity in human heart failure.
Topics: Adrenergic beta-Agonists; Dobutamine; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Renal Plasma Flow; Sympathetic Nervous System | 2008 |
Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.
Topics: Age Factors; Animals; Cardiac Output; Cardiomyopathy, Restrictive; Cardiotonic Agents; Cell Size; Diastole; Disease Progression; Dobutamine; Echocardiography, Doppler; Genotype; Heart Failure; Heart Rate; Mice; Mice, Transgenic; Mutation; Myocardial Contraction; Phenotype; Troponin I | 2008 |
Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Pyridazines; Simendan; Time Factors | 2008 |
The prolonged lowering effect of levosimendan on brain natriuretic peptide levels in patients with decompansated heart failure: clinical implications.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Pyridazines; Simendan; Time Factors | 2008 |
Combined haemodynamic effects of low doses of dopamine and dobutamine in patients with acute infarction and cardiac failure.
Topics: Acute Disease; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Dopamine; Drug Therapy, Combination; Electroencephalography; Heart Failure; Heart Rate; Hemodynamics; Humans; Kidney; Myocardial Infarction; Pulmonary Circulation; Vascular Resistance | 1984 |
Possible value of H2-receptor agonists for treatment of catecholamine-insensitive congestive heart failure.
Topics: Adenylyl Cyclases; Adult; Aged; Catecholamines; Dihydroalprenolol; Dobutamine; Female; Heart Failure; Heart Valve Diseases; Hemodynamics; Humans; Imidazoles; Impromidine; Male; Middle Aged; Myocardial Contraction; Receptors, Adrenergic, beta; Receptors, Histamine; Receptors, Histamine H2 | 1984 |
[Therapy of heart failure with beta adrenoceptor agonists].
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Heart Failure; Humans; Practolol; Prenalterol | 1983 |
New and old inotropic drugs: controversies and challenges, Oslo, Norway, May 21-22, 1982: reflections on inotropic drugs: a personal commentary.
Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Dopamine; Heart Failure; Humans; Kinetics; Myocardial Contraction | 1984 |
[Alternatives to digitalis therapy?].
Topics: Albuterol; Captopril; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Teprotide | 1981 |
Sympathomimetic amines: potential clinical applications in ischemic heart disease.
Topics: Animals; Coronary Disease; Deoxyepinephrine; Dobutamine; Dogs; Dopamine; Heart Failure; Humans; Levodopa; Myocardial Contraction; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Sympathomimetics | 1982 |
Effect of combined nitroglycerin and dobutamine infusion in left ventricular dysfunction.
Topics: Catecholamines; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin | 1983 |
Dobutamine effects on blood gases and hemodynamics in acute myocardial infarction with heart failure.
Topics: Aged; Carbon Dioxide; Cardiac Output; Catecholamines; Dobutamine; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen; Pulmonary Circulation; Pulmonary Wedge Pressure | 1984 |
Cardiogenic pulmonary edema.
Topics: Aminophylline; Cardiovascular Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Morphine; Nitroglycerin; Nitroprusside; Pulmonary Edema; Verapamil | 1984 |
[Diagnostic possibilities and therapy in the acute phase of myocardial infarct].
Topics: Digitalis Glycosides; Diuretics; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Nitroglycerin; Nitroprusside; Norepinephrine; Prognosis; Vasodilator Agents | 1984 |
[Catecholamines in internal medicine emergencies].
Topics: Acute Disease; Catecholamines; Coronary Disease; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Oxygen Consumption; Shock, Cardiogenic; Shock, Septic | 1984 |
Hemodynamic effects of dobutamine in patients below and over 65 years, with left heart failure secondary to an acute myocardial infarction.
Topics: Age Factors; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Stroke Volume; Vascular Resistance | 1984 |
Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiotonic Agents; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Injections, Intravenous; Male; Myocardial Contraction; Pyrazines; Quinolines | 1984 |
[Combined medication of nitroprusside and dopamine or dobutamine in acute heart failure].
Topics: Acute Disease; Adult; Aged; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Humans; Male; Middle Aged; Nitroprusside | 1984 |
Drugs five years later. Dobutamine.
Topics: Animals; Cardiac Output; Catecholamines; Coronary Disease; Dobutamine; Dogs; Dopamine; Heart Failure; Heart Rate; Heart Ventricles; Humans; Myocardial Contraction; Myocardial Infarction; Stroke Volume | 1983 |
[Dopamine and dobutamine as circulatory drugs].
Topics: Catecholamines; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Vasodilator Agents | 1983 |
[Heart failure and acute myocardial infarct. Current treatment].
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Imidazoles; Labetalol; Myocardial Infarction; Phentolamine; Vasodilator Agents | 1983 |
Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Time Factors; Vascular Resistance | 1984 |
[Dobutamine in childhood].
Topics: Adolescent; Age Factors; Blood Pressure; Catecholamines; Child; Child, Preschool; Dobutamine; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn | 1984 |
Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine.
Topics: Blood Flow Velocity; Cardiac Output; Catecholamines; Dobutamine; Exercise Test; Heart; Heart Failure; Hemodynamics; Humans; Lactates; Leg; Muscles; Oxygen Consumption | 1984 |
Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
Topics: Adult; Blood Pressure; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Myocardial Contraction; Pulmonary Artery; Pulmonary Wedge Pressure; Stimulation, Chemical; Vascular Resistance | 1984 |
Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Catecholamines; Dobutamine; Drug Synergism; Heart Failure; Hemodynamics; Humans; Middle Aged; Nitroglycerin; Pulmonary Wedge Pressure | 1980 |
Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure.
Topics: Catecholamines; Catheterization; Dobutamine; Drug Tolerance; Female; Heart Failure; Humans; Infusions, Parenteral; Male; Middle Aged; Outpatient Clinics, Hospital; Quality of Life; Stroke Volume; Time Factors | 1983 |
Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure.
Topics: Adult; Catecholamines; Coronary Circulation; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Stimulation, Chemical; Vasodilation | 1983 |
The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
Topics: Catecholamines; Dobutamine; Dopamine; Ethanolamines; Heart Failure; Hemodynamics; Humans; Practolol; Prenalterol | 1983 |
Radiocardiographic assessment of dobutamine and isosorbide dinitrate therapy in patients with mitral stenosis and pulmonary congestion.
Topics: Adult; Aged; Blood Pressure; Blood Volume; Cardiac Output; Catecholamines; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Mitral Valve Stenosis; Pulmonary Edema | 1983 |
[Positive inotropic effects of doxaminol in congestive heart failure].
Topics: Aged; Chemical Phenomena; Chemistry; Dibenzoxepins; Dobutamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Sympathomimetics; Thermodilution | 1983 |
Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure.
Topics: Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Oxygen Consumption; Pulmonary Wedge Pressure; Stroke Volume | 1983 |
The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy.
Topics: Adenosine Triphosphate; Adult; Aged; Blood Urea Nitrogen; Catecholamines; Coronary Circulation; Creatine; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardium; Sodium | 1983 |
[Noninvasive monitoring of stroke volume during intravenous infusion of dobutamine].
Topics: Adult; Cardiac Output; Catecholamines; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Infusions, Parenteral; Male; Middle Aged; Monitoring, Physiologic; Plethysmography, Impedance; Stroke Volume | 1983 |
Dobutamine: a new inotropic agent.
Topics: Adult; Catecholamines; Digoxin; Dobutamine; Female; Heart Failure; Humans; Myocardial Infarction | 1980 |
Haemodynamic effects of dobutamine in patients with congestive heart failure receiving captopril.
Topics: Aged; Captopril; Cardiac Output; Catecholamines; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardium; Oxygen Consumption; Proline | 1981 |
Cardiotonic agents in the management of chronic cardiac failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Ethanolamines; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Kidney Function Tests; Male; Middle Aged; Oxygen Consumption | 1982 |
Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery disease.
Topics: Adult; Aged; Catecholamines; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption | 1982 |
Hemodynamic effects of dobutamine in children with cardiovascular failure.
Topics: Adolescent; Blood Pressure; Cardiac Output; Catecholamines; Child; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Infant; Infant, Newborn; Pulmonary Artery; Stroke Volume; Vascular Resistance | 1982 |
[Hemodynamic effects of dobutamine in patients with severe low-output heart failure (author's transl)].
Topics: Adult; Aged; Cardiac Output, Low; Cardiomyopathy, Hypertrophic; Catecholamines; Coronary Disease; Dobutamine; Heart Failure; Hemodynamics; Humans; Middle Aged | 1980 |
The comparison of the effects of AR-L 115 BS and dobutamine in patients with severe cardiac failure.
Topics: Blood Pressure; Cardiotonic Agents; Catecholamines; Dobutamine; Female; Heart Failure; Heart Rate; Humans; Imidazoles; Male | 1981 |
[Standard therapy of acute myocardial infarction.--II. Management of hemodynamic complications. (author's transl)].
Topics: Analgesics; Atropine; Digoxin; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Rupture; Hemodynamics; Humans; Hypertension; Hypotension; Myocardial Infarction; Propranolol; Shock, Cardiogenic; Vasodilator Agents | 1981 |
Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease.
Topics: Adult; Aged; Catecholamines; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Hemodynamics; Humans; Lactates; Male; Middle Aged; Myocardium; Radionuclide Imaging | 1981 |
Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Aminopyridines; Amrinone; Cardiac Output; Catecholamines; Chronic Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Time Factors | 1981 |
[Catecholamines in the treatment of therapy-refractory heart insufficiency].
Topics: Catecholamines; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans | 1981 |
Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
Topics: Administration, Oral; Adult; Cardiotonic Agents; Dobutamine; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Heart Failure; Hemodynamics; Humans; Time Factors; Vasodilator Agents | 1981 |
Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics.
Topics: Aged; Catecholamines; Coronary Circulation; Coronary Disease; Dobutamine; Female; Heart Failure; Humans; Lactates; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Pulmonary Wedge Pressure; Stroke Volume | 1981 |
Ventricular failure.
Topics: Dobutamine; Heart Failure; Heart Ventricles; Humans; Intra-Aortic Balloon Pumping | 1981 |
[Sympathomimetics in intensive medicine].
Topics: Anaphylaxis; Critical Care; Dobutamine; Dopamine; Epinephrine; Heart Failure; Humans; Isoproterenol; Metaproterenol; Norepinephrine; Resuscitation; Sympathomimetics | 1981 |
[Dobutamine in low cardiac output syndrome. Haemodynamic study (author's transl)].
Topics: Adult; Cardiac Output, Low; Catecholamines; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Isoproterenol; Male; Postoperative Complications | 1981 |
New approaches to therapy of acute heart failure.
Topics: Antihypertensive Agents; Dobutamine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Oxygen Inhalation Therapy; Prazosin | 1980 |
Drug regimens for congestive heart failure.
Topics: Cardiac Glycosides; Cardiotonic Agents; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Vasodilator Agents | 1980 |
Tolerance to dobutamine after a 72 hour continuous infusion.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Drug Tolerance; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Systole; Time Factors | 1980 |
A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure.
Topics: Aged; Blood Pressure; Catecholamines; Digoxin; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Vascular Resistance | 1980 |
Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
Topics: Catecholamines; Coronary Circulation; Dobutamine; Heart Failure; Humans; Mitochondria, Heart | 1980 |
New catecholamines in clinical cardiovascular medicine.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Catecholamines; Dobutamine; Heart Diseases; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Myocardium; Oxygen Consumption | 1980 |
Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Ethanolamines; Female; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume; Vascular Resistance | 1981 |
Dobutamine as palliative drug in home-care advanced cancer patients.
Topics: Dobutamine; Female; Heart Failure; Home Care Services; Humans; Middle Aged; Neoplasms; Palliative Care | 1994 |
Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure.
Topics: Dobutamine; Heart Failure; Heart Rate; Humans; Receptors, Adrenergic, beta | 1995 |
Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.
Topics: Amrinone; Animals; Blood Pressure; Bucladesine; Calcium; Cardiomyopathies; Cardiotonic Agents; Cricetinae; Digoxin; Disease Models, Animal; Dobutamine; Energy Metabolism; Heart Failure; Isoproterenol; Magnetic Resonance Spectroscopy; Mesocricetus; Myocardial Contraction; Oxygen Consumption; Phosphates; Phosphorylation | 1995 |
The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure.
Topics: Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Disease Models, Animal; Dobutamine; Dogs; Dose-Response Relationship, Drug; Female; Heart; Heart Failure; Heart Rate; Infusions, Intravenous; Injections, Intra-Arterial; Male; Methoxamine; Myocardium; Nitroglycerin; Propranolol; Structure-Activity Relationship; Vascular Resistance; Ventricular Function, Left | 1994 |
Digoxin in chronic heart failure.
Topics: Digoxin; Dobutamine; Exercise Tolerance; Heart Failure; Humans | 1995 |
Long-term dobutamine in heart failure.
Topics: Dobutamine; Drug Administration Schedule; Heart Failure; Home Care Services; Humans; Male; Middle Aged | 1994 |
[Dobutamine pulse therapy in patients with severe heart failure. Is it a beneficial measure?].
Topics: Dobutamine; Heart Failure; Humans; Infusions, Intravenous | 1994 |
Exercise training in a patient with congestive heart failure on continuous dobutamine.
Topics: Dobutamine; Exercise Test; Exercise Therapy; Exercise Tolerance; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Oxygen Consumption; Physical Endurance | 1994 |
[Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
Topics: Aged; Cardiac Output, Low; Cohort Studies; Coronary Disease; Critical Care; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Stroke Volume; Vasodilation | 1994 |
Left ventricular remodelling and disparate changes in contractility and relaxation during the development of and recovery from experimental heart failure.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Dobutamine; Dogs; Electrocardiography; Heart; Heart Failure; Heart Rate; Male; Myocardial Contraction; Stroke Volume; Ventricular Function, Left | 1994 |
Divergent effects of intravenous dobutamine and nitroprusside on left atrial contribution to ventricular filling in dogs with chronic heart failure.
Topics: Animals; Chronic Disease; Coronary Angiography; Diastole; Dobutamine; Dogs; Echocardiography, Doppler; Heart Atria; Heart Failure; Hemodynamics; Infusions, Intravenous; Nitroprusside; Ventricular Function, Left | 1994 |
Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate.
Topics: Dichloroacetic Acid; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Myocardium; Oxygen Consumption; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvate Dehydrogenase Complex | 1994 |
Managing dobutamine infusions.
Topics: Dobutamine; Drug Monitoring; Heart Failure; Humans; Infusions, Intravenous; Nursing Assessment; Patient Care Planning | 1993 |
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echocardiography, Doppler; Forced Expiratory Volume; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Nitroprusside; Vasodilator Agents; Vital Capacity | 1993 |
Down-regulation of beta-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure.
Topics: Adult; Aged; Dobutamine; Down-Regulation; Epinephrine; Female; Heart Failure; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Male; Middle Aged; Norepinephrine; Receptors, Adrenergic, beta; Ventricular Function, Left | 1993 |
Cardiac study by dobutamine stress echocardiography in thalassemic patients.
Topics: Adolescent; Adult; beta-Thalassemia; Chelation Therapy; Child; Combined Modality Therapy; Deferoxamine; Diastole; Dobutamine; Echocardiography; Female; Heart Failure; Hemosiderosis; Humans; Iron; Male; Transfusion Reaction | 1993 |
Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Dobutamine; Exercise; Female; Heart Failure; Hemodynamics; Humans; Isoquinolines; Lymphocytes; Male; Middle Aged; Quinapril; Receptors, Adrenergic, beta; Tetrahydroisoquinolines; Up-Regulation | 1993 |
Hemodynamic response of a canine model of chronic heart failure to intravenous dobutamine, nitroprusside, enalaprilat, and digoxin.
Topics: Animals; Blood Pressure; Cardiac Output; Digoxin; Disease Models, Animal; Dobutamine; Dogs; Enalaprilat; Heart Failure; Heart Rate; Hemodynamics; Nitroprusside; Stroke Volume; Vascular Resistance; Ventricular Function, Left | 1993 |
Cardiac index vs oxygen-derived parameters for rational use of dobutamine in patients with congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiac Output; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Humans; Lactates; Male; Middle Aged; Oxygen; Oxygen Consumption | 1993 |
Long-term dobutamine therapy.
Topics: Dobutamine; Heart Failure; Humans; Time Factors | 1993 |
Arterial hemodynamics and cardiac effects of enoximone, dobutamine, and their combination in severe heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1993 |
Cardiovascular effects of dopamine and dobutamine in conscious pigs with chronic heart failure.
Topics: Animals; Chronic Disease; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Male; Prospective Studies; Swine; Ventricular Function, Left | 1993 |
The renal effects of dopamine and dobutamine in stable chronic heart failure.
Topics: Dobutamine; Dopamine; Heart Failure; Humans; Kidney | 1993 |
Degree of external force to the left ventricle determines hemodynamic response to nitroprusside in failing hearts: comparison with the response to dobutamine.
Topics: Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; Heart Failure; Microspheres; Nitroprusside; Pressure; Random Allocation; Vasodilator Agents; Ventricular Function, Left | 1995 |
Experimental rat model representing both acute and chronic heart failure related to autoimmune myocarditis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Autoimmune Diseases; Blood Pressure; Body Weight; Chronic Disease; Disease Models, Animal; Dobutamine; Electrocardiography; Heart; Heart Failure; Male; Myocarditis; Myocardium; Myosins; Organ Size; Rats; Rats, Inbred Lew; Staining and Labeling; Ventricular Function, Left | 1995 |
[Anesthesiologic management in cardiomyoplasty].
Topics: Adult; Aged; Anesthesia, General; Anti-Arrhythmia Agents; Cardiomyoplasty; Cardiotonic Agents; Dobutamine; Electrocardiography; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Lidocaine; Male; Middle Aged; Monitoring, Intraoperative; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 1995 |
[Treatment of heart failure in children].
Topics: Adult; Age Factors; Cardiotonic Agents; Child; Diuretics; Dobutamine; Dopamine; Heart Defects, Congenital; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn; Phosphodiesterase Inhibitors; Vasodilator Agents | 1995 |
Regional alterations of left ventricular contraction and inotropic reserve in conscious dogs with heart failure.
Topics: Analysis of Variance; Animals; Cardiac Pacing, Artificial; Dobutamine; Dogs; Heart Failure; Myocardial Contraction; Stimulation, Chemical; Ventricular Dysfunction, Left | 1995 |
Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
Topics: Adult; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Enalapril; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Survival Rate; Treatment Outcome; Waiting Lists | 1996 |
Effect of prostaglandin E1 infusion on kidney function in patients with severe heart failure.
Topics: Alprostadil; Creatinine; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Kidney; Kidney Function Tests; Male; Middle Aged; Retrospective Studies; Vasodilator Agents | 1996 |
Reproducibility of heart rate variability indices during exercise stress testing and inotrope infusion in chronic heart failure patients.
Topics: Aged; Chronic Disease; Dobutamine; Electrocardiography; Exercise Test; Heart Failure; Heart Rate; Humans; Middle Aged; Reproducibility of Results; Signal Processing, Computer-Assisted; Sympathomimetics | 1996 |
Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure.
Topics: Ambulatory Care; Amrinone; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Drug Administration Schedule; Emergency Service, Hospital; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Milrinone; Patient Admission; Patient Education as Topic; Pyridones; Time Factors | 1996 |
Inotropic interventions in the assessment of myocardial failure associated with taurine deficiency in domestic cats.
Topics: Animals; Blood Pressure; Cats; Dobutamine; Echocardiography; Female; Food, Fortified; Heart; Heart Failure; In Vitro Techniques; Male; Myocardial Contraction; Taurine; Ventricular Function, Left | 1996 |
Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle.
Topics: Acetylcholine; Adrenergic beta-Agonists; Atropine; Catheterization; Dobutamine; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Receptors, Muscarinic | 1996 |
Right ventricular performance and contractile reserve in patients with severe heart failure. Assessment by pressure-area relations and association with outcome.
Topics: Adult; Cardiac Output; Cardiotonic Agents; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Pulmonary Artery; Pulmonary Wedge Pressure; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Right | 1996 |
[Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cyclooxygenase Inhibitors; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Dobutamine; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Heart Failure; Humans; Nitrates; Phosphodiesterase Inhibitors; Vasodilator Agents | 1995 |
[Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
Topics: Aged; Atrial Natriuretic Factor; Dobutamine; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Ventricular Function, Left | 1996 |
[Epidural anesthesia for herniorrhaphy in a patient with severe dilated cardiomyopathy (DCM) under pimobendan control].
Topics: Anesthesia, Epidural; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Dopamine; Fentanyl; Heart Failure; Hernia, Inguinal; Humans; Hypotension; Intraoperative Complications; Male; Middle Aged; Postoperative Complications; Pyridazines | 1997 |
Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
Topics: Alprostadil; Cardiotonic Agents; Catheters, Indwelling; Chronic Disease; Disease Progression; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Safety; Treatment Outcome; Vasodilator Agents | 1997 |
The effect of positive inotropes on the failing human myocardium.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Calcium; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Milrinone; Myocardial Contraction; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones | 1997 |
Cardiac risk assessment before vascular surgery: a prospective study comparing clinical evaluation, dobutamine stress echocardiography, and dobutamine Tc-99m sestamibi tomoscintigraphy.
Topics: Aged; Aortic Aneurysm, Abdominal; Carotid Stenosis; Coronary Artery Bypass; Dobutamine; Echocardiography; Endarterectomy, Carotid; Exercise Test; Female; Heart Failure; Humans; Intraoperative Complications; Ischemia; Leg; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Prospective Studies; Risk Factors; Sympathomimetics; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vascular Diseases | 1997 |
[Current views on Milrinon--a PDE-III-inhibitor].
Topics: Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Heart Ventricles; Humans; Milrinone; Oxygen Consumption; Pyridones | 1994 |
Is dobutamine stress echocardiography useful for noninvasive differentiation of ischemic from idiopathic dilated cardiomyopathy?
Topics: Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Echocardiography; Exercise Test; Feasibility Studies; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Ventricular Function, Left | 1997 |
Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes.
Topics: Cardiotonic Agents; Cause of Death; Costs and Cost Analysis; Direct Service Costs; Dobutamine; Female; Heart Failure; Home Care Services; Humans; Length of Stay; Male; Middle Aged; Milrinone; Pyridones; Retrospective Studies; Stroke Volume; Survival Rate; Treatment Outcome | 1997 |
Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.
Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Dopamine; Drug Delivery Systems; Female; Heart Failure; Hemodynamics; Home Nursing; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors; Treatment Outcome | 1997 |
[Improvement of short-term prognosis in patients with refractory heart failure].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Assisted Circulation; Cardiotonic Agents; Coronary Care Units; Data Interpretation, Statistical; Dobutamine; Dopamine; Epinephrine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Hemofiltration; Humans; Male; Middle Aged; Norepinephrine; Prognosis; Survival Rate; Sympathomimetics; Time Factors; Ventilators, Mechanical | 1997 |
Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinolones; Ventricular Function, Left | 1994 |
Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
Topics: Atrial Function, Left; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Mitral Valve; Nitroprusside; Pulmonary Wedge Pressure; Vasodilator Agents; Ventricular Function, Left | 1997 |
Hyperkalemia: a dangerous diagnosis for patients with congestive heart failure.
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Electrocardiography; Heart Failure; Humans; Hyperkalemia | 1997 |
Acute changes of left atrial distensibility in congestive heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiomyopathy, Dilated; Dobutamine; Echocardiography; Female; Heart Atria; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Propanolamines; Vasodilator Agents | 1998 |
Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Body Weight; Cardiomyopathies; Celiprolol; Cricetinae; Dobutamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Hemodynamics; Liver; Lung; Mesocricetus; Motor Activity; Myocardium; Organ Size; Random Allocation; Receptors, Adrenergic, beta; Renin; Survival Rate; Ventricular Function, Left | 1998 |
Lack of beneficial effects of growth hormone treatment in conscious dogs during development of heart failure.
Topics: Adrenergic beta-Agonists; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cardiac Pacing, Artificial; Dobutamine; Dogs; Growth Hormone; Heart Failure; Insulin-Like Growth Factor I; Isoproterenol; Kidney; Microscopy, Electron; Myocardial Contraction; Myocardium; Vascular Resistance; Ventricular Function, Left | 1998 |
[Perioperative management of two patients with severe dilated cardiomyopathy].
Topics: Aged; Aged, 80 and over; Anesthesia, General; Cardiomyopathy, Dilated; Cardiotonic Agents; Diuretics; Dobutamine; Dopamine; Female; Furosemide; Heart Failure; Humans; Intraoperative Complications; Male; Middle Aged; Monitoring, Intraoperative; Perioperative Care; Postoperative Complications | 1998 |
Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Topics: Acute Disease; Adrenergic beta-Agonists; Anesthesia; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Dobutamine; Dogs; Female; Heart Conduction System; Heart Failure; Heart Rate; Hemodynamics; Male; Nicardipine; Nitroglycerin; Vasodilator Agents | 1998 |
[Peritoneal dialysis and chronic dobutamine, two experiences contrasted. Possible role and indications in refractory cardiac decompensation].
Topics: Aged; Cardiotonic Agents; Dobutamine; Drug Evaluation; Feasibility Studies; Female; Heart Failure; Hemofiltration; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Salvage Therapy; Survival Rate; Treatment Outcome; Water-Electrolyte Balance | 1998 |
Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine.
Topics: Aged; Aged, 80 and over; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Middle Aged; Milrinone; Monitoring, Physiologic; Observer Variation; Oxygen; Pyridones; Retrospective Studies; Thermodilution; Tricuspid Valve Insufficiency | 1998 |
Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure.
Topics: Cardiotonic Agents; Chronic Disease; Coronary Artery Bypass; Coronary Disease; Dobutamine; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Stunning; Patient Selection; Predictive Value of Tests; Regression Analysis; Tomography, Emission-Computed | 1998 |
Value of the venous-arterial PCO2 gradient to reflect the oxygen supply to demand in humans: effects of dobutamine.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Carbon Dioxide; Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Intensive Care Units; Male; Middle Aged; Oxygen Consumption; Prospective Studies; Veins | 1998 |
Dissociation between regional dysfunction and beta-adrenergic receptor signaling in heart failure.
Topics: Adenylyl Cyclases; Animals; Atrial Function, Left; beta-Adrenergic Receptor Kinases; Blood Pressure; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Echocardiography; Female; G-Protein-Coupled Receptor Kinase 5; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Heart; Heart Failure; Hemodynamics; Isoproterenol; Myocardium; Norepinephrine; Protein Serine-Threonine Kinases; Receptor Protein-Tyrosine Kinases; Receptors, Adrenergic, beta; Signal Transduction; Swine | 1998 |
Atrioventricular plane displacement during low dose dobutamine infusion predicts recovery of left ventricular dyssynergies.
Topics: Atrioventricular Node; Cardiotonic Agents; Dobutamine; Echocardiography; Heart Failure; Humans; Prognosis | 1998 |
Dobutamine-induced changes in pulmonary artery pressure in patients with congestive heart failure and their relation to abnormalities of lung diffusing capacity.
Topics: Adult; Aged; Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pulmonary Diffusing Capacity; Pulmonary Wedge Pressure; Respiratory Function Tests; Ventricular Dysfunction, Left | 1998 |
[The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
Topics: Aged; Amrinone; Cardiotonic Agents; Diuresis; Dobutamine; Dopamine; Drug Evaluation; Drug Therapy, Combination; Edema, Cardiac; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Contraction; Prospective Studies | 1998 |
[Extracorporeal membrane oxygenation in myocardial failure after pediatric heart surgery].
Topics: Bioprosthesis; Cardiac Output, Low; Cardiotonic Agents; Child, Preschool; Combined Modality Therapy; Dobutamine; Dopamine; Down Syndrome; Electric Countershock; Epinephrine; Extracorporeal Membrane Oxygenation; Female; Heart Failure; Heart Septal Defects; Hemodynamics; Humans; Infant; Male; Postoperative Complications; Reoperation; Surgical Wound Dehiscence; Tetralogy of Fallot; Ventricular Fibrillation | 1998 |
Reversal of severe pulmonary hypertension with beta blockade in a patient with end stage left ventricular failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Cardiac Output; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Heart Failure; Heart Transplantation; Humans; Hypertension, Pulmonary; Male; Metoprolol; Middle Aged; Patient Selection; Vascular Resistance | 1998 |
Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability.
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Echocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Ischemia; Prognosis; Prospective Studies; Quality of Life; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
Torsade de pointes ventricular tachycardia during low dose intermittent dobutamine treatment in a patient with dilated cardiomyopathy and congestive heart failure.
Topics: Adrenergic beta-Agonists; Cardiomyopathy, Dilated; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Humans; Infusions, Intravenous; Middle Aged; Potassium; Torsades de Pointes | 1999 |
Arrhythmic effects of intermittent dobutamine therapy in chronic heart disease failure. The Working Group of Cardiology of the Academic Committee of Veszprém, Hungary.
Topics: Adrenergic beta-Agonists; Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged | 1998 |
Effects of dobutamine on ischemic vasodilation of the forearm in patients with severe congestive heart failure.
Topics: Adrenergic beta-Agonists; Aged; Dobutamine; Forearm; Heart Failure; Humans; Hyperemia; Ischemia; Middle Aged; Peripheral Vascular Diseases; Regional Blood Flow; Vascular Resistance; Vasodilation; Ventricular Dysfunction, Left | 1999 |
Partial left ventriculectomy in a two-year-old girl with dilated cardiomyopathy.
Topics: Antihypertensive Agents; Captopril; Cardiomyopathy, Dilated; Cardiotonic Agents; Child, Preschool; Digoxin; Diuretics; Dobutamine; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Heart Ventricles; Hemodynamics; Humans; Mitral Valve; Mitral Valve Insufficiency; Papillary Muscles | 1999 |
Dobutamine: a drug utilization evaluation.
Topics: Boston; Dobutamine; Drug Utilization; Heart Failure; Hospital Bed Capacity, 500 and over; Humans; Hypotension | 1988 |
Dynamic cardiomyoplasty in patients with end-stage heart failure: anaesthetic considerations.
Topics: Adult; Aged; Anesthesia, General; Cardiomyopathy, Dilated; Cardiomyoplasty; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Intraoperative Care; Male; Middle Aged; Monitoring, Intraoperative | 1999 |
Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Circadian Rhythm; Coronary Angiography; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Predictive Value of Tests; Prospective Studies; ROC Curve; Survival Rate; Ventricular Dysfunction, Left | 1999 |
Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Coronary Disease; Dobutamine; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; ROC Curve; Stroke Volume; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 1999 |
Intermittent inotropes for advanced heart failure: inquiring minds want to know.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone; Treatment Outcome | 1999 |
Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction.
Topics: Adolescent; Adult; Aged; Brain Death; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Exercise Test; Female; Graft Survival; Heart Arrest; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Contraction; Troponin T | 1999 |
Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Infusions, Parenteral; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Retrospective Studies; Treatment Outcome; Vasodilator Agents | 1999 |
Can dobutamine stress echocardiography predict cardiac events in nonrevascularized diabetic patients following acute myocardial infarction?
Topics: Aged; Angina, Unstable; Cardiac Catheterization; Cardiotonic Agents; Coronary Angiography; Diabetes Complications; Disease-Free Survival; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Infarction; Prognosis; Prospective Studies; Recurrence; Survival Rate | 1999 |
Heart failure management.
Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Male; United States | 1999 |
Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
Topics: Acute Disease; Adult; Aged; Biomarkers; Body Mass Index; Cachexia; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Prognosis; Tumor Necrosis Factor-alpha | 1999 |
Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Dobutamine; Drug Interactions; Fatal Outcome; Heart Failure; Heart Rate; Humans; Hypotension; Male; Propanolamines | 1999 |
Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake.
Topics: Adult; Aged; Biopsy; Cardiotonic Agents; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Dobutamine; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Stunning; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Inotropes in the beta-blocker era.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Phosphodiesterase Inhibitors; Signal Transduction | 2000 |
Hemodynamic effects of a novel sodium channel activator in dogs with chronic heart failure.
Topics: Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chronic Disease; Digoxin; Disease Models, Animal; Dobutamine; Dogs; Heart Failure; Hemodynamics; Sodium Channels; Sympathomimetics; Ventricular Function | 2000 |
Transpulmonary passage of Albunex as a marker of intracardiac hemodynamics and outcome in chronic congestive heart failure.
Topics: Adult; Aged; Albumins; Capillary Permeability; Cardiotonic Agents; Chronic Disease; Contrast Media; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prognosis; Survival Rate; Treatment Outcome | 2000 |
Pre-operative coagulopathy management of a neonate with complex congenital heart disease: a case study.
Topics: Acidosis, Respiratory; Anti-Bacterial Agents; Antithrombin III; Antithrombin III Deficiency; Blood Coagulation Tests; Colloids; Combined Modality Therapy; Disseminated Intravascular Coagulation; Dobutamine; Dopamine; Drug Therapy, Combination; Endocarditis, Bacterial; Fatal Outcome; Fungemia; Heart Defects, Congenital; Heart Diseases; Heart Failure; Humans; Infant, Newborn; Male; Nitric Oxide; Plasma; Platelet Transfusion; Postoperative Complications; Preoperative Care; Sodium Bicarbonate; Streptococcal Infections; Thrombosis | 2000 |
Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
Topics: Adrenergic beta-Agonists; Aged; Cardiomyopathy, Dilated; Disease Progression; Dobutamine; Exercise Test; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen Consumption; Prognosis; Reproducibility of Results | 2000 |
Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Cause of Death; Coronary Disease; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Risk Assessment | 2000 |
Carbamazepine-associated severe left ventricular dysfunction.
Topics: Adult; Antimanic Agents; Carbamazepine; Cardiotonic Agents; Dobutamine; Drug Overdose; Echocardiography; Female; Heart Failure; Humans; Suicide, Attempted; Ventricular Dysfunction, Left; Ventricular Function, Left | 2000 |
Neuroadrenergic activation and response to dobutamine in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Cardiotonic Agents; Chromatography, High Pressure Liquid; Dobutamine; Echocardiography; Female; Heart Failure; Heart Rate; Humans; Linear Models; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Stroke Volume | 2000 |
Prognostic value of 12-lead electrocardiogram during dobutamine stress echocardiography.
Topics: Angina Pectoris; Death, Sudden, Cardiac; Dobutamine; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Prognosis; Retrospective Studies; Risk Factors | 2000 |
Differential alteration of cardiotonic effects of EMD 57033 and beta-adrenoceptor agonists in volume-overload rabbit ventricular myocytes.
Topics: Adrenergic beta-Agonists; Animals; Cardiomegaly; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Evaluation, Preclinical; Electrocardiography; Heart Failure; Hemodynamics; Isoproterenol; Male; Myocardial Contraction; Myofibrils; Phosphodiesterase Inhibitors; Quinolines; Rabbits; Thiadiazines | 2000 |
Transient dobutamine-mediated pulsus alternans.
Topics: Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Dobutamine; Electrocardiography; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Myocardial Contraction | 2001 |
Dobutamine as bridge to angiotensin-converting enzyme inhibitor-nitrate therapy in endstage heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Isosorbide Dinitrate; Lisinopril; Prospective Studies; Stroke Volume; Treatment Outcome; Ultrasonography; Vasodilator Agents | 2001 |
Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy.
Topics: Adult; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radionuclide Ventriculography; Stroke Volume; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs.
Topics: Adrenergic beta-Agonists; Animals; Cyclic GMP; Diastole; Dobutamine; Dogs; Drug Synergism; Heart; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Nitric Oxide; Reference Values; Second Messenger Systems; Systole; Ventricular Function, Left | 2001 |
Can pre-treatment with beta-agonists reduce stress test time and the use of atropine in dobutamine stress testing?
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Atropine; Coronary Disease; Diabetes Mellitus; Dobutamine; Dose-Response Relationship, Drug; Electrocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Hypertension; Male; Middle Aged; Premedication; Risk Factors; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed, Single-Photon | 2001 |
Mitochondrial ATPase and high-energy phosphates in failing hearts.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiac Pacing, Artificial; Coronary Circulation; Disease Models, Animal; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Infusions, Intravenous; Magnetic Resonance Spectroscopy; Mitochondria, Heart; Myocardial Infarction; Organ Size; Phosphocreatine; Protein Subunits; Proton-Translocating ATPases; Swine; Ventricular Remodeling | 2001 |
How many patients with ischemic cardiomyopathy exhibit viable myocardium?
Topics: Aged; Comorbidity; Disease Progression; Dobutamine; Echocardiography, Doppler; Exercise Test; Female; Heart Failure; Heart Function Tests; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Prevalence; Prognosis; Prospective Studies; Risk Factors; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2001 |
Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.
Topics: Cardiac Output, Low; Chi-Square Distribution; Dobutamine; Heart Failure; Heart Transplantation; Humans; Middle Aged; Nitroprusside; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2001 |
Long-term results of coronary artery bypass grafting procedure in the presence of left ventricular dysfunction and hibernating myocardium.
Topics: Adult; Aged; Coronary Artery Bypass; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Stunning; Prognosis; Prospective Studies; Recurrence; Risk Factors; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Nitric oxide and cardiac contractility in human heart failure: time for reappraisal.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Failure; Humans; Isoenzymes; Myocardial Contraction; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Substance P; Ventricular Function, Left | 2001 |
Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Topics: Cost-Benefit Analysis; Dobutamine; Dopamine; Drug Costs; Female; Heart Failure; Hemodynamics; Humans; Length of Stay; Male; Middle Aged; Milrinone; Nitroglycerin; Nitroprusside; Retrospective Studies; Treatment Outcome; United States | 2001 |
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Propanolamines; Prospective Studies; Pulmonary Wedge Pressure; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2001 |
The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure.
Topics: Adrenergic beta-Agonists; Aged; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Middle Aged; Treatment Outcome; Ventricular Function, Left | 2002 |
Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
Topics: Cardiotonic Agents; Chronic Disease; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Monitoring, Physiologic; Patient Selection; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2002 |
Value of Doppler index combining systolic and diastolic myocardial performance in predicting cardiopulmonary exercise capacity in patients with congestive heart failure: effects of dobutamine.
Topics: Adrenergic beta-Agonists; Dobutamine; Echocardiography, Doppler; Exercise Test; Female; Heart; Heart Failure; Humans; Lung; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Severity of Illness Index | 2002 |
Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure.
Topics: Animals; Cardiomyopathy, Dilated; Coronary Thrombosis; Dobutamine; Dogs; Heart Failure; Image Processing, Computer-Assisted; Models, Animal; Myocardial Contraction; Polyesters; Prostheses and Implants; Ventricular Dysfunction, Left; Ventricular Pressure; Ventricular Remodeling | 2002 |
[Catecholamines for treatment of severe heart failure (author's transl)].
Topics: Catecholamines; Coronary Circulation; Dobutamine; Dopamine; Epinephrine; Heart Failure; Humans; Isoproterenol; Microcirculation; Myocardial Infarction; Norepinephrine; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stimulation, Chemical; Strophanthins | 1979 |
The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume | 1979 |
Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
Topics: Chronic Disease; Dobutamine; Dopamine; Heart; Heart Failure; Hemodynamics; Humans; Hydralazine; Monitoring, Physiologic; Nitrates; Nitroprusside; Phentolamine; Prazosin; Teprotide; Vasodilator Agents | 1979 |
Dobutamine in left heart failure after acute myocardial infarction.
Topics: Acute Disease; Blood Pressure; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction | 1979 |
[Hemodynamic effects of dobutamine in the low-output cardiac syndrome].
Topics: Adult; Aged; Catecholamines; Coronary Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1979 |
Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Dopamine; Dyspnea; Heart Failure; Hemodynamics; Humans; Kidney; Lung; Middle Aged; Regional Blood Flow | 1978 |
Selection of vasodilator, inotropic or combined therapy for the management of heart failure.
Topics: Blood Pressure; Cardiac Output; Coronary Disease; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Myocardial Contraction; Myocardium; Oxygen Consumption; Sympathomimetics; Time Factors; Vascular Resistance; Vasodilator Agents | 1978 |
Efficacy of new inotropic drugs in clinical coronary heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Phonocardiography; Phosphodiesterase Inhibitors; Piperidines; Pressure; Quinazolines; Vascular Resistance | 1978 |
New and traditional therapy of congestive heart failure. A European view.
Topics: Delayed-Action Preparations; Digitalis Glycosides; Diuretics; Dobutamine; Heart Failure; Humans; Isosorbide Dinitrate; Nitroprusside; Phentolamine | 1978 |
Vasodilator and inotropic therapy of heart failure [panel discussion].
Topics: Animals; Cardiac Output; Coronary Circulation; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Failure; Humans; Hydralazine; Myocardial Contraction; Myocardial Infarction; Nitroprusside; Phentolamine; Prazosin; Propranolol; Vasoconstrictor Agents; Vasodilator Agents | 1978 |
Dobutamine pharmacokinetics in severe heart failure.
Topics: Adult; Aged; Catecholamines; Dobutamine; Female; Heart Failure; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged | 1978 |
[The effect of sodium nitroprusside and dobutamine on the ventricular myocardium in patients with severe left cardiac insufficiency].
Topics: Catecholamines; Dobutamine; Female; Ferricyanides; Heart; Heart Failure; Hemodynamics; Humans; Male; Nitroprusside | 1978 |
Dobutamine (Dobutrex).
Topics: Cardiovascular System; Catecholamines; Dobutamine; Heart Failure; Humans | 1979 |
Haemodynamic effects of dobutamine in patients with coronary artery disease.
Topics: Aged; Blood Pressure; Cardiac Output; Catecholamines; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Vascular Resistance | 1977 |
Cardiovascular effects of dobutamine in severe congestive heart failure.
Topics: Adult; Aged; Catecholamines; Dobutamine; Drug Evaluation; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction | 1977 |
The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
Topics: Adolescent; Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Diuresis; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Female; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Pulmonary Circulation; Sodium; Stimulation, Chemical; Vascular Resistance | 1977 |
Comparative haemodynamic effects of dobutamine and isoproterenol in man.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Drug Evaluation; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isoproterenol; Male; Middle Aged; Vascular Resistance | 1977 |
Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
Topics: Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Drug Evaluation; Ferricyanides; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Nitroprusside; Pulmonary Circulation; Vascular Resistance | 1977 |
[Haemodynamic effect of dobutamine in cardiac failure (author's transl)].
Topics: Adult; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Humans; Middle Aged; Myocardial Contraction; Vascular Resistance | 1976 |
[Hemodynamic effect of dobutamine in patients with cardiac insufficiency].
Topics: Adult; Catecholamines; Coronary Disease; Dobutamine; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardial Contraction | 1976 |
Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy.
Topics: Adult; Cardiomyopathy, Dilated; Catecholamines; Dobutamine; Dopamine; Electrocardiography; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Neuropeptide Y; Receptors, Adrenergic, beta | 1992 |
Alterations in left ventricular mechanics, energetics, and contractile reserve in experimental heart failure.
Topics: Animals; Body Weight; Cardiac Output; Cardiac Pacing, Artificial; Dobutamine; Dogs; Dose-Response Relationship, Drug; Energy Metabolism; Heart Failure; Models, Cardiovascular; Myocardial Contraction; Organ Size; Receptors, Adrenergic, beta; Ventricular Function, Left | 1992 |
Dobutamine therapy for outpatients.
Topics: Community Health Nursing; Dobutamine; Heart Failure; Humans; Outpatients | 1992 |
Increased uncoupling of beta-, beta 1- and beta 2-adrenoceptor to myocardial contraction in failing human myocardium.
Topics: Adult; Aged; Binding, Competitive; Dobutamine; Down-Regulation; Female; Heart Failure; Humans; Iodocyanopindolol; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Pindolol; Quinazolines; Receptors, Adrenergic, beta; Terbutaline | 1992 |
[A study on the human beta-receptor regulation by dobutamine and propranolol].
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Propranolol; Receptors, Adrenergic, beta; Up-Regulation | 1992 |
Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Iodobenzenes; Male; Middle Aged; Myocardial Contraction; Neurons; Norepinephrine; Radionuclide Imaging; Receptors, Adrenergic, beta | 1992 |
Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
Topics: Adult; Cardiac Output; Cardiomyopathy, Dilated; Chronic Disease; Coronary Vessels; Dobutamine; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neuropeptide Y; Norepinephrine; Sympathetic Nervous System | 1992 |
Late doxorubicin cardiotoxicity.
Topics: Coronary Angiography; Dobutamine; Doxorubicin; Female; Heart Failure; Humans; Middle Aged; Time Factors; Ventricular Function, Left | 1992 |
Effect of dobutamine on pulmonary gas exchange in patients with severe heart failure.
Topics: Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Gas Exchange | 1992 |
Continuous measurement of the pressure-volume relationship in experimental heart failure produced by rapid ventricular pacing in conscious dogs.
Topics: Animals; Blood Pressure; Blood Volume; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiac Volume; Diastole; Dobutamine; Dogs; Heart Failure; Heart Rate; Manometry; Models, Cardiovascular; Myocardial Contraction; Stroke Volume; Ventricular Function, Left | 1992 |
Dobutamine-induced fever.
Topics: Aged; Dobutamine; Female; Fever; Heart Failure; Humans; Vancomycin | 1992 |
Ventricular-load optimization in patients with heart failure.
Topics: Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Phenylephrine; Ventricular Function, Left | 1992 |
Ventricular contractility evaluated by mechanical perturbation of the myocardium--experimental and clinical approach adopting small amplitude vibration input.
Topics: Animals; Dobutamine; Dogs; Heart Failure; Humans; Myocardial Contraction; Propranolol; Ventricular Function, Left; Vibration | 1992 |
Effects of cardiovascular drugs on oxygen consumption/oxygen delivery relationship in patients with congestive heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Catheterization, Swan-Ganz; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxygen Consumption; Phosphodiesterase Inhibitors; Pulmonary Edema | 1992 |
Perioperative management of a case of severe peripartum cardiomyopathy.
Topics: Adult; Captopril; Cardiomegaly; Cesarean Section; Critical Care; Digoxin; Dobutamine; Dopamine; Female; Furosemide; Heart Failure; Heparin; Humans; Potassium; Pregnancy; Pregnancy Complications, Cardiovascular | 1992 |
[Additive effects of milrinone and dobutamine in severe heart failure].
Topics: Aged; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Pyridones | 1992 |
Effects of beta-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle.
Topics: Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Receptors, Adrenergic, beta; Ventricular Function, Left | 1991 |
Acute effects of beta-adrenergic stimulation with dobutamine on the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with chronic heart failure.
Topics: Aged; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Chronic Disease; Cyclic GMP; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1991 |
Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Catecholamines; Dihydropyridines; Dobutamine; Dogs; Electric Stimulation; GTP-Binding Proteins; Heart Failure; Heart Rate; Hemodynamics; Pertussis Toxin; Receptors, Adrenergic, beta; Virulence Factors, Bordetella | 1991 |
Combined intravenous pharmacotherapy in the treatment of patients with decompensated congestive heart failure.
Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Goals; Heart Failure; Heart Transplantation; Humans; Injections, Intravenous; Phosphodiesterase Inhibitors; Vasodilator Agents | 1991 |
Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Aorta; Blood Pressure; Dobutamine; Dogs; Heart Failure; Heart Rate; Isoproterenol; Myocardial Contraction; Myocardium; Nadolol; Norepinephrine; Receptors, Adrenergic, beta | 1991 |
Acute neurohormonal and hemodynamic response to a new peak III phosphodiesterase inhibitor (ICI 153,110) in patients with chronic heart failure.
Topics: Dihydropyridines; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Norepinephrine; Phosphodiesterase Inhibitors; Pyridazines; Renin | 1990 |
Two weeks of intermittent dobutamine therapy restores cardiac performance and inotropic responsiveness in conscious rats with heart failure.
Topics: Animals; Coronary Vessels; Dobutamine; Drug Administration Schedule; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Myocardial Infarction; Rats; Rats, Inbred Strains | 1991 |
Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure.
Topics: Adult; Aged; Albuterol; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Dobutamine; Female; Furosemide; Heart Failure; Heart Rate; Hematocrit; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardium; Pulmonary Wedge Pressure | 1991 |
Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
Topics: Cardiac Volume; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Myocardial Contraction; Phosphodiesterase Inhibitors; Radionuclide Angiography; Stroke Volume | 1991 |
Could glucose-insulin-potassium be considered only a step of a complete nutritional program for complicated cardiac patients?
Topics: Cardiopulmonary Bypass; Chronic Disease; Dobutamine; Glucose; Heart Failure; Humans; Insulin; Parenteral Nutrition; Potassium | 1991 |
[Hemodynamic changes in patients with myocardial infarct complicated by acute left ventricular failure during combined nitroglycerin and dobutamine therapy].
Topics: Aged; Blood Pressure; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Nitroglycerin | 1991 |
Mechanics of contraction and relaxation of the ventricle in experimental heart failure produced by rapid ventricular pacing in the conscious dog.
Topics: Animals; Cardiac Pacing, Artificial; Dobutamine; Dogs; Heart Failure; Imidazoles; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Ventricular Function, Left | 1991 |
Dobutamine stress testing in chronic heart failure--dose-response effects assessed by echo-Doppler.
Topics: Aged; Chronic Disease; Dobutamine; Drug Administration Schedule; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1991 |
Physical and pharmacological conditioning in chronic heart failure: a proposal for pulsed inotrope therapy.
Topics: Chronic Disease; Dobutamine; Drug Administration Schedule; Exercise Therapy; Heart Failure; Humans | 1991 |
Usefulness of hydralazine to withdraw from dobutamine in severe congestive heart failure.
Topics: Adult; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male | 1991 |
Effects of short-term administration of dobutamine on left ventricular performance, exercise capacity, norepinephrine levels, and lymphocyte adrenergic receptor density in congestive heart failure.
Topics: Dobutamine; Heart Failure; Hemodynamics; Humans; Lymphocytes; Male; Middle Aged; Norepinephrine; Physical Exertion; Receptors, Adrenergic, beta; Ventricular Function, Left | 1990 |
Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Ethanolamines; Female; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Stimulation, Chemical | 1990 |
Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output.
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Male; Middle Aged; Time Factors; Urine | 1990 |
[Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
Topics: Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Heart Failure; Hemodynamics; Humans; Vasodilator Agents | 1990 |
Effects of chronic dobutamine on cardiac mechanics and biochemistry after myocardial infarction in rats.
Topics: Animals; Contractile Proteins; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; In Vitro Techniques; Myocardial Infarction; Myocardium; Organ Size; Oxygen Consumption; Rats; Rats, Inbred Strains; Time Factors | 1991 |
[Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Pyridones | 1991 |
Ventricular-load optimization by inotropic stimulation in patients with heart failure.
Topics: Adult; Aged; Dobutamine; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Oxygen Consumption; Stroke Volume; Ventricular Function, Left | 1991 |
Systolic time intervals as indicators for cardiac function in rat models for heart failure.
Topics: Age Factors; Animals; Blood Flow Velocity; Captopril; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Heart Ventricles; Humans; Hypertension; Milrinone; Myocardial Infarction; Pyridones; Rats; Rats, Inbred SHR; Systole | 1990 |
[Medical strategy in patients awaiting emergency heart transplantation].
Topics: Adult; Assisted Circulation; Cardiac Output, Low; Cardiotonic Agents; Contraindications; Critical Care; Diuretics; Dobutamine; Dopamine; Emergencies; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Shock, Cardiogenic | 1990 |
Intra-cellular electrolyte changes and levels of endogenous digoxin-like substance within the plasma in patients with congestive heart failure.
Topics: Adult; Aged; Blood Proteins; Cardenolides; Digoxin; Dobutamine; Electrolytes; Erythrocyte Membrane; Female; Heart Failure; Humans; Male; Middle Aged; Monitoring, Physiologic; Saponins; Sodium-Potassium-Exchanging ATPase | 1990 |
A new direction for dobutamine.
Topics: Aged; Dobutamine; Heart Failure; Home Care Services; Humans; Infusions, Intravenous; Male; Patient Discharge | 1990 |
Outpatient dobutamine for end-stage congestive heart failure.
Topics: Adult; Aged; Ambulatory Care; Catheterization, Peripheral; Dobutamine; Heart Failure; Humans; Infusion Pumps; Infusions, Intravenous; Middle Aged | 1990 |
[Short-term dobutamine therapy in severe cardiac insufficiency].
Topics: Adult; Aged; Dobutamine; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Lidocaine; Male; Middle Aged | 1990 |
Inotropic response to dobutamine in elderly patients with decompensated congestive heart failure.
Topics: Aged; Aged, 80 and over; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Stimulation, Chemical | 1990 |
Effect of inotropic and vasodilator therapy on left ventricular diastolic filling in dogs with severe left ventricular dysfunction.
Topics: Animals; Diastole; Disease Models, Animal; Dobutamine; Dogs; Echocardiography; Ferricyanides; Heart Failure; Hemodynamics; Myocardial Contraction; Nitroprusside | 1990 |
Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure.
Topics: Dobutamine; Femoral Vein; Heart Failure; Hemodynamics; Humans; Hydrogen-Ion Concentration; Leg; Magnetic Resonance Spectroscopy; Middle Aged; Muscles; Oxygen Consumption; Phosphorus; Regional Blood Flow | 1990 |
Oxygen uptake/supply dependency. Effects of short-term dobutamine infusion.
Topics: Acidosis, Lactic; Aged; Bacterial Infections; Dobutamine; Female; Heart Failure; Humans; Lactates; Lactic Acid; Male; Middle Aged; Oxygen Consumption; Oxyhemoglobins; Respiration, Artificial; Respiratory Distress Syndrome | 1990 |
Intermittent dobutamine infusion in severe chronic heart failure in elderly patients.
Topics: Aged; Chronic Disease; Clinical Protocols; Dobutamine; Drug Administration Schedule; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male | 1990 |
Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
Topics: Aged; Captopril; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurosecretory Systems; Nitroglycerin; Time Factors; Vasodilator Agents | 1987 |
Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Dobutamine; Dogs; Heart Failure; Hemodynamics; Male; Milrinone; Pyridones; Regional Blood Flow; Vasodilator Agents | 1987 |
Chronic therapy of severe heart failure with enoximone.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged | 1989 |
A one-sided affair? Myocardial infarction with pulmonary edema and forward failure.
Topics: Aged; Dobutamine; Female; Furosemide; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; Posture; Pulmonary Edema; Radiography | 1989 |
Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure.
Topics: Aged; Cardiac Catheterization; Cardiac Output; Dobutamine; Echocardiography, Doppler; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Nitroglycerin; Stroke Volume | 1989 |
Potentiation of the effects of enoximone by a dobutamine infusion.
Topics: Aged; Aged, 80 and over; Cardiac Output; Dobutamine; Drug Synergism; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Humans; Imidazoles; Phosphodiesterase Inhibitors | 1989 |
[Severe cardiac decompensation: value in the early hours of a combination of amrinone and dobutamine].
Topics: Aged; Aged, 80 and over; Amrinone; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Stimulation, Chemical | 1989 |
The effect of dobutamine on myocardial performance and high-energy phosphate metabolism at different stages of heart failure in cardiomyopathic hamsters: a 31P MRS study.
Topics: Adenosine Triphosphate; Animals; Cricetinae; Dobutamine; Heart; Heart Failure; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Mesocricetus; Myocardium; Oxygen Consumption; Phosphates; Phosphocreatine | 1989 |
Assessing cardiac pumping capability by exercise testing and inotropic stimulation.
Topics: Adult; Aged; Cardiac Output; Cardiomyopathy, Dilated; Dobutamine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Stimulation, Chemical | 1989 |
[Acute postoperative psychosyndromes. A prospective study and multivariate analysis of risk factors].
Topics: Adult; Aged; Aged, 80 and over; Brain Damage, Chronic; Delirium; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Neurocognitive Disorders; Oxygen; Postoperative Complications; Prospective Studies; Respiration, Artificial; Risk Factors; Tomography, X-Ray Computed | 1989 |
Dynamics of functional mitral regurgitation during dobutamine therapy in patients with severe congestive heart failure: a Doppler echocardiographic study.
Topics: Aged; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Stroke Volume | 1989 |
Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs.
Topics: 5'-Nucleotidase; Adenylyl Cyclases; Animals; Chlorides; Colforsin; Dihydroalprenolol; Dobutamine; Dogs; Guanylyl Imidodiphosphate; Heart Failure; Hemodynamics; In Vitro Techniques; Isoproterenol; Kinetics; Manganese; Manganese Compounds; Myocardium; Norepinephrine; Nucleotidases; Receptors, Adrenergic, beta | 1987 |
Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
Topics: Catecholamines; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Middle Aged; Milrinone; Myocardial Contraction; Pyridones; Receptors, Adrenergic, beta | 1988 |
[The sympathetic nervous activity and beta-adrenergic receptor function in congestive heart failure].
Topics: Bucladesine; Dobutamine; Heart Failure; Humans; Lymphocytes; Norepinephrine; Receptors, Adrenergic, beta; Sympathetic Nervous System | 1987 |
Cardiovascular effects of dibutyryl cyclic AMP in patients with congestive heart failure--comparison with dobutamine and captopril.
Topics: Aged; Blood Pressure; Bucladesine; Captopril; Cardiac Output; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Vascular Resistance | 1988 |
The role of adrenergic and dopamine receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Adrenergic; Receptors, Dopamine | 1985 |
[Positive inotropic agents. Generalities and classification].
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Calcium; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Ethanolamines; Heart Failure; Heart Ventricles; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Practolol; Prenalterol | 1985 |
Comparison of the renal and pulmonary hemodynamic effects of fenoldopam, dobutamine, dopamine and norepinephrine in the anesthetized dog.
Topics: Animals; Benzazepines; Cardiotonic Agents; Dobutamine; Dogs; Dopamine; Female; Fenoldopam; Heart Failure; Humans; Male; Norepinephrine; Pulmonary Circulation; Renal Circulation; Vascular Resistance | 1988 |
[Use of new inotropic agents in the treatment of acute cardiac failure].
Topics: Adrenergic Agonists; Amrinone; Calcium Channel Blockers; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones | 1988 |
Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? III. Antagonist's viewpoint.
Topics: Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Chronic Disease; Death, Sudden; Dobutamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1988 |
[Effects of prazosin, SGB-1534, dobutamine and isoproterenol on congestive heart failure in dogs].
Topics: Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Dobutamine; Dogs; Heart Failure; Hemodynamics; Isoproterenol; Prazosin; Quinazolines | 1988 |
Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.
Topics: Coronary Circulation; Coronary Vessels; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1989 |
Effect of dobutamine on plasma potassium in congestive heart failure secondary to idiopathic or ischemic cardiomyopathy.
Topics: Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Potassium | 1989 |
Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathies; Cardiomyopathy, Dilated; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged | 1986 |
Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
Topics: Aged; Arginine Vasopressin; Cardiotonic Agents; Depression, Chemical; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Norepinephrine; Renin; Stimulation, Chemical | 1986 |
Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy.
Topics: Administration, Oral; Cardiac Output; Cardiotonic Agents; Dobutamine; Drug Evaluation; Enoximone; Heart Failure; Heart Rate; Humans; Imidazoles; Injections, Intravenous; Physical Exertion | 1986 |
Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?
Topics: Amrinone; Cardiotonic Agents; Digoxin; Dobutamine; Enoximone; Ethanolamines; Heart; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Imidazoles | 1986 |
General overview and update of positive inotropic therapy.
Topics: Amrinone; Blood Pressure; Cardiotonic Agents; Digitoxin; Dobutamine; Dopamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoproterenol; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Time Factors | 1986 |
New positive inotropic drugs for the treatment of congestive heart failure.
Topics: Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Dipeptides; Dobutamine; Enalapril; Heart Failure; Humans; Milrinone; Myocardial Contraction; Pyridones; Stimulation, Chemical; Vascular Resistance; Vasodilator Agents | 1985 |
Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response.
Topics: Adult; Biopsy; Calcium Gluconate; Cardiac Catheterization; Dobutamine; Endocardium; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Radioligand Assay; Receptors, Adrenergic, beta | 1986 |
Synergistic effect of captopril and dobutamine on left ventricular pressure-volume and pressure-shortening relations in severe cardiac failure.
Topics: Aged; Blood Pressure; Captopril; Cardiac Output; Cardiac Volume; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Stroke Volume | 1988 |
[Therapy of acute heart failure].
Topics: Acute Disease; Combined Modality Therapy; Digitalis Glycosides; Dobutamine; Dopamine; Drug Therapy, Combination; Epinephrine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Nitroglycerin; Norepinephrine; Oxygen; Vascular Resistance | 1986 |
Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
Topics: Aged; Blood Pressure; Catecholamines; Dobutamine; Enoximone; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged; Pulmonary Artery; Stroke Volume; Vascular Resistance | 1985 |
CI-930, a new cardiotonic and vasodilating agent: hemodynamic comparison to dobutamine and long-term clinical effects.
Topics: Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Middle Aged; Phosphodiesterase Inhibitors; Pyridazines; Time Factors | 1988 |
Dobutamine rescue for intractable CHF.
Topics: Chronic Disease; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Monitoring, Physiologic | 1988 |
Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy.
Topics: Adult; Amrinone; Arginine Vasopressin; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Renin; Renin-Angiotensin System | 1987 |
[Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
Topics: Animals; Captopril; Dobutamine; Heart Failure; Hemodynamics; Male; Milrinone; Muscles; Myocardial Infarction; Pyridones; Rats; Rats, Inbred Strains; Regional Blood Flow; Renal Circulation; Skin; Splanchnic Circulation | 1987 |
Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of isosorbide dinitrate, dobutamine and captopril.
Topics: Animals; Captopril; Cardiomyopathies; Dobutamine; Doxorubicin; Heart Failure; Hemodynamics; Isosorbide Dinitrate; Rabbits; Regional Blood Flow | 1987 |
Inotropic therapy for cardiac failure associated with acute myocardial infarction.
Topics: Amrinone; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Myocardial Infarction; Vasodilator Agents | 1988 |
Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
Topics: Blood Pressure; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Myocardial Contraction; Neurosecretory Systems; Norepinephrine; Vascular Resistance; Vasodilation | 1988 |
[Determination of active components of amrinone by analysis of pressure-volume results; use of the conductance (volume) catheter technic and rapid load change by balloon occlusion of the inferior vena cava].
Topics: Amrinone; Cardiac Catheterization; Cardiac Output, Low; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardium; Nitroprusside; Oxygen Consumption | 1987 |
[Combination of different inotropic agents in the treatment of chronic refractory cardiac insufficiency].
Topics: Amrinone; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1987 |
Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infant, Newborn; Myocardial Contraction | 1987 |
Short- and long-term dobutamine treatment in chronic ischemic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Radionuclide Angiography; Stroke Volume; Time Factors | 1987 |
Hemodynamic and regional blood flow response to piroximone (MDL 19,205) in dogs with congestive heart failure: a comparison with dobutamine.
Topics: Animals; Coronary Circulation; Dobutamine; Dogs; Heart Failure; Heart Rate; Hemodynamics; Imidazoles; Regional Blood Flow | 1987 |
[Effects of dobutamine on hemodynamics, myocardial metabolism and mechanical efficiency in patients with old myocardial infarctions].
Topics: Adult; Aged; Coronary Circulation; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Vascular Resistance | 1987 |
Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.
Topics: Adult; Aged; Ambulatory Care; Cardiac Output; Chronic Disease; Dobutamine; Dopamine; Equipment Failure; Female; Heart Failure; Humans; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; Stroke Volume | 1987 |
Prolonged beneficial effects of dobutamine in refractory heart failure--case histories.
Topics: Dobutamine; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Time Factors | 1987 |
[Treatment of cardiac insufficiency in adults].
Topics: Adult; Anticoagulants; Digitalis Glycosides; Diuretics; Dobutamine; Heart Failure; Humans; Isoproterenol; Vasodilator Agents | 1986 |
Beta-adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion.
Topics: Blood Pressure; Coronary Vessels; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Injections; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Sympathomimetics | 1987 |
The hemodynamic effects of ventricular pacing with and without atrioventricular synchrony in patients with normal and diminished left ventricular function.
Topics: Adult; Aged; Aged, 80 and over; Atrioventricular Node; Cardiac Pacing, Artificial; Dobutamine; Female; Heart Conduction System; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Syncope | 1987 |
Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside.
Topics: Adult; Aged; Dobutamine; Drug Administration Schedule; Ferricyanides; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside; Radionuclide Imaging | 1987 |
Acute hemodynamic effects of dopamine, dobutamine, and isoproterenol in congested infants or young children with large ventricular septal defect.
Topics: Dobutamine; Dopamine; Heart Failure; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Infant; Isoproterenol; Pulmonary Circulation | 1987 |
[Tolerance development during a 1-week course of dobutamine treatment].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Dobutamine; Drug Tolerance; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Stimulation, Chemical; Water-Electrolyte Balance | 1986 |
Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Dobutamine; Drug Synergism; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Stroke Volume | 1986 |
[Effects of intravenous amrinone (Win 40680) on heart failure complicated by acute myocardial infarction: comparative study with dopamine and dobutamine].
Topics: Aged; Amrinone; Dobutamine; Dopamine; Female; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction | 1986 |
Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure.
Topics: Aged; Ambulatory Care; Cardiac Output; Dobutamine; Follow-Up Studies; Heart Failure; Humans; Infusion Pumps; Male; Middle Aged; Time Factors | 1986 |
Effects of intravenous amrinone on heart failure complicated by acute myocardial infarction: comparative study with dopamine and dobutamine.
Topics: Aged; Amrinone; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction | 1986 |
Drug therapy for congestive heart failure.
Topics: Amrinone; Dobutamine; Heart Failure; Humans | 1986 |
The value of mixed venous oxygen saturation as a therapeutic indicator in the treatment of advanced congestive heart failure.
Topics: Cardiac Output; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Monitoring, Physiologic; Oxygen; Prognosis; Veins | 1987 |
Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Cardiovascular Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Drug Administration Schedule; Edema; Heart Diseases; Heart Failure; Heart Rate; Hemodynamics; Horse Diseases; Horses; Injections, Intravenous; Lidocaine; Procainamide; Propranolol; Quinidine | 1985 |
[Significance of nitrates in acute therapy of heart failure with and without lung edema].
Topics: Cardiac Output, Low; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Pulmonary Edema; Regional Blood Flow; Shock, Cardiogenic | 1985 |
Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure.
Topics: Cardiac Output; Dobutamine; Exercise Test; Heart Failure; Humans; Male; Middle Aged; Physical Exertion; Prazosin; Pulmonary Gas Exchange; Pulmonary Wedge Pressure | 1986 |
Chronic congestive heart failure. Where have we been? Where are we heading?
Topics: Aminopyridines; Amrinone; Biopsy; Calcium Channel Blockers; Cardiology; Chronic Disease; Digitalis; Dobutamine; Dopamine; Forecasting; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Contraction; Myocardium; Plants, Medicinal; Plants, Toxic; Prognosis; Quality of Life; Vasodilator Agents | 1986 |
Arrhythmias associated with intermittent outpatient dobutamine infusion.
Topics: Ambulatory Care; Arrhythmias, Cardiac; Dobutamine; Heart Failure; Humans; Infusions, Parenteral | 1986 |
Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Computers; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Nitroprusside; Pulmonary Circulation; Vascular Resistance | 1986 |
Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.
Topics: Aged; Coronary Circulation; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Myocardium; Pyridones | 1986 |
Outpatient dobutamine infusion using a totally implantable infusion pump for refractory congestive heart failure.
Topics: Aged; Ambulatory Care; Catecholamines; Dobutamine; Equipment Design; Heart Failure; Humans; Infusions, Parenteral; Male; Prostheses and Implants | 1985 |
Comparative vasoactive therapy for heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Tachycardia; Vascular Resistance | 1985 |
Pathophysiology of cardiac failure.
Topics: Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; Furosemide; Heart; Heart Failure; Humans; Myocardial Contraction; Nitroprusside; Norepinephrine; Oxygen Consumption; Vascular Resistance; Vasoconstriction | 1985 |
[Regional left ventricular function in dilated cardiomyopathy: observation of regional left ventricular wall motion before and during dobutamine administration].
Topics: Adult; Cardiomyopathy, Dilated; Dobutamine; Echocardiography; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve; Myocardial Contraction; Papillary Muscles; Prognosis | 1985 |